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Chapter 1
Introduction
In studies in human genetics we want to answer questions such as: how im-
portant are genetic effects on a phenotype; what kind of action and interaction
exists between gene products in the pathways between genotypes and pheno-
type; are the genetic effects on a phenotype consistent across sexes; do some
genes have particularly outstanding effects when compared to others; what are
the locations of the genes involved in the phenotype of interest (Neale and Car-
don, 1992)? Twin studies and association studies as described in this thesis are
designed to answer the first and the last questions in this list.
A twin study is designed to determine genetic and environmental influences
on phenotypes by comparing the similarity of monozygotic (identical) and the
similarity of dizygotic (fraternal) twins. Structural equation models of uni-
variate and multivariate phenotype data can be used to decompose genetic,
shared and unshared environmental components. Usually these models are fit-
ted to data using the method of maximum likelihood. However, this method
of estimation is difficult to implement when applied to highly complex models
(e.g. models including gene-by-environment interaction and gene-environment
correlation, item-response measurement models, repeated mesures, longitudinal
structures, extended pedigrees) (van den Berg et al., 2006b). Bayesian meth-
ods provide an alternative to overcome some of these problems. Models that
require estimation of parameters related to e.g. longitudinal genetic correlations
or epistasis, must be based on appropriate designs. In the first part of this thesis
we describe a Bayesian approach to model twin data in order to estimate the
genetic component of univariate and multivariate categorical phenotypes.
There are two broad approaches for mapping complex diseases: linkage stud-
ies and association studies. Linkage studies are based on studying genotypes
and phenotypes in families (pedigrees), and infer genetic determinants from the
patterns of inheritance observed among the members of the pedigree. Only the
inheritance of genotypes at so-called marker loci can be (partially) observed. If
the inheritance pattern at a marker locus is consistent, in a broad sense, with
the observed patterns of the phenotypes, then the marker is inferred to be linked
to a functional or causal locus for the phenotype, i.e. the marker is then in the
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proximity of such a locus and shares its inheritance patterns to a certain degree.
Although the twin design is one of the possibilities for a linkage study, we do
not discuss linkage methods in this thesis. For a review of linkage studies, see
Ott (1999).
Association studies have recently received more interest. They are thought
either to allow more precise localization of disease susceptibility genes, or to
be more powerful altogether, although these claims are being debated. See for
instance, Balding (2006) and Terwilliger and Hiekkalinna (2006). Association
studies can be classified in case-control studies and family-based association
studies. The latter, which include for instance studies based on the Transmis-
sion Disequilibrium Test (TDT), reenter an element of linkage into the analysis
by including some genetic data on family members (e.g. sibships or parents).
This has the purpose to correct for possible artefacts (spurious correlations) in
case-control studies. In this thesis we focus on case-control studies, which sim-
ply compare the genotypes of individuals who have a disease (cases) with the
genotype of individuals without the disease (controls). The proportions in each
group having a characteristic of interest (for instance the numbers of alleles of
a given type) are then compared to determine whether there is an association
between the disease and the characteristic of interest.
Just as linkage studies association studies must use markers in the analy-
sis, these being by definition the observable characteristics of the genome. In
this thesis we study in particular methods based on Single Nucleotide Poly-
morphisms (SNPs). Such markers may be measured to investigate a particular
target region of the genome, for “fine-mapping” a functional gene. Increasingly
SNP data are also gathered all across the genome (e.g. 10000 SNPs). Whole-
genome analysis is focused on scanning this complete set of markers. A simple
case-control test applied to this multitude of markers, or set of markers, would
of course lead to many false positives, whence a correction is necessary. In the
second part of the thesis we describe several methods to analyze SNP data,
using single or multiple SNPs, and next apply them to whole-genome SNP data
with appropriate correction procedures, including Bayesian approaches.
An outline of the thesis is as follows. In the remainder of the present chap-
ter we provide short reviews of twin studies and association studies. In the
second chapter we describe statistical modeling in twin studies in more detail
and discuss Bayesian methods to estimate the genetic component of phenotypes
of interest. In Chapter 3 we describe several methods to analyze SNP data
in a case-control study, such as the Chi-square Test, the Likelihood Ratio Test,
generalized T 2 Test, and Logistic Regression. Next two Bayesian approaches for
the same purpose of analyzing SNP data are presented in Chapter 4. Finally, in
Chapter 5 we show how to analyse whole-genome SNP data, using the methods
described in the previous chapters as basis.
2
1.1 Twin and Family Studies
Consider a phenotype or quantitative trait X of an individual chosen at random
from a population. We assume that the quantitative trait X follows the additive
model
X = f(G) + F,
where f(G) and F are the genetic and environmental component, respectively.
Furthermore, we assume that G and F are independent.
When we consider two individuals, with traits X1 and X2, we must deal
with two environmental influences. A common model is to introduce a shared
(common) environmental factor C and unshared (specific) environmental factors
E1 and E2, and to assume that these factors are independent and act additively.
The model can be expressed as
X1 = f(G1) + C +E1,
X2 = f(G2) + C +E2,
where (G1, G2), C, E1, E2 are independent, andE1, E2 are identically distributed.
The genetic factors f(Gi) are often further decomposed as f(Gi) = Ai + Di,
where the additive genetic effect Ai and dominance effect Di are again assumed
independent (or at least uncorrelated). The joint distributions of (A1, A2) and
(D1, D2) reflect the genetic relationship of the two individuals. We come back
to this later. The model is known as the ADCE model. When the dominance
factor is absent, the model is known as the ACE model.
Biometrical Analysis
Given a trait with decomposition X = f(G) + F, the heritability is defined as
the fraction genetically determined variance as follows
Var(f(G))
Var(X)
=
Var(f(G))
Var(f(G)) + Var(F )
.
This quantity can be estimated from the observed trait values of relatives, under
some assumptions.
In the ACDE model and under conditions of equilibrium and random mating
the variance and covariances of the traits X1 and X2 of two relatives can be
decomposed as
Var(X1) = Var(X2) = σ
2
A + σ
2
D + σ
2
C + σ
2
E ,
Cov(X1, X2) = 2Ψσ
2
A + ∆σ
2
D + σ
2
C . (1.1.1)
Here σ2A, σ
2
D , σ
2
C , σ
2
E are additive, dominance, shared environment and unshared
environment variances, respectively, and Ψ and ∆ are coefficients, called the kin-
ship and fraternity coefficient, that depend on the type of relation between the
relatives (see for instance Lange, 2002). If we have a random sample of traits
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of relatives, then the left hand sides can be estimated from the observed data.
Replacing the variance and covariance at the left side by their estimates, we ob-
tain equations that may be solved to find estimates for the unknown parameters
σ2A, σ
2
D, σ
2
C , σ
2
E . Somewhat better estimates are obtainable by maximum like-
lihood or Bayesian methods, provided approximate distributional assumptions
can be made.
Equations (1.1.1) are linear equations in four unknowns and we need at least
four independent equations to identify the parameters. This may be achieved
by sampling relatives of various kinds, leading to different pairs of kinship and
fraternity coefficients Ψ and ∆. Here we should be careful that the shared
environment variances may vary with the different relatives also, and perhaps
must be represented by multiple parameters. Also, the genetic parameters may
be different in veralites of different ages. Another possibility to reduce the
number of parameters is to assume that the dominance variance is zero.
Twin Design
Monozygotic (MZ) and dizygotic (DZ) twins can be viewed as comparable in
all respects except genetic set-up. In particular, the environmental variances
for monozygotic and dizygotic twin relatives could be modeled by the same
parameter. Because monozygotic twins are genetically identical, their kinship
and fraternity coefficients are 1/2 and 1. The genetic relationship of dizygotic
twins differs not from ordinary sibs, their kinship and fraternity coefficients can
be computed to be 1/4 and 1/4 (see Lange, 2002).
Given random samples both of monozygotic and dizygotic twins, the correla-
tion between their traits can be estimated by the sample correlation coefficients,
say rMZ and rDZ . It follows from the preceding that the true correlation co-
efficient ρMZ and ρDZ satisfy, with σ
2 the variance of the trait of an arbitrary
person,
ρMZ =
σ2A + σ
2
D + σ
2
C
σ2
,
ρDZ =
1
2σ
2
A +
1
4σ
2
D + σ
2
C
σ2
.
If we assume that the dominance variance σ2D is 0, then this can be solved to
give the fraction of genetic variance
σ2A
σ2
= 2(ρMZ − ρDZ).
This can be estimated by replacing the correlation coefficients on the right by
their estimates. Furthermore, the fraction of shared environmental variance can
be estimated by
σ2C
σ2
= 2ρDZ − ρMZ ,
and the fraction of unshared environmental variance can next be estimated by
σ2E
σ2
= 1− σ
2
A
σ2
− σ
2
C
σ2
.
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This method is known as the moment method.
Alternatives to the moment method are the method of maximum likelihood
and Bayesian estimation. Assuming normal distributions for the shared envi-
ronmental component C and the unshared environmental components E1, E2
leads to a bivariate normal distribution of the trait values, with mean vector
and covariance matrix of the form(
µ
µ
)
and σ2
(
1 ρ
ρ 1
)
.
The correlation coefficient ρ is different for monozygotic and dizygotic twins,
and satisfies, still under the assumption σ2D = 0,
ρMZ =
σ2A + σ
2
C
σ2
,
ρDZ =
1
2σ
2
A + σ
2
C
σ2
.
Thus the parameter can be taken as (µ, σ2, σ2A, σ
2
C), and ranges over
Θ = {(µ, σ2, σ2A, σ2C)|µ ∈ R, σ2A, σ2C ≥ 0, σ2 − σ2A − σ2C ≥ 0}.
The parameters can be estimated using the maximum likelihood method, or by
putting a prior on Θ and computing the corresponding posterior distribution.
Categorical Traits
The variance decomposition of a trait applies both to quantitative traits (which
by definition can assume a continuum of possible values) and traits that can
assume only finitely many values. However, for the latter “categorical” traits
the decompositions are often viewed as less appropriate as a starting point for
the analysis. It is often assumed that such a trait is the result of a hidden,
unobservable trait, called a liability. The observed trait, for instance “disease
or not”, “depression of a certain type or not depressed” would then correspond
to the liability exceeding or not exceeding certain thresholds.
Suppose we assume the existence of a normally distributed random variable
X which is related to the disease status Y of the individual by means of a
threshold model
Y =
{
0 if X ≤ b,
1 if X > b,
where b is a threshold parameter. Thus the individual is affected if the liability
X exceeds the threshold b. Since the random variable X is not observed, it is
not possible to identify its mean and variance, and we can set these parameters
without loss of generality equal to 0 and 1, respectively.
To estimate the heritability of a binary trait from trait data (Y1, Y2) on
pairs of relatives, we relate both Y1 and Y2 to liabilities X1 and X2 through a
threshold model as given, and model the pair of liabilities (X1, X2) through an
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ACE model as discussed previously. The heritability of the binary trait is then
by definition the proportion of genetic variance in the liabilities.
The distribution of the observed data (Y1, Y2) is given by the four probabil-
ities P (Y1 = y1, Y2 = y2), for y1, y2 ∈ {0, 1}, and is related to the distribution
of the liabilities by the equations
P (Y1 = 0, Y2 = 0) = P (X1 ≤ b,X2 ≤ b) =
∫ b
−∞
∫ b
−∞
f(x1, x2, ρ)dx1dx2,
P (Y1 = 0, Y2 = 1) = P (X1 ≤ b,X2 > b) =
∫ b
−∞
∫ ∞
b
f(x1, x2, ρ)dx1dx2,
P (Y1 = 1, Y2 = 0) = P (X1 > b,X2 ≤ b) =
∫ ∞
b
∫ b
−∞
f(x1, x2, ρ)dx1dx2,
P (Y1 = 1, Y2 = 1) = P (X1 > b,X2 > b) =
∫ ∞
b
∫ ∞
b
f(x1, x2, ρ)dx1dx2.
The density f is parameterized by (σ2A, σ
2
C) giving θ = (b, σ
2
A, σ
2
C) as the param-
eter of the model for the observations (Y1, Y2). The parameters can be estimated
by the method of maximum likelihood or a Bayesian method. Implementation
of a Bayesian method is described in detail in Chapter 2.
1.2 Association Studies
Genetic markers are loci on the genome whose state is (relatively) easy to mea-
sure. Because the complete sequencing of the genome is impossible for samples
of individuals, studies to identify genes responsible for disease susceptibility are
actually focused on finding such markers. It is hoped the causal disease genes
will lie in the proximity of markers that are associated to the disease.
There are several types of genetic markers. Restriction fragment length poly-
morphisms (RFLPs) are polymorphic differences in the size of allelic restriction
fragments as a result of the polymorphic presence or absence of a particular
restriction site. Short tandem repeats (STRs) (also called microsatellites) are
small runs (usually shorter than 0.1 kilo base pairs) of tandem repeats of a
very simple DNA (Deoxiribonucleic Acid) sequence, usually 1 to 4 base pairs,
for example (CA)n, where nucleotide C and A are cytosine and adenine, re-
spectively. Finally, a single nucleotide polymorhism (SNP, pronounced snip) is
a DNA sequence variation involving a single nucleotide (adenine (A), thymine
(T), cytosine (C) or guanine (G)) in the genome. For example, the base pair se-
quences TAGATA and TGGATA differ in the second nucleotide. The complete
human genome consists of 3 × 109 base pairs, of which around 10 million are
thought to occur in (at least) two variants each with frequency bigger than 1%
in the human population. The restriction on the prevalence exceeding 1% rules
out single nucleotides that occur essentially in one form with only extremely
rare variants, which are usually understood not to be proper SNPs. Modern
technology has made the measurement of large numbers of SNPs (up to 500K)
in single individuals relatively inexpensive, and it is thought that SNPs will play
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a central role for mapping complex diseases in the near future. One potential
disavantage of SNPs is that with current technology the various SNPs are ob-
served in (unordered) pairs for the two chromosomes, one SNP at a time. Thus
phase information (i.e. paternal and maternal origins) is absent, and haplotypes
are not directly observed.
Traditional association studies begin with a candidate gene or genetic region
that researchers already suspect is associated with the disease. This approach
will type markers near the gene and proceed by investigating association of these
markers to the disease. New genes or genetic regions that might be associated
are not identified.
In contrast whole-genome association studies are focused on discovering
novel genes. The genomes of samples of diseased people (cases) and healthy
people (controls) are typed at markers (in particular SNPs) spread over the
whole genome, without prior knowledge about regions that may be associated
to the disease. It is thought that it suffices to type approximately 300K well
chosen SNPs to cover the whole genome, the remaining 10000K minus 300K
SNPs being in strong correlation with this subset. The international HapMap
project is a major undertaking with one of its purposes to create a set of SNPs
spanning the genome that is representative for the full set of SNPs, and is ex-
pected to accelerate whole-genome association studies. For this thesis we have
worked with data from 10K SNP arrays.
A case-control association study proceeds by comparing markers between
random samples of cases and controls. The strategy to compare markers rather
than the full genomes can be successful only if the population is in linkage dise-
quilibrium (DE) or if the causal loci are among the measured markers. Indeed,
linkage equilibrium (LE) is by definition that the loci on a randomly drawn hap-
lotype from the population are independent, so under LE a marker would never
be informative about any other locus than itself. In order to find a causal locus,
LD between the causal locus and an observed marker locus is required. Because
pieces of chromosome are inherited rather than single loci, such linkage disequi-
librium is likely to exist for markers that are close to the disease locus, as these
will have a joint segregation history. Thus if we measure markers close enough
to the disease location, a two-sample (case and control) comparison approach
might work (van der Vaart, 2006).
The phrase association appears to refer both to the correlation between
the marker and the disease locus (i.e. LD) and to the correlation between
the marker and the disease (case-control status). The second correlation is of
course mediated by the first, and would therefore disappear as the population
would approach LE. In this context LD is thought to arise through mutations
at the disease locus, which are jointly segregated together with nearby marker
loci. Eventually (e.g. after repeatedly forming new populations under random
mating) recombinations would break up the disease alleles and marker alleles,
and the two loci would become independent in the population. Because the
process of recombination works faster if the two loci are more distant, it is hoped
that association is strong for markers near to the causal locus and decreases with
the distance between a marker and the causal locus.
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While the association between marker and disease loci makes the case-control
approach possible, it also creates potential difficulties. A case-control test will
flag any marker locus as associated to the disease that happens to be corre-
lated with a disease locus. Various confounding effects may cause two loci to be
correlated in the population without them being close on the genome. In partic-
ular, substructure in the population may lead to spurious correlation between
arbitrary loci on the genome. This is in agreement with Simpson’s paradox,
which says that two variables may well be uncorrelated given a third variable,
but correlated unconditionally. Very recently, there have been several attempts
to correct for population structure, but not all geneticists are convinced of the
superiority of association over linkage studies.
Formally, linkage disequilibrium between two loci can be defined as follows.
Given an allele A at the first locus and an allele B at the second LD can be
quantified by measuring the difference between pAB , the probability of observ-
ing haplotype AB (i.e. the linear arrangement of the two alleles on the same
chromosome sampled as a unit), and the product pApB , where pA and pB are
the probabilities of observing alleles A and B, respectively, i.e.
D = pAB − pApB .
Usually, the haplotype frequencies are not known, but can be estimated from
genotype data. In the case of two biallelic marker loci (e.g. SNP), we can
also define a standardized version of D, so that its range is from -1 to 1. One
possibility, apparently “preferred” by geneticists, is
D′ =
D
Dmax
,
where Dmax = min{pA(1− pB), (1− pA)pB} if D > 0 and
Dmax = min{(1− pA)(1− pB), pApB}
if D < 0. A large value of |D′| indicates strong LD between the two loci, while
D′ = 0 means that the two loci are statistically independent or two loci in
linkage equilibrium. An alternative standardization is the correlation coefficient
r between two loci as
r =
D√
pA(1− pA)pB(1− pB)
.
This second standardization is often preferred by statisticians, because it is
linked to the power of the chisquare test for testing association.
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Chapter 2
Statistical Modeling in
Twin Studies
The introduction of this chapter is taken from the introduction and methods
sections of the paper by van den Berg et al. (2006a). In this thesis, we only use
the data from the first cohort to explain how to model the data. In section 2,
we develop a statistical model for the menarcheal status in girls as a dichotomic
trait and estimate the tetrachoric correlation and the heritability. The model
can be extended to polychotomic trait, such as breast development and pubic
hair development (section 3). In section 4, we propose a model of two traits
and the model can be applied to breast-pubic hair development traits, breast-
menarcheal development traits and pubic hair-menarcheal development traits.
Finally, the full analysis of two cohorts using the whole data can be seen in van
den Berg et al. (2006a).
2.1 Introduction to the Data
Entering puberty, children undergo large changes in their physiology and phys-
ical appearance which will turn them into adults. All these changes can be re-
lated to the endocrine system, specifically the hypothalamic-pituitary-gonadal
(HPG) and the hypothalamic-pituitary-adrenal (HPA) axes. Gonadarche, or
reproductive puberty, results from a reactivation of the gonado-tropin-releasing
hormone (GnRH) pulse generator, which in girls leads to the stimulation of the
ovaries producing estradiol. Breast tissue is the primary target for estradiol and
therefore breast development is usually the first sign of puberty. Menarche most
often occurs in middle or late puberty.
Puberty actually consists of two independent but overlapping endocrine pro-
cesses. As opposed to gonadarche, adrenarche is the result of the activation of
the HPA axis which leads to increased concentrations of the three adrenal an-
drogens DHEA, DHEAS and androstenedione. These lead to pubic hair, body
odour and often acne. Adrenarche is a much more gradual process which may
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start at an age as early as six years in girls or even earlier and continues well
into the third decade of life (Dorn and Rotenstein, 2004).
There is quite some variability in the timing of the overt onset of puberty: it
may start at an age even as young as seven years. To some extent this variability
is related to pathologies that make some children enter puberty either very early
(precocious puberty) or relatively late (delayed puberty). What is called pre-
cocious, normal or delayed is based on statistical considerations (Palmert and
Boepple, 2001). Usually a deviance of 2-2.5 times the standard deviation from
the mean in the population is regarded as abnormal. Precocious puberty may
be the result of a lesion in the central nervous system, but often it is the result of
the same increase of GnRH secretion that is also the start of puberty in children
within the normal age-range; the only difference being its early start. Also with
delayed puberty onset, in most cases there seems to be no underlying pathology.
Therefore, most of the variation in puberty onset remains largely unexplained,
except that it is the direct result of increases in GnRH and androgen secretion
that start off a whole array of physiological changes. One motivation for study-
ing individual differences in pubertal timing and their aetiology is that early
puberty onset has consistently been shown to be associated with psychosocial
problems (Johansson and Ritzen, 2005).
In most countries the median age of puberty onset has been decreasing for
a long time, but seems to have stabilized during the nineties of the last century.
There still seems to be some decrease in the US (Herman-Giddens et al., 1997;
Herman-Giddens, Kaplowitz, and Wasserman, 2004), although this is disputed
by some (Styne, 2004; Coleman and Coleman, 2002). Precocity has been asso-
ciated with migrating children: children adopted from other countries mature
faster when compared with both foster country and country of origin (Parent
et al., 2003). In addition, there are reports that menarche is earlier in girls in
homes with absent fathers (e.g., Maestripieri et al., 2004). It is uncertain how-
ever to what extent these environmental correlations are indeed attributable to
non-genetic causes. For instance, the absent-father effect could be partially ex-
plained by the transmission of a particular allele of the androgen receptor gene
inherited from the father (Comings, Muhleman, Johnson, and MacMurray, 2002,
but see Jorm et al., 2003). Other (environmental) factors are nutrition-related,
particularly to food substances such as phyto-oestrogens and lignans (Muinck
Keizer-Schrama and Mul, 2001) and malnutrition in early and prenatal life (Da
Silva Faria, Fonte Ramos, and Sampaio, 2004; Veening, van Weissenbruch, Ro-
ord, and Delemarre-Van Waal, 2004). There also seems to be a relation between
the amount of body fat and delayed menarche (Frisch, 1996). But again, genetic
factors responsible for this association cannot be ruled out.
Be that as it may, these factors together explain only a small portion of the
total variability. There seem to be significant yet unexplained genetic influences
on pubertal timing, with heritability estimates up to 50 to 80% (Palmert and
Hirschhorn, 2003; Meyer et al., 1991; Loesch et al., 1995; Fischbein, 1977;
Sklad, 1977; Eaves et al., 2004) depending on phenotype definition and mode of
assessment. Molecular studies have found more direct evidence for the influence
of genes. The Oct-2 transcription factor, a homeodomain gene of the POU
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family, and the thyroid transcription factor-1 (TTF-1) have been associated
with the onset of puberty in female mammals (Ojeda et al., 1999; Ojeda et al.,
2000).
It is unknown to what extent the genes that explain individual differences in
age at menarche are the same genes as those involved in other processes related
to pubertal development, such as breast development and pubic hair growth.
There have been two recent reports on the heritability of different indicators of
puberty (Mustanski et al., 2004; Eaves et al., 2004) but both are based on com-
mon factor models that explicitly postulate one latent trait underlying several
indicator variables and do not allow for extra covariance between a subset of
indicators. Thus, the fact that there are two distinguishable endocrinological
processes is not taken into account in these models. This study therefore aims
at estimating the extent to which the same genes and the same environmental
factors are involved in individual differences in menarche, the timing of breast
development and pubic hair in females. Low genetic/environmental correlations
would indicate that timing of two pubertal phenotypes is influenced by differ-
ent genes/environmental factors. High correlations would indicate that, even
though the underlying processes may be different, their timing is influenced by
the same genetic/environmental factors. Since gonadarche and adrenarche are
determined by independent physiological processes, it is hypothesised that both
genetic and environmental correlations between menarche and breast develop-
ment are high, but their respective correlations with pubic hair development are
low.
Female twins came from two cohorts. The first cohort was 12 years old
in 1998, when data on pubertal status were obtained from female twins who
participated in a longitudinal study on hormone levels, cognition and behaviour
problems in children (Bartels et al., 2002). All participants were registered with
the Netherlands Twin Registry (NTR; Boomsma et al., 2002). There were 102
twin pairs with at least one data point on a female twin (mean age: 12.2 years,
SD = 0.2, range = 11.7 - 12.8). There were 35 monozygotic pairs with complete
data on both twins, and two monozygotic pairs with complete data on one twin
but incomplete data on the other twin. There were 33 same-sex dizygotic pairs
with complete data on both twins, one pair with data complete on only one twin
and incomplete data on the other, and one pair with incomplete data on both
twins. From the female twins with a male co-twin, 28 females had complete
data, and only two had incomplete data. Zygosity status of same-sex twins was
based on either DNA (15%) or blood polymorphisms (61%) or, if no DNA or
blood was available, questionnaire data (24%).
The second cohort consists of female twins who were 12 years old in 2003
and participated in a similar study. All twins were registered with the NTR
and were selected on the basis of age, zygosity and geography: children were
selected at the age of five and only if they lived within a 100 km radius from
Amsterdam (Groot et al., 2004). The parents of the twins were invited by mail to
participate in a study on neuropsychological development and attention. None
of the children suffered from severe physical or mental handicaps. Parents and
children signed an informed consent before participation. There were 82 twin
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pairs with at least one data point on a female twin (mean age: 12.4 years,
SD = 0.1, range = 12.1 - 12.9). There were 39 pairs of monozygotic female
twins with complete data on both twins, one pair with complete data on only
one twin, and three pairs with incomplete data on both twins. There were
11 pairs of same-sex dizygotic female twins with complete data on both twins,
two pairs with complete data on only one twin, and one pair with incomplete
data on both twins. There were 22 female twins with a male co-twin on whom
we had complete data; on three others we had incomplete data. Zygosity was
determined from DNA polymorphisms.
In the first cohort, female twins filled out an extended Tanner questionnaire
(based on Marshall and Tanner, 1969) asking about their menarche (no/yes),
breast development (5 ordered categories), and pubic hair development (5 cat-
egories). The categories consisted of drawn figures showing all stages of de-
velopment. In the second cohort, female twins filled out an extended Tanner
questionnaire asking about their menarche (no/yes), breast development (5 cat-
egories), and pubic hair development (6 categories). The categories were indi-
cated by photographs showing all stages of development. Tanner self-reports
correlate .82 with GP (physician) ratings (Coleman and Coleman, 2002).
To obtain estimates for heritabilities and genetic correlations based on cat-
egorical data, some assumptions need to be made. It was assumed that for
each variable, the frequencies in the different categories reflected a continuous
underlying normally distributed trait with a number of thresholds (Lynch and
Walsh, 1998; Falconer, 1965; Crittenden, 1961). When there were very few
observations in one category, adjacent categories were collapsed (for the first
cohort we had three categories for breast development and three for pubic hair;
for the second cohort, two and four respectively). Polychoric correlations were
calculated for the three phenotypes, separately for monozygotic and dizygotic
twins and for both cohorts. Modeling these correlations on the latent contin-
uous traits in monozygotic and dizygotic twins would then allow estimation of
heritabilities (based on within-trait, cross-twin correlations) and genetic corre-
lations (based on cross-trait, cross-twin correlations). It was assumed that, even
though slightly different measurement instruments were used (i.e., photographs
and drawings), heritabilities and genetic correlations were similar for the two
cohorts.
2.2 Statistical Modeling of a Dichotomic Trait
2.2.1 Estimation of Tetrachoric Correlation
Let Y1 and Y2 be the measurements of a binary (dichotomic) trait on the two
members of a twin. We assume that the dichotomic vector (Y1, Y2)
t depends on
latent variables (X1, X2) and a threshold b, through the equations
Y1 =
{
0 if X1 ≤ b,
1 if X1 > b,
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Y2 =
{
0 if X2 ≤ b,
1 if X2 > b.
The tetrachoric correlation is defined as the correlation coefficient between the
latent variables X1 and X2. It is assumed that (X1, X2)
t possesses a bivariate
normal distribution.
We shall estimate the tetrachoric correlation by a Bayesian method. To
set-up a MCMC-algorithm, it is useful to decompose the latent vector as(
X1
X2
)
=
(
A1
A2
)
+
(
E1
E2
)
, (2.2.1)
where (
A1
A2
)
∼ N2
((
0
0
)
,
(
χ2 χ2ρ
χ2ρ χ2
))
,
and (
E1
E2
)
∼ N2
((
0
0
)
,
(
κ2 0
0 κ2
))
,
and where (A1, A2)
t and (E1, E2)
t are independent, and ρ ∈ [−1, 1] (for a review
on MCMC, see Appendix 2.6.2). The matrix (X1, X2)
t is decomposed in two
parts (A1, A2)
t and (E1, E2)
t where (A1, A2)
t is a part of (X1, X2)
t such that
Corr(A1, A2) = ρ and (E1, E2)
t is a part of (X1, X2)
t such that E1 and E2 are
independent. The decomposition could be interpreted in terms of a “reduced
ACE model”, but may also be viewed as a means to set up an MCMC-algorithm.
Note that (in the absence of further observations), the model is overparameter-
ized (non-identifiable), but this is not a problem as long as we consider posterior
distributions of identifiable functions of the parameters only (for more explana-
tion, see Appendix 2.6.1).
The tetrachoric correlation is identifiable and can be expressed in the pa-
rameters as
τ = Corr(X1, X2) =
Cov(X1, X2)√
Var(X1)
√
Var(X2)
=
χ2ρ√
χ2 + κ2
√
χ2 + κ2
=
χ2ρ
χ2 + κ2
. (2.2.2)
The conditional probability that Y1 = 0 given A1 and A2 is
P (Y1 = 0|A1, A2) = P (X1 ≤ b|A1, A2)
= P (A1 +E1 ≤ b|A1, A2)
= P (E1 ≤ b−A1|A1, A2)
= Φ
(b− a1√
κ2
)
, (2.2.3)
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and the conditional probability that Y1 = 1 given A1 and A2 is
P (Y1 = 1|A1, A2) = P (X1 > b|A1, A2)
= 1− P (Y1 = 0|A1, A2)
= 1− Φ
(b− a1√
κ2
)
. (2.2.4)
In other words, given A1 and A2 the variable Y1 possesses a Bernoulli distribu-
tion with “success” probability
s1 = 1− Φ
(b− a1√
κ2
)
.
In a similar way, one can find the conditional probability of Y2 given A1 and
A2. Given A1 and A2, the variables Y1 and Y2 are independent. A standardized
threshold is defined as
b′ =
b√
Var(Xj)
=
b√
χ2 + κ2
(2.2.5)
for j = 1, 2.
Let the mapping (y1, y2, a1, a2) 7→ p(y1, y2, a1, a2) be the density of the vector
(Y1, Y2, A1, A2) and yj 7→ p(yj |a1, a2) the conditional density of Yj given A1 and
A2 for j = 1, 2. The likelihood function for observing the vector (Y1, Y2, A1, A2)
in n independent twins is
L =
n∏
i=1
p(yi1, yi2, ai1, ai2)
=
n∏
i=1
p(yi1, yi2|ai1, ai2)f(ai1, ai2)
=
n∏
i=1
p(yi1|ai1, ai2)p(yi2|ai1, ai2)f(ai1, ai2)
=
n∏
i=1
q(yi1, ai)q(yi2, ai)g(ai1|ai2)h(ai2),
where f is the joint density of (A1, A2), g is the conditional density of A1 given
A2 and h is the marginal density of A2, given by
f(ai1, ai2) =
1
2piχ2
√
1− ρ2 exp
[
− 1
2χ2(1− ρ2)
(
a2i1 − 2ρai1ai2 + a2i2
)]
,
g(ai1|ai2) = 1√
2pi[1− ρ2]χ2 exp
[
− (ai1 − ρai2)
2
2[1− ρ2]χ2
]
,
h(ai2) =
1√
2piχ2
exp
[
− a
2
i2
2χ2
]
,
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and
q(y, a) =
[
Φ
(b− a√
κ2
)]1−y[
1− Φ
(b− a√
κ2
)]y
=
[
Φ
(
(b− a)
√
θ1
)]1−y[
1− Φ
(
(b− a)
√
θ1
)]y
,
for θ1 = 1/κ
2. Of course, we do not observe (A1, A2). The given likelihood
can be considered the “full likelihood”, where the true likelihood would be
marginalized over the missing data. To construct our Bayesian sampler we need
this full likelihood. This likelihood function is proportional to
L ∝ [χ2]−n[1− ρ2]−n2 exp[−x]
n∏
i=1
q(yi1, ai1)q(yi2, ai2),
where
x =
∑n
i=1(ai1 − ρai2)2
2(1− ρ2)χ2 +
∑n
i=1 a
2
i2
2χ2
.
In other words, the likelihood function for n twins is proportional to
L ∝ θn2 [1− ρ2]−
n
2 exp[−z]
n∏
i=1
q(yi1, ai1)q(yi2, ai2),
where
z =
[∑n
i=1(ai1 − ρai2)2
2(1− ρ2) +
∑n
i=1 a
2
i2
2
]
θ2,
for θ2 = 1/χ
2.
We choose conjugate prior distributions for the parameters θ2 = 1/χ
2, θ1 =
1/κ2 from the gamma family of distributions, i.e. the prior densities are given
by
pi(θ2) =
pp12
Γ(p1)
θp1−12 exp
(− p2θ2),
pi(θ1) =
pp34
Γ(p3)
θp3−11 exp
(− p4θ1),
the prior distribution for parameter ρ :
pi(ρ) =
1
2
I[−1,1](ρ),
and a prior distribution for the parameter b from the normal family of distribu-
tions, i.e. the prior densities are given by
pi(b) =
1√
2pip6
exp
[
− (b− p5)
2
2p6
]
,
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where p1, p2, . . . , p6 are given parameters. Based on an independence assump-
tion of the parameters, the joint prior density is then
pi(θ2, ρ, θ1, b) = pi(θ2)pi(ρ)pi(θ1)pi(b).
Hence the joint posterior density pi(θ2, ρ, θ1, b|data) is
pi(θ2, ρ, θ1, b|data) ∝ pi(θ2)pi(ρ)pi(θ1)pi(b)L, (2.2.6)
which is proportional to
θ
(p1+n−1)
2 θ
(p3−1)
1 [1− ρ2]−
n
2 I[−1,1](ρ)exp[−w]
n∏
i=1
q(yi1, ai1)q(yi2, ai2), (2.2.7)
where
w = p4θ1 + uθ2 +
(b− p5)2
2p6
and
u = p2 +
1
2(1− ρ2)
n∑
i=1
(ai1 − ρai2)2 + 1
2
n∑
i=1
a2i2
= p2 + v,
where
v =
1
2(1− ρ2)
[ n∑
i=1
a2i1 − 2ρ
n∑
i=1
ai1ai2 +
n∑
i=1
a2i2
]
.
Based on the joint posterior distribution pi(θ2, ρ, θ1, b|data), the full conditional
distribution for each parameter can be determined as follows :
pi(θ2|rest) ∝ θ(p1+n−1)2 exp(−uθ2),
pi(ρ|rest) ∝ [1− ρ2]−n2 exp(−vθ2)I[−1,1](ρ),
pi(θ1|rest) ∝ θ(p3−1)1 exp(−p4θ1)
n∏
i=1
q(yi1, ai1)q(yi2, ai2),
pi(b|rest) ∝ exp
[
− (b− p5)
2
2p6
] n∏
i=1
q(yi1, ai1)q(yi2, ai2).
For the latent variables, the full conditional distribution can be determined as
follows :
pi(ai1|rest) ∝ exp
[
− (ai1 − ρai2)
2θ2
2(1− ρ2)
]
q(yi1, ai1)
for i = 1, 2, . . . , n, and
pi(ai2|rest) ∝ exp
[
− (ai2 − ρai1)
2θ2
2(1− ρ2)
]
q(yi2, ai2)
for i = 1, 2, . . . , n.
To construct a multi-dimensional Markov Chain Monte Carlo sampler we
use the Gibbs Sampler algorithm as follows :
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1. Initialize ([θ2]0, ρ0, [θ1]0, b0, [a11]0, [a12]0, . . . , [an1]0, [an2]0) and set j = 1.
2. Generate [θ2]j from θ2 7→ pi(θ2| rest).
3. Generate ρj from ρ 7→ pi(ρ| rest).
4. Generate [θ1]j from θ1 7→ pi(θ1| rest).
5. Generate bj from b 7→ pi(b| rest).
6. Generate [ai1]j from ai1 7→ pi(ai1| rest) for i = 1, 2, . . . , n.
7. Generate [ai2]j from ai2 7→ pi(ai2| rest) for i = 1, 2, . . . , n.
8. Repeat step 2 until step 7 for j = 2, 3, . . . until the chain approaches
“convergence”.
In twin studies, there are many twins in which only one member of twin
agrees to cooperate. These twins are called discordant-participant twins as op-
posed to concordant-participant twins, for whom data are collected from both
members of the twin. If only one member of a twin agrees to cooperate in a twin
study, then we have missing data. Suppose we have missing data on the first
twin. Given A1 and A2, the parameters and the data, the variable Y1 possesses
a Bernoulli distribution with “success” probability
s2 = 1− Φ
(
(b− a1)
√
θ1
)
. (2.2.8)
It is easy to handle missing variables in the MCMC scheme : we simply
1. Initialize ([θ2]0, ρ0, [θ1]0, b0, [a11]0, [a12]0, . . . , [an1]0, [an2]0) and set j = 1.
2. Generate Ymissing|rest from Bernoulli(s2) where s2 is given in equation
(2.2.8).
3. Generate [θ2]j from θ2 7→ pi(θ2| rest).
4. Generate ρj from ρ 7→ pi(ρ| rest).
5. Generate [θ1]j from θ1 7→ pi(θ1| rest).
6. Generate bj from b 7→ pi(b| rest).
7. Generate [ai1]j from ai1 7→ pi(ai1| rest) for i = 1, 2, . . . , n.
8. Generate [ai2]j from ai2 7→ pi(ai2| rest) for i = 1, 2, . . . , n.
9. Repeat step 2 until step 8 for j = 2, 3, . . . until the chain approaches
convergence.
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The full conditional distribution of the parameter θ2 is a Gamma distribu-
tion Γ(p1 + n, u), which is standard, so that the sampling of θ2 is easily imple-
mented. The full conditional distribution of θ1 is a non-standard distribution.
To generate a sample from it, we used the Metropolis-Hastings algorithm with
an exponential density with mean θ1 as a proposed density, i.e.,
q(y|θ1) = 1
θ1
exp
(
− y
θ1
)
, y > 0.
The full conditional distribution of ρ is also a non-standard distribution. To gen-
erate a sample we use the Metropolis-Hastings algorithm with proposed density
q(y|ρ) = 1
2
,
where min{ρ − ,−1} < y < max{ρ+ , 1} and for example,  = 0.3. Further-
more, the full conditional distribution of b is a non-standard distribution. We
approximate it using the Metropolis-Hasting algorithm with a proposal distri-
bution N(b, 1). The parameters ai1 and ai2 for i = 1, 2, . . . , n can be done in a
similar way.
We implemented the MCMC-algorithm in WinBUGS version 1.4 (for a re-
view on WinBUGS version 1.4, see Cowles, 2004). In WinBUGS, it sufficies to
specify the probability distributions of Y1 and Y2 given A1 and A2, the prior
distributions of the parameters θ2, b, ρ and θ1, an initial value of every param-
eter, the number of iterations for “burn in”, and the number of iterations after
“burn in”. WinBUGS will next construct the Gibbs Sampler.
2.2.2 Empirical Data
A contingency table based on the raw data of menarcheal status (with missing
data ignored) in MZ twins is given in Table 2.1. Menarcheal status ’1’ refers to
a girl who has already started menstruation.
Twin 2
Twin 1 Category 0 Category 1
Category 0 28 3
Category 1 2 3
Table 2.1: Contingency table of menarcheal status in MZ twin pairs
The tetrachoric correlation is estimated by using the script in WinBUGS
language. In order to decrease the effect of the priors on the final result, we chose
relatively flat (i.e. non informative) priors for the parameters. Nevertheless, the
choice of priors is not a completely trivial matter. For the parameters 1/χ2 and
1/κ2, we chose Γ(4, 4) priors where Γ(p1, p2) is
pi(x; p1, p2) =
pp12
Γ(p1)
xp1−1exp(−p2x), x > 0.
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Based on these priors, the variance of the latent variable X1 (Var(X1) = χ
2+κ2)
gives high probability to the interval (0,10). If the prior of the parameter b′ (the
standardized threshold) is N(0,1), then in view of equation (2.2.5) the parameter
b gives high probability to the interval (−3√10, 3√10). In other words, we can
choose N(0,10) for the prior of parameter b. We chose the prior distribution of
ρ to be uniform on [-1,1].
Table 2.2 gives information about the posterior mean, standard deviation,
median and 95 % credible interval of the standardized threshold ( b′ ) and the
tetrachoric correlation (τ) in MZ twins.
Statistic Mean SD 2.5%-ile Median 97.5%-ile
Threshold ( b′ ) 1.0500 0.1969 0.6735 1.0460 1.4490
Tetrachoric Correlation (τ) 0.3744 0.2105 -0.0629 0.3875 0.7550
Table 2.2: Estimates of threshold b′ and tetrachoric correlation τ based on a sample of 10000
MCMC iterations after 5000 iterations “burn in”.
The simulated values of b′ in two MCMC chains are given in Figure 2.1
(above). Both the first and second chain consists of the 10000 iterations after
5000 ’burn in’ iterations by using different initial values. The
√
Rˆc value of the
two MCMC chains of parameter b′ is 1 and the 95% upper limit is 1.00 (for
more explanation, see Appendix 2.6.1). Figure 2.1 (middle) shows the same
output for the two corresponding MCMC chains for τ . The
√
Rˆc value of the
two MCMC chains τ is 1.01 and the 95% upper limit is 1.06. Both chains are
considered to have converged because the upper limits of
√
Rˆc are not larger
than 1.1.
We performed a sensitivity analysis to see the effect of choosing different
priors. Table 2.3 gives the chosen prior distribution in four cases, the resulting
posterior means for the parameters b′ and τ. We conclude that the estimates do
not change dramatically.
Case The prior distribution of b 1/χ2 and 1/κ2 b′ τ
1 N(0, 10) Γ(4, 4) 1.0500 0.3744
2 N(0, 10) Γ(5, 5) 1.0520 0.3739
3 N(0, 10) Γ(6, 6) 1.0470 0.3760
4 N(0, 8) Γ(7, 7) 1.0510 0.3882
Table 2.3: The chosen prior distribution in each case and estimates based on a sample of
10000 MCMC iterations after 5000 iteration “burn in”.
2.2.3 Estimation of Heritability
Let Y1 and Y2 be the measurements of a dichotomic trait on the two members
of a twin. We assume that the vector (Y1, Y2)
t depends on latent variables
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Figure 2.1: The history of MCMC and Kernel Density Estimation for threshold b′ and
tetrachoric correlation τ .
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(X1, X2) and a threshold b, through the equations
Y1 =
{
0 if X1 ≤ b,
1 if X1 > b,
Y2 =
{
0 if X2 ≤ b,
1 if X2 > b.
It is assumed that (X1, X2)
t has a bivariate normal distribution and can be de-
composed into a genetic component A1, A2, a shared environmental component
C and unshared environmental components E1, E2, as follows(
X1
X2
)
=
(
A1
A2
)
+
(
C
C
)
+
(
E1
E2
)
, (2.2.9)
where for MZ twins, (
A1
A2
)
∼ N2
((
0
0
)
,
(
ν2 ν2
ν2 ν2
))
,
for DZ twins, (
A1
A2
)
∼ N2
((
0
0
)
,
(
ν2 0.5ν2
0.5ν2 ν2
))
,
and (
C
C
)
∼ N2
((
0
0
)
,
(
η2 η2
η2 η2
))
,
(
E1
E2
)
∼ N2
((
0
0
)
,
(
κ2 0
0 κ2
))
,
and where (A1, A2)
t, (C,C)t and (E1, E2)
t are independent.
The conditional probability that Y1 = 0 given A1, A2 and C is
P (Y1 = 0|A1, A2, C) = P (X1 ≤ b|A1, A2, C)
= P (A1 + C +E1 ≤ b|A1, A2, C)
= P (E1 ≤ b−A1 − C|A1, A2, C)
= Φ
(b− a1 − c√
κ2
)
, (2.2.10)
and the conditional probability that Y1 = 1 given A1, A2 and C is
P (Y1 = 1|A1, A2, C) = P (X1 > b|A1, A2, C)
= 1− P (Y1 = 0|A1, A2, C)
= 1− Φ
(b− a1 − c√
κ2
)
. (2.2.11)
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In other words, the variable Y1 given A1, A2 and C possesses a Bernoulli distri-
bution with ”success” probability
s3 = 1− Φ
(b− a1 − c√
κ2
)
. (2.2.12)
Given A1, A2 and C, the variables Y1 and Y2 are independent. The conditional
probability of Y2 given A1, A2 and C can be found in a similar way. The
standardized threshold is defined as
b′ =
b√
Var(Xj)
=
b√
ν2 + η2 + κ2
(2.2.13)
where j = 1, 2. Furthermore, the heritability (genetic component) of menarcheal
status (related to the measurements Y1 and Y2) can be found by using the
formula :
Vg =
Var(A1)
Var(X1)
=
ν2
ν2 + η2 + κ2
, (2.2.14)
the shared environmental component by :
Vs =
Var(C)
Var(X1)
=
η2
ν2 + η2 + κ2
, (2.2.15)
and the unshared environmental component by :
Vu =
Var(E1)
Var(X1)
=
κ2
ν2 + η2 + κ2
. (2.2.16)
Let the mapping (y1, y2, a, c) 7→ p(y1, y2, a, c) be the density of the vector
(Y1, Y2, A, C) and yj 7→ p(yj |a, c) the conditional density of Yj given (A,C) for
j = 1, 2. The likelihood function for observing the vector (Y1, Y2, A, C) in n
randomly selected MZ twins (where A := A1 = A2) is
LMZ =
n∏
i=1
p(yi1, yi2, ai, ci)
=
n∏
i=1
p(yi1, yi2|ai, ci)fA(ai)fC(ci)
=
n∏
i=1
p(yi1|ai, ci)p(yi2|ai, ci)fA(ai)fC(ci)
=
n∏
i=1
q(yi1, ai, ci)q(yi2, ai, ci)fA(ai)fC(ci),
where fA and fC are marginal densities of A and C, given by
fA(ai) =
1√
2piν2
exp
[
− a
2
i
2ν2
]
,
fC(ci) =
1√
2piη2
exp
[
− c
2
i
2η2
]
,
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and
q(y, a, c) =
[
Φ
(b− a− c√
κ2
)]1−y[
1− Φ
(b− a− c√
κ2
)]y
=
[
Φ
(
(b− a− c)
√
θ1
)]1−y[
1− Φ
(
(b− a− c)
√
θ1
)]y
,
where θ1 = 1/κ
2. This likelihood function is proportional to
LMZ ∝ [ν2]−n/2[η2]−n/2exp
[
−
∑n
i=1 a
2
i
2ν2
]
exp
[
−
∑n
i=1 c
2
i
2η2
]
×
n∏
i=1
q(yi1, ai, ci)q(yi2, ai, ci).
In other words, the likelihood function for n MZ twins is proportional to
LMZ ∝ θn/23 θn/24 exp
[
− θ3
∑n
i=1 a
2
i
2
]
exp
[
− θ4
∑n
i=1 c
2
i
2
]
×
n∏
i=1
q(yi1, ai, ci)q(yi2, ai, ci),
where θ3 = 1/ν
2 , θ4 = 1/η
2.
The likelihood function for observing (Y1, Y2, A1, A2, C) in m randomly se-
lected DZ twins can be obtained in an analogous manner, where only the joint
density of (A1, A2) changes. It is given by
LDZ =
m∏
i=1
p(yi1, yi2, ai1, ai2, ci)
=
m∏
i=1
p(yi1, yi2|ai1, ai2, ci)f(ai1, ai2)fC(ci)
=
m∏
i=1
p(yi1|ai1, ai2, ci)p(yi2|ai1, ai2, ci)f(ai1, ai2)fC(ci)
=
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)g(ai1|ai2)fA(ai2)fC(ci),
where f is the joint density of (A1, A2) and g is the conditional density of A1
given A2, given by
f(ai1, ai2) =
1
2piν2
√
1− [ 12 ]2
exp
[
− 1
2ν2(1− [ 12 ]2)
(
a2i1 − 2(0.5)ai1ai2 + a2i2
)]
,
g(ai1|ai2) = 1√
2pi[ 34 ]ν
2
exp
[
− (ai1 − 0.5ai2)
2
2[ 34 ]ν
2
]
.
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This likelihood function is proportional to
LDZ ∝ [ν2]−m[η2]−m/2exp[−x]
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)
where
x =
2
∑m
i=1(ai1 − 0.5ai2)2
3ν2
+
∑m
i=1 a
2
i2
2ν2
+
∑m
i=1 c
2
i
2η2
.
In other words, the likelihood function for m DZ twin pairs is proportional to
LDZ ∝ θm3 θm/24 exp[−z]
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)
where
z =
2θ3
∑m
i=1(ai1 − 0.5ai2)2
3
+
θ3
∑m
i=1 a
2
i2
2
+
θ4
∑m
i=1 c
2
i
2
.
The contribution to the likelihood function of r twins for which only Y1 is
observed, and not Y2, is, for r pairs (Y1, Y2),
LSG =
r∏
i=1
P (Yi1 = yi1)
=
r∏
i=1
[P (Xi1 ≤ b)]1−yi1 [1− P (Xi1 ≤ b)]yi1
=
r∏
i=1
[
Φ
( b√
ν2 + η2 + κ2
)]1−yi1[
1− Φ
( b√
ν2 + η2 + κ2
)]yi1
=
r∏
i=1
s1−yi14 (1− s4)yi1
and
s4 = Φ
(
b
√
θ1θ3θ4
θ4θ1 + θ3θ1 + θ3θ4
)
.
We choose conjugate prior densities for the parameters θ3, θ4, θ1 from the
gamma family of distributions, i. e. the prior densities are given by
pi1(θ3) =
pp12
Γ(p1)
θp1−13 exp(−p2θ3),
pi2(θ4) =
pp34
Γ(p3)
θp3−14 exp(−p4θ4),
pi3(θ1) =
pp56
Γ(p5)
θp5−11 exp(−p6θ1),
and a conjugate prior distribution for the parameter b from the normal family
of distributions, i.e. the prior densities are given by
pi4(b) =
1√
2pip8
exp
[
− (b− p7)
2
2p8
]
.
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Here p1, p2, . . . , p8 are suitably chosen parameters. Based on an independence
assumption of the parameters, the joint prior density is then
pi(θ3, θ4, θ1, b) = pi1(θ3)pi2(θ4)pi3(θ1)pi4(b).
Hence the joint posterior density is proportional to
(θ1, θ3, θ4, b) 7→ pi(θ3, θ4, θ1, b)LMZLDZLSG.
In the preceding we have used the same notation (Yi1, Yi2) for both MZ and DZ
twins and the notation Yi1 for single individuals. Of course, we assume that these
three classes of observations, and the corresponding latent variables are different
and independent. In the following the notations LMZ , LDZ , LSG are understood
to be the expressions derived previously with the appropriate observed values
(MZ,DZ, SG) substituted. The joint posterior density pi(θ3, θ4, θ1, b|data) sat-
isfies
pi(θ3, θ4, θ1, b|data) ∝ θ(p1+
n
2 +m−1)
3 θ
(p3+
n
2 +
m
2 −1)
4 exp[−w1]w2,
where
w1 = p6θ1 + uθ3 + vθ4 +
(ce− p7)2
2p8
,
w2 =
n∏
i=1
q(yi1, ai, ci)q(yi2, ai, ci)
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)
×
r∏
i=1
s1−yi14 (1− s4)yi1 ,
and
u = p2 +
1
2
n∑
i=1
a2i +
2
3
m∑
i
(ai1 − 0.5ai2)2 + 1
2
m∑
i=1
a2i2
= p2 +
1
2
n∑
i=1
a2i +
2
3
[ m∑
i
a2i1 −
m∑
i=1
ai1ai2 +
m∑
i=1
a2i2
]
,
v = p4 +
1
2
n∑
i=1
c2i1 +
1
2
m∑
i=1
c2i2.
Based on the joint posterior density, the full conditional distribution for each
parameter can be determined as follows :
pi(θ3|rest) ∝ θ(p1+
n
2 +m−1)
3 exp(−uθ3)
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)
×
r∏
i=1
s1−yi14 (1− s4)yi1 ,
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pi(θ4|rest) ∝ θ(p3+
n
2 +
m
2 −1)
4 exp(−vθ4)
m∏
i=1
q(yi1, ai1, ci)q(yi2, ai2, ci)
×
r∏
i=1
s1−yi14 (1− s4)yi1 ,
pi(θ1|rest) ∝ θp5−11 exp(−p6θ1)w2,
pi(b|rest) ∝ exp
[
− (b− p7)
2
2p8
]
w2.
For the latent variables, the full conditional distribution can be determined as
follows :
pi(ai|rest) ∝ exp
[
− a
2
i θ3
2
]
q(yi1, ai, ci)q(yi2, ai, ci)
for i = 1, 2, . . . , n,
pi(ci|rest) ∝ exp
[− c2i θ4
2
]
q(yi1, ai, ci)q(yi2, ai, ci)
for i = 1, 2, . . . , n+m,
pi(ai1|rest) ∝ exp
[
− 2(ai1 − 0.5ai2)
2θ3
3
]
q(yi1, ai1, ci)
for i = 1, 2, . . . ,m,
pi(ai2|rest) ∝ exp
[− 2(ai2 − 0.5ai1)2θ3
3
]
q(yi2, ai2, ci)
for i = 1, 2, . . . ,m.
To construct a multi-dimensional Markov Chain Monte Carlo sampler, we
use a Gibbs Sampler algorithm as follows :
1. Initialize ([θ3]0, [θ4]0, [θ1]0, b0, [A1]0, [C1]0, . . . , [An]0, [Cn]0, [A11]0,
[A12]0, [C1]0, . . . , [Am2)]0, [Cm]0) , and set j = 1.
2. Generate [θ3]j ∼ θ3 7→ pi(θ3| rest).
3. Generate [θ4]j ∼ θ4 7→ pi(θ4| rest).
4. Generate [θ1]j ∼ θ1 7→ pi(θ1| rest).
5. Generate bj ∼ b 7→ pi(b| rest).
6. Generate [ai]j ∼ ai 7→ pi(ai| rest) for i = 1, 2, . . . , n.
7. Generate [ci]j ∼ ci 7→ pi(ci| rest) for i = 1, 2, . . . , n+m.
8. Generate [ai1]j ∼ ai1 7→ pi(ai1| rest) for i = 1, 2, . . . ,m.
9. Generate [ai2]j ∼ ai2 7→ pi(ai2| rest) for i = 1, 2, . . . ,m.
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10. Repeat step 2 until step 12 for j = 2, 3, . . . until the chain approaches
convergence.
None of the conditional distributions belong to a standard family. To sample
from those conditionals we use the Metropolis-Hastings algorithm, with the
following proposed distributions :
1. the exponential distribution with mean the previous value of θ3 for pa-
rameter θ3, i.e.,
p(y|θ3) = 1
θ3
exp
(
− y
θ3
)
, y > 0
2. the exponential distribution with mean the previous value of θ4 for pa-
rameter θ4,
3. the exponential distribution with mean the previous value of θ1 for pa-
rameter θ1,
4. the normal distribution with mean the previous value of b and variance 1
for parameter b,
5. the normal distribution with mean the previous value of ai and variance
1 for latent variable ai,
6. the normal distribution with mean the previous value of ci and variance
1 for latent variable ci,
7. the normal distribution with mean the previous value of ai1 and variance
1 for latent variable ai1,
8. the normal distribution with mean the previous value of ai2 and variance
1 for latent variable ai2.
2.2.4 Empirical Data
Contingency tables based on the raw data of menarcheal status in MZ and DZ
twins are given in Table 2.1 and Table 2.4, respectively. Opposite sex twins only
contribute singleton observations, for obvious reasons. There are 6 girls with
the menarcheal status ’yes’ among the 29 singletons.
Twin 2
Twin 1 Category 0 Category 1
Category 0 29 2
Category 1 1 2
Table 2.4: Contingency table of menarcheal status in DZ twins
For the parameters 1/ν2, 1/η2 and 1/κ2, we chose Γ(5, 5) priors. Based on
these priors, the variance of the latent variable X1 (Var(X1) = ν
2 + η2 + κ2)
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gives high probability to the interval (0,8). If the prior of the parameter b′
(the standardized threshold) is N(0,1), then in view of equation (2.2.12) we see
that the parameter b gives high probability to the interval (−3√8, 3√8). A
N(0,8) for the prior of the parameter b appears then reasonable. Table 2.5 gives
information about the posterior mean, standard deviation, median and 95%
credible interval. Thus the point estimate of the heritability is 32%.
Statistic Mean SD 2.5%-ile Median 97.5%-ile
Threshold ( b′ ) 1.0650 0.1355 0.8038 1.0630 1.3350
Genetic Component (Vg) 0.3356 0.1275 0.1270 0.3200 0.6151
Shared Env. Comp. (Vs) 0.3774 0.1350 0.1482 0.3661 0.6626
Unshared Env. Comp. (Vu) 0.2870 0.0974 0.1285 0.2762 0.5043
Table 2.5: Estimates based on a sample of 20000 MCMC iterations after 10000 iteration
“burn in”.
The simulated values of b′ in two independent MCMC chains starting from
different initial values, are given in Figure 2.2. These pictures show the first
20000 iterations after 10000 “burn in” iterations. The corrected potential scale
reduction factor
√
Rˆc of the two MCMC chains of parameter b
′ (the standard-
ized threshold) is 1 and the 95% upper limit is 1. Figure 2.2 (middle) shows
two chains of the simulated values of the parameter Vg . The value of
√
Rˆc is
1.00 and the 95% upper limit is 1.01. We may presume that all chains have
converged, because the upper limits of
√
Rˆc are not larger than 1.1. Figure 2.3
shows the chains of Vs (above) and Vu (middle). The upper limit of
√
Rˆc for
Vs and Vu are 1 and 1.01, respectively.
We also performed a sensitivity analysis to see the effect of choosing dif-
ferent priors. The results are given in Table 2.6, where each of the four cases
corresponds to a choice of priors. In case 1, 2 and 3 we used a N(0,8) prior for
b, whereas we used a N(0, 6) prior in case 4. The prior distributions for the
parameter 1/ν2, 1/η2 and 1/κ2 in the four cases were Γ(5, 5), Γ(6, 6), Γ(7, 7)
and Γ(8, 8), respectively. Again, the results of the statistics do not change
dramatically.
Case b′ Vg Vs Vu
1 1.065 0.3356 0.3774 0.2870
2 1.066 0.3334 0.3727 0.2939
3 1.065 0.3394 0.3600 0.3006
4 1.066 0.3279 0.3663 0.3057
Table 2.6: Estimates based on a sample of 20000 MCMC iterations after 10000 iterations
“burn in” in sensitivity analysis.
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Figure 2.2: The history of MCMC and Kernel Density Estimation for the threshold b′ and
the genetic component Vg .
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Figure 2.3: The history of MCMC and Kernel Density Estimation for the shared environ-
mental component Vs and the unshared environmental component Vu.
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2.3 Statistical Modeling of a Polychotomic Trait
2.3.1 Estimation of Polychoric Correlation
Let Y1 and Y2 be the measurements of a polychotomic trait on the two mem-
bers of a twin. We assume that the polychotomic vector (Y1, Y2)
t depends on
the latent variables (X1, X2) and some thresholds b1, b2 and b3, through the
equations
Y1 =

1 if X1 ≤ b1,
2 if b1 < X1 ≤ b2,
3 if b2 < X1 ≤ b3,
4 if X1 > b3,
Y2 =

1 if X2 ≤ b1,
2 if b1 < X2 ≤ b2,
3 if b2 < X2 ≤ b3,
4 if X2 > b3.
(2.3.1)
It is assumed that (X1, X2)
t has a bivariate normal distribution and can be
decomposed as (
X1
X2
)
=
(
A1
A2
)
+
(
E1
E2
)
, (2.3.2)
where (
A1
A2
)
∼ N2
((
0
0
)
,
(
χ2 χ2ρ
χ2ρ χ2
))
,
(
E1
E2
)
∼ N2
((
0
0
)
,
(
κ2 0
0 κ2
))
,
and where (A1, A2)
t and (E1, E2)
t are independent, and ρ ∈ [−1, 1]. The matrix
(X1, X2)
t is decomposed in two parts (A1, A2)
t and (E1, E2)
t where (A1, A2)
t
is a part of (X1, X2)
t such that Corr(A1, A2) = ρ and (E1, E2)
t is a part of
(X1, X2)
t such that E1 and E2 are independent. The polychoric correlation is
defined as the coefficient of correlation between X1 and X2 :
τ = Corr(X1, X2) =
Cov(X1, X2)√
Var(X1)
√
Var(X2)
=
χ2ρ√
χ2 + κ2
√
χ2 + κ2
=
χ2ρ
χ2 + κ2
. (2.3.3)
The conditional probability that Y1 = 1 given A1 and A2 is
P (Y1 = 1|A1, A2) = P (X1 ≤ b1|A1, A2)
= P (A1 +E1 ≤ b1|A1, A2)
= P (E1 ≤ b1 −A1|A1, A2)
= Φ
(b1 − a1√
κ2
)
, (2.3.4)
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and the conditional probability that Y1 = 2 given A1 and A2 is
P (Y1 = 2|A1, A2) = P (b1 < X1 ≤ b2|A1, A2)
= P (b1 < A1 +E1 ≤ b2|A1, A2)
= Φ
(b2 − a1√
κ2
)
− Φ
(b1 − a1√
κ2
)
. (2.3.5)
All other conditional probabilities can be written out analogously.
Given A1 and A2, the variables Y1 and Y2 are independent. We define the
standardized thresholds by
b′j =
bj√
Var(Xi)
=
bj√
χ2 + κ2
(2.3.6)
for i = 1, 2 and j = 1, 2, 3.
2.3.2 Empirical Data
As an example, Table 2.7 gives the contingency table of breast development in
MZ twin pairs if we ignore the missing data. As in our treatment of estimating a
tetrachoric correlation we chose Γ(4, 4) priors for the parameters 1/χ2 and 1/κ2,
and a N(0, 10) prior for the parameter b. Furthermore, the prior distribution of
ρ is chosen uniform on [−1, 1]. The results of a Bayesian analysis using MCMC,
along the same lines as in section 2.1.2 are given in Table 2.8. Thus the point
estimate of the polychoric correlation is 81.86%.
Twin 2 Cat. 1 Twin 2 Cat. 2 Twin 2 Cat. 3 Twin 2 Cat. 4
Twin 1 Cat. 1 4 1 0 0
Twin 1 Cat. 2 3 13 1 0
Twin 1 Cat. 3 0 0 6 2
Twin 1 Cat. 4 0 0 3 3
Table 2.7: Contingency table of breast development in MZ twin pairs
Statistics Mean SD 2.5%-ile Median 97.5%-ile
First Threshold (b′1) -1.0450 0.2207 -1.4820 -1.0450 -0.6149
Second Threshold (b′2) 0.3186 0.1966 -0.0769 0.3251 0.6893
Third Threshold (b′3) 1.1960 0.2248 0.7383 1.1990 1.6280
Polychoric Correlation (τ) 0.8062 0.0807 0.6191 0.8186 0.9276
Table 2.8: Estimates of thresholds and polychoric correlation based on a sample of 10000
MCMC iterations after 5000 “burn in” iterations.
2.3.3 Estimation of Heritability
As before let Y1 and Y2 be the measurements of a polychotomic trait on the
two members of a twin pair. We assume that the polychotomic vector (Y1, Y2)
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depends on latent variables (X1, X2) and some thresholds b1, b2 and b3, through
the equations (2.3.1). In this section we wish to decompose the correlation be-
tween the latent trait in two relatives in genetic and environmental components.
The data consists of categorical vectors for both MZ and DZ twin pairs.
It is assumed that (X1, X2)
t has a bivariate normal distribution and can be
decomposed into genetic componentsA1, A2, a shared environmental component
C and unshared environmental components E1, E2 as follows :(
X1
X2
)
=
(
A1
A2
)
+
(
C
C
)
+
(
E1
E2
)
, (2.3.7)
where for MZ twins,(
A1
A2
)
∼ N2
((
0
0
)
,
(
ν2 ν2
ν2 ν2
))
,
whereas for DZ twin pairs,(
A1
A2
)
∼ N2
((
0
0
)
,
(
ν2 0.5ν2
0.5ν2 ν2
))
.
Furthermore, (
C
C
)
∼ N2
((
0
0
)
,
(
η2 η2
η2 η2
))
,
(
E1
E2
)
∼ N2
((
0
0
)
,
(
κ2 0
0 κ2
))
,
and where (A1, A2)
t, (C,C)t, and (E1, E2)
t are independent.
The conditional probability that Y1 = 1 given A1, A2 and C is
P (Y1 = 1|A1, A2, C) = P (X1 ≤ b1|A1, A2, C)
= P (A1 + C +E1 ≤ b1|A1, A2, C)
= P (E1 ≤ b1 −A1 − C|A1, A2, C)
= Φ
(b1 − a1 − c√
κ2
)
, (2.3.8)
and the conditional probability that Y1 = 2 given A1, A2 and C is
P (Y1 = 2|A1, A2, C) = P (b1 < X1 ≤ b2|A1, A2, C)
= P (b1 < A1 + C +E1 ≤ b2|A1, A2, C)
= P (b1 −A1 − C < E1 ≤ b2 −A1 − C|A1, A2, C)
= Φ
(b2 − a1 − c√
κ2
)
− Φ
(b1 − a1 − c√
κ2
)
. (2.3.9)
All other conditional probabilities can be written out analogously. Given A1,
A2 and C, the variables Y1 and Y2 are independent.
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A standardized threshold is determined by
b′j =
bj√
Var(Xi)
=
bj√
ν2 + η2 + κ2
(2.3.10)
for i = 1, 2 and j = 1, 2, 3. Furthermore, the heritability (relative variance of
the genetic component) of breast development (related to the measurements Y1
and Y2) can be found by using the formula :
Vg =
Var(A1)
Var(X1)
=
ν2
ν2 + η2 + κ2
, (2.3.11)
the variance of the shared environmental component by :
Vs =
Var(C)
Var(X1)
=
η2
ν2 + η2 + κ2
, (2.3.12)
and the variance of the unshared environmental component by :
Vu =
Var(E1)
Var(X1)
=
κ2
ν2 + η2 + κ2
. (2.3.13)
2.3.4 Empirical Data
Table 2.9 gives the contingency table of breast development status if we ignore
the missing data. Apart from the data in this table, breast development was
observed for 30 girls in opposite sex twins. Among these 4, 13 , 9 and 4 girls
had category 1, 2, 3 and 4, respectively. These data together with Table 2.7 are
used to estimate the parameters. As in section 2.2.2 we chose Γ(3, 3) priors for
the parameter 1/χ2 and 1/κ2, and a N(0, 8) prior for parameter b. Table 2.10
gives the means, standard deviations, medians and 95% credible intervals of the
parameters of interest. Thus, the point estimate of the heritability is 68.49%.
Twin 2 Cat. 1 Twin 2 Cat. 2 Twin 2 Cat. 3 Twin 2 Cat. 4
Twin 1 Cat. 1 6 3 1 0
Twin 1 Cat. 2 3 3 3 1
Twin 1 Cat. 3 2 4 4 1
Twin 1 Cat. 4 0 0 2 1
Table 2.9: Contingency table of breast development in DZ twin pairs
2.4 Statistical Modeling of Two Traits
2.4.1 Estimation of Polychoric Correlation
If we are interested in estimating the polychoric correlation between two traits
in twins, a twin can be considered as two individuals who each have two traits
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Statistic Mean SD 2.5%-ile Median 97.5%-ile
First threshold (b′1) -0.8145 0.1220 -1.0530 -0.8145 -0.5750
Second threshold (b′2) 0.2293 0.1092 0.0205 0.2279 0.4472
Third threshold (b′3) 1.1950 0.1385 0.9246 1.1940 1.4710
Genetic Component (Vg) 0.6559 0.1678 0.2874 0.6849 0.9012
Shared Env. Comp. (Vs) 0.2241 0.1404 0.0103 0.1946 0.5503
Unshared Env. Comp. (Vu) 0.1200 0.0543 0.0029 0.1107 0.2512
Table 2.10: Estimates of thresholds, genetic, shared and unshared environmental compo-
nents based on a sample of 10000 MCMC iterations after 5000 “burn in” iterations.
of interest. Let (Y1, Y2)
t be the measurements of two polychotomic traits on
one individual. We assume that the polychotomic vector (Y1, Y2)
t depends on
latent variables (X,Z)t, some thresholds b1, b2, b3 and some thresholds d1, d2
and d3, through the equations
Y1 =

1 if X ≤ b1,
2 if b1 < X ≤ b2,
3 if b2 < X ≤ b3,
4 if X > b3,
Y2 =

1 if Z ≤ d1,
2 if d1 < Z ≤ d2,
3 if d2 < Z ≤ d3,
4 if Z > d3.
(2.4.1)
It is assumed that (X,Z) has a bivariate normal distribution and can be de-
composed as (
X
Z
)
=
(
A
G
)
+
(
E
R
)
, (2.4.2)
where (A,G), (E,R) are independent, and(
A
G
)
∼ N2
((
0
0
)
,
(
χ2 χρδ
χρδ δ2
))
,
(
E
R
)
∼ N2
((
0
0
)
,
(
χ2 0
0 γ2
))
.
The matrix (X,Z)t is decomposed in two parts (A,G)t and (E,R)t where
(A,G)t is a part of (X,Z)t such that Corr(A,G) = ρ and (E,R)t is a part
of (X,Z)t such that E and R are independent. The polychoric correlation be-
tween two traits is defined as the coefficient of correlation between X and Z
:
τ = Corr(X,Z) =
Cov(X,Z)√
Var(X)
√
Var(Z)
=
χρδ√
χ2 + κ2
√
δ2 + γ2
. (2.4.3)
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The conditional probability that Y1 = 1 given A and G is
P (Y1 = 1|A,G) = P (X1 ≤ b1|A,G)
= P (A+E ≤ b1|A,G)
= P (E ≤ b1 −A|A,G)
= Φ
(b1 − a√
κ2
)
, (2.4.4)
and the conditional probability that Y1 = 2 given A1 and G1 is
P (Y1 = 2|A,G) = P (b1 < X ≤ b2|A,G)
= P (b1 < A+E ≤ b2|A,G)
= P (b1 −A < E ≤ b2 −A|A,G)
= Φ
(b2 − a√
κ2
)
− Φ
(b1 − a√
κ2
)
. (2.4.5)
All other conditional probabilities can be written out analogously. Given A and
G, the variables Y1 and Y2 are independent. We define standardized thresholds
by
b′j =
bj√
Var(Xi)
=
bj√
χ2 + κ2
, (2.4.6)
and
d′j =
dj√
Var(Zi)
=
bj√
δ2 + γ2
(2.4.7)
for i = 1, 2 and j = 1, 2, 3.
2.4.2 Empirical Data
Based on the raw data of breast and pubic hair development (with missing data
ignored) in MZ twins, one can make the contingency table in Table 2.11. As in
section 2.2.1 for prior distributions of 1/χ2, 1/κ2, 1/δ2 and 1/γ2, we chose the
Γ(3, 3) distribution. Furthermore, we chose a N(-1,8) prior distribution for the
thresholds b1 and d1, a N(0,8) prior distribution for thresholds b2 and d2, and
a N(1,8) prior distribution for threshold b3 and d3. Finally, the prior for ρ is
uniform on [−1, 1]. The results are given in Table 2.12.
2.4.3 Estimation of Polychoric Cross-correlation
Suppose we are interested in estimating the polychoric cross-correlation between
two traits in twins. Let (Y1, Y2, Y3, Y4) be the measurements of two polychotomic
traits on the two members of a twin, where Y1 refers to the first latent trait
variable of the first individual, Y2 to the second latent trait variable of the
first individual, Y3 to the first latent trait variable of the second individual,
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Trait 2 Cat. 1 Trait 2 Cat. 2 Trait 2 Cat. 3 Trait 2 Cat. 4
Trait 1 Cat. 1 10 0 0 0
Trait 1 Cat. 2 10 9 6 4
Trait 1 Cat. 3 1 10 6 7
Trait 1 Cat. 4 1 4 2 5
Table 2.11: Contingency table of breast development (Trait 1) × pubic hair development
(Trait 2) status in MZ twins
Statistic Mean SD 2.5%-ile Median 97.5%-ile
First threshold of breast dev. (b′1) -1.0300 0.1768 -1.3900 -1.0250 -0.7018
Second threshold of breast dev. (b′2) 0.3144 0.1481 0.0256 0.3144 0.6044
Third threshold of breast dev. (b′3) 1.0880 0.1718 0.7570 1.0870 1.4280
First threshold of pub. hair dev. (d′1) -0.6141 0.1573 -0.9288 -0.6104 -0.3133
Second threshold of pub. hair dev. (d′2) -0.0718 0.1483 -0.3727 -0.0692 0.2088
Third threshold of pub. hair dev. (d′3) 0.8325 0.1634 0.5075 0.8326 1.1500
Polychoric Correlation (τ) 0.5950 0.0892 0.4022 0.6022 0.7511
Table 2.12: Estimates of thresholds and polychoric correlation between two traits based on
a sample of 10000 MCMC iterations after 5000 “burn in” iterations.
and Y4 to the second latent trait variable of the second individual, respectively.
The correlation within the latent vectors corresponding to (Y1, Y4) or (Y3, Y2) is
called the polychoric cross-correlation.
Based on the raw data of breast and pubic hair development (with missing
data ignored) in MZ twin pairs, one can make the contingency tables given by
Table 2.13. We use the same priors as in the polychoric correlation case. The
results are given in Table 2.14. As we expected, the polychoric cross-correlation
in MZ twins is smaller than the polychoric correlation.
Trait 2 Cat. 1 Trait 2 Cat. 2 Trait 2 Cat. 3 Trait 2 Cat. 4
Trait 1 Cat. 1 5 5 0 0
Trait 1 Cat. 2 10 7 8 5
Trait 1 Cat. 3 1 0 9 8
Trait 1 Cat. 4 1 1 6 3
Table 2.13: Contingency table of breast development (Trait 1) × pubic hair development
(Trait 2) status in MZ twins
2.4.4 Estimation of Heritability
Let (Y1, Y2, Y3, Y4) be the measurement of two polychotomic traits on the two
members of a twin, (Y1, Y2) referring to the first individual and (Y3, Y4) to the
second. We assume that the polychotomic vector (Y1, Y2, Y3, Y4)
t depends on
latent variables (X1, Z1, X2, Z2)
t, some thresholds b1, b2 , b3 and some thresholds
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Statistics Mean SD 2.5%-ile Median 97.5%-ile
First threshold of breast dev. (b′1) -1.0200 0.1768 -1.3760 -1.0160 -0.6805
Second threshold of breast dev. (b′2) 0.2970 0.1446 0.0184 0.2955 0.5866
Third threshold of breast dev. (b′3) 1.0830 0.1726 0.7537 1.0800 1.4270
First threshold of pub. hair dev. (d′1) -0.6472 0.1586 -0.9628 -0.6474 -0.3381
Second threshold of pub. hair dev. (d′2) -0.1013 0.1484 -0.3918 -0.1024 0.1854
Third threshold of pub. hair dev. (d′3) 0.8192 0.1611 0.5065 0.8162 1.1420
Polychoric Cross-Correlation (τ) 0.4749 0.0994 0.2705 0.4793 0.6576
Table 2.14: Estimates of thresholds and polychoric cross-correlation between two traits on
a sample of 10000 MCMC iterations after 5000 “burn in” iterations.
d1, d2 and d3, through the equations
Y1 =

1 if X1 ≤ b1,
2 if b1 < X1 ≤ b2,
3 if b2 < X1 ≤ b3,
4 if X1 > b3,
Y2 =

1 if Z1 ≤ d1,
2 if d1 < Z1 ≤ d2,
3 if d2 < Z1 ≤ d3,
4 if Z1 > d3,
Y3 =

1 if X2 ≤ b1,
2 if b1 < X2 ≤ b2,
3 if b2 < X2 ≤ b3,
4 if X2 > b3,
Y4 =

1 if Z2 ≤ d1,
2 if d1 < Z2 ≤ d2,
3 if d2 < Z2 ≤ d3,
4 if Z2 > d3.
(2.4.8)
It is assumed that (X1, Z1, X2, Z2)
t has a multivariate normal distribution and
can be decomposed into a genetic component (A1, G1, A2, G2)
t, a shared en-
vironmental component (C,Q,C,Q)t, and unshared environmental component
(U1, V1, U2, V2)
t and (E1, R1, E2, R2)
t as follows
X1
Z1
X2
Z2
 =

A1
G1
A2
G2
+

C
Q
C
Q
+

U1
V1
U2
V2
+

E1
R1
E2
R2
 , (2.4.9)
where the four vectors on the right are assumed independent, and for MZ twins
: 
A1
G1
A2
G2
 ∼ N4
(
0
0
0
0
 ,

ν2 νρ1α ν
2 νρ1α
νρ1α α
2 νρ1α α
2
ν2 νρ1α ν
2 νρ1α
νρ1α α
2 νρ1α α
2

)
,
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whereas for DZ twins :
A1
G1
A2
G2
 ∼ N4
(
0
0
0
0
 ,

ν2 νρ1α 0.5ν
2 0.5νρ1α
νρ1α α
2 0.5νρ1α 0.5α
2
0.5ν2 0.5νρ1α ν
2 νρ1α
0.5νρ1α 0.5α
2 νρ1α α
2

)
.
Furthermore, the environmental components satisfy
C
Q
C
Q
 ∼ N4
(
0
0
0
0
 ,

η2 ηρ2β η
2 ηρ2β
ηρ2β β
2 ηρ2β β
2
η2 ηρ2β η
2 ηρ2β
ηρ2β β
2 ηρ2β β
2

)
,

U1
V1
U2
V2
 ∼ N4
(
0
0
0
0
 ,

χ2 χρ3δ 0 0
χρ3δ δ
2 0 0
0 0 χ2 χρ3δ
0 0 χρ3δ δ
2

)
,
and 
E1
R1
E2
R2
 ∼ N4
(
0
0
0
0
 ,

κ2 0 0 0
0 γ2 0 0
0 0 κ2 0
0 0 0 γ2

)
.
The parameter ρ1 is the coefficient of correlation between the two latent
trait variables in the genetic component, and ρ2 is the coefficient of correlation
between the two latent trait variables in the shared environmental component.
The coefficient of correlation between the two latent trait variables in the un-
shared environmental component is
ρ′ =
Cov(U1 +E1, V1 +R1)√
Var(U1 +E1)
√
Var(V1 +R1)
=
Cov(U1 +E1, V1 +R1)√
Var(U1) + Var(E1)
√
Var(V1) + Var(R1)
=
χρ3δ√
χ2 + κ2
√
δ2 + γ2
. (2.4.10)
The unshared environmental component is decomposed into two parts, the vec-
tor (U1, V1, U2, V2)
t and the vector (E1, R1, E2, R2)
t, where (U1, V1, U2, V2)
t ac-
counts for the correlation between two variables in the unshared environmental
component and (E1, R1, E2, R2)
t is a part of the unshared environmental com-
ponent such that E1, R1, E2, R2 are independent. This decomposition is useful
for implementing an MCMC algorithm, but is not estimable from the data.
Given L = (A1, A2, G1, G2, C,Q, U1, U2, V1, V2), the variables Y1, Y2, Y3, Y4
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are independent. The conditional probability of Y1 = 1 given L is
P (Y1 = 1|L) = P (X1 ≤ b1|L)
= P (A1 + C + U1 +E1 ≤ b1|L)
= P (E1 ≤ b1 −A1 − C − U1|L)
= Φ
(b1 − a1 − c− u1√
κ2
)
, (2.4.11)
and the conditional probability that Y1 = 2 given L is
P (Y1 = 2|L) = P (b1 < X1 ≤ b2|L)
= P (b1 < A1 + C + U1 +E1 ≤ b2|L)
= P (b1 −A1 − C − U1 < E1 ≤ b2 −A1 − C − U1|L)
= Φ
(b2 − a1 − c− u1√
κ2
)
− Φ
(b1 − a1 − c− u1√
κ2
)
.
(2.4.12)
All other conditional probabilities can be written out analogously.
Standardized thresholds are determined by
b′j =
bj√
Var(Xi)
=
bj√
ν2 + η2 + χ2 + κ2
(2.4.13)
and
d′j =
dj√
Var(Zi)
=
dj√
α2 + β2 + δ2 + γ2
(2.4.14)
for i = 1, 2 and j = 1, 2, 3. Furthermore, the heritability (relative variance of
the genetic component) of breast development (related to the measurements Y1
and Y3) can be found by :
Vg =
Var(A1)
Var(X1)
=
ν2
ν2 + η2 + χ2 + κ2
, (2.4.15)
the variance of the shared environmental component by :
Vs =
Var(C)
Var(X1)
=
η2
ν2 + η2 + χ2 + κ2
, (2.4.16)
and the variance of the unshared environmental component by :
Vu =
Var(E1)
Var(X1)
=
χ2 + κ2
ν2 + η2 + χ2 + κ2
. (2.4.17)
In a similar way, the heritability of pubic hair development (related to the
measurements Y2 and Y4) can be found.
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2.4.5 Empirical Data
We chose Γ(3, 3) priors for the parameters 1/ν2 , 1/η2, 1/χ2, 1/κ2, 1/α2, 1/β2,
1/δ2 and 1/γ2. Then, the variance of the latent variable X1 (Var(X1) = ν
2 +
η2 + χ2 + κ2) gives high probability to the interval (0,20). If the priors of the
parameters b′1, b
′
2, b
′
3 have variance 1, then in view of equation (2.4.13) we see
that the priors for the parameters b1, b2, b3 give high probability to the interval
(−3√20, 3√20). In other words, as priors for b1, b2, b3 normal distributions
with variance 20 are not unreasonable. The means of the priors are chosen
such that b1 < b2 < b3. In this case, we chose the initial value of the means
b1 = −1, b2 = 0, b3 = 1. The prior distribution of parameters d1, d2, d3 can be
motivated using similar reasoning. Furthermore, the prior distribution of the
parameters ρ1, ρ2, ρ3 is uniform on [−1, 1]. The results are given in Table 2.17.
Thus, the heritabilities of breast development and pubic hair development are
70.76% and 49.15%, respectively.
Statistics Mean SD 2.5%-ile Median 97.5%-ile
First threshold of breast dev. (b′1) -0.8262 0.1237 -1.0800 -0.8243 -0.5877
Second threshold of breast dev. (b′2) 0.2473 0.1101 0.0271 0.2494 0.4589
Third threshold of breast dev. (b′3) 1.2280 0.1427 0.9375 1.2300 1.4980
First threshold of pub. hair dev. (d′1) -0.6770 0.1207 -0.9142 -0.6749 -0.4459
Second threshold of pub. hair dev. (d′2) 0.0441 0.1152 -0.1825 0.0463 0.2729
Third threshold of pub. hair dev. (d′3) 0.8498 0.1316 0.5902 0.8484 1.1050
Genetic Component of breast dev. (Vg1) 0.6813 0.1575 0.3309 0.7076 0.9114
Shared Env. Comp. of breast dev. (Vs1) 0.1733 0.1268 0.0239 0.1409 0.4804
Unshared Env. Comp. of breast dev. (Vu1) 0.1454 0.0629 0.0524 0.1347 0.3018
Genetic Comp. of pub. hair dev. (Vg2) 0.5340 0.2262 0.1444 0.4915 0.9183
Shared Env. Comp. of pub. hair dev. (Vs2) 0.3368 0.2061 0.0231 0.3600 0.7216
Unshared Env. Comp. of pub. hair dev. (Vu2) 0.1292 0.0523 0.0473 0.1222 0.2540
Rho1 (ρ1) 0.7738 0.1252 0.5131 0.7832 0.9539
Rho2 (ρ2) 0.2673 0.4076 -0.8008 0.3574 0.8901
Rho′ (ρ′) 0.4234 0.1538 0.0529 0.4454 0.6642
Table 2.15: Estimates based on a sample of 10000 MCMC iterations after 5000 “burn in”
iterations in two traits.
2.5 Discussion
In this chapter, we have proposed statistical models of categorical phenotypes
(traits) data in twin studies. The method of Markov Chain Monte Carlo im-
plemented in WinBUGS can be used to estimate polychoric correlation and
heritability of one and two traits in the models. Furthermore, this method can
also be used to estimate the coefficients of correlation in the genetic, shared and
unshared environmental components between two traits. In our analysis, we
used relatively noninformative priors to estimate the parameters. A relatively
long “burn in” (5000 iterations) and a large sample (10000 iterations) of MCMC
gave reasonable estimate of the parameters.
The statistical model of two traits can be extended to a model with three
traits, which uses two cohorts. The results of the analysis of the whole data can
be found in van den Berg et al. (2006). The application of a Bayesian methods
and MCMC to problems related to behavior genetics (especially twin studies)
is still relatively young (Eaves and Erkanli, 2003). Recent papers related to the
41
present work are, for examples, Eaves et al. (2004), Eaves et al. (2005) and
van den Berg et al. (2006b). Using Bayesian methods, the explained models
in this chapter can also be extended to model interaction between genetic and
environmental factors. For other models in twin and family studies, we refer to
Neale and Cardon (1992).
2.6 Appendix
2.6.1 Bayesian Methods for Non-identifiable Parameters
The model fitted to the data in this chapter is not identifiable. This is not a
problem in our Bayesian approach as priors on all parameters will lead to a
posterior, even without identifiability. In this section we note that information
in the posterior about the non-identifiable part of the parameter stems purely
from the prior. Hence one should not interpret this as a useful result of the
analysis. On the other hand putting a prior on a non identifiable parameter can
be viewed as a method of defining a prior on the distribution of the data and will
as such result in a sensible posterior for identifiable aspects of this distribution.
We show this in an abstract setting in this section.
Suppose that {pη : η ∈ H} is a statistical model for the observation X : for
each parameter value η the function x 7→ pη(x) is a density of X . Let η = g(θ)
be a specification of η through another parameter θ, which could be higher
dimensional than η and/or non-identifiable from the data. Then we can also
think of the statistical model for X as a model {pg(θ) : θ ∈ Θ} indexed by θ. We
can put a prior pi on θ and next compute the posterior distribution of θ given
X . The prior on θ induces a prior on η = g(θ) and hence we can also compute
the posterior distribution of η given X . Furthermore, we have a prior on the
pair (θ, η) and hence a conditional distribution of θ given η under the prior. We
claim that the posterior of θ given X can be factorized as the prior of θ given η
times the posterior of η given X . More precisely, a draw from the posterior of
θ given X can be obtained in two steps :
1. generate η from the posterior of η given X .
2. given this η generate θ from the prior of θ given η.
The significance of this observation is that information about θ in the posterior
beyond the value η = g(θ) stems purely from the prior and has no relation to
the data. To prove the claim, we will use Bayesian notation as follows :
1. Θ is drawn from the prior pi for θ.
2. H = g(Θ).
3. Given (Θ, H) the observation X has density pH .
It follows from this description that given H the variables X and Θ are inde-
pendent. This proves the claim. We can also prove this with formulas. In the
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case that all variables are discrete we have
P (Θ = θ,X = x,H = η) =
{
P (X = x,Θ = θ) if η = g(θ)
0 else
=
{
pi(θ)pg(θ)(x) if η = g(θ)
0 else.
Consequently,
P (X = x,H = η) =
∑
θ;g(θ)=η
pi(θ)pg(θ)(x)
= pη(x)
∑
θ;g(θ)=η
pi(θ)
= pη(x)P (H = η).
Thus,
P (Θ = θ|X = x,H = η) =
{
pi(θ)pg(θ)(x)
pη(x)P (H=η)
if η = g(θ)
0 else
=
{
pi(θ)
P (H=η) if η = g(θ)
0 else.
Because the last expression does not depend on x it follows that
P (Θ = θ|X = x,H = η) = P (Θ = θ|H = η).
2.6.2 Markov Chain Monte Carlo
In Monte Carlo integration, we draw a sample {Xt, t = 1, 2, . . . , n} from a
probability distribution pi and approximate the population mean of f(X), i.e.
E[f(X)] =
∫
fdpi, by using the sample mean
1
n
n∑
t=1
f(Xt).
When the variables Xt are independent and n→∞, the Law of Large Numbers
ensures, almost surely, that
1
n
n∑
t=1
f(Xt)→ E[f(X)].
If drawing an i.i.d sample {Xt} is not feasible, then the variables {Xt} can
often be generated through a Markov Chain that has the target distribution pi
as its stationary distribution. This method is called Markov Chain Monte Carlo
(Gilks et al. 1996).
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In Markov Chain Monte Carlo (MCMC), a sequence of random variables,
{X0, X1, X2, . . .} is generated such that the next Xt+1 is sampled from a dis-
tribution P (Xt+1|Xt) which depends only on the current state of the chain
Xt for t = 0, 1, 2, . . .. Given Xt, the next state Xt+1 does not depend on
{X0, X1, X2, . . . , Xt−1}. The distribution P (.|.) is called the transition kernel
of the chain. It is assumed here that the chain is time-homogeneous : that is
P (.|.) does not depend on t. Subject to regularity conditions, the chain will
’forget’ its initial state. After a sufficiently long burn-in, say m iterations, the
variables {Xt : t = m + 1,m + 2, . . . , n} will constitute a (dependent) sam-
ple drawn approximately from pi. We can now use the output from the Markov
Chain to estimate the expectation E[f(X)] where X has distribution pi. Burn-in
samples are usually discarded from this calculation, giving the estimator,
E[f(X)] ≈ 1
n−m
n∑
t=m+1
f(Xt). (2.6.1)
The Gibbs sampler method is a special case of MCMC and can be used
to construct multi-dimensional MCMC. The Gibbs sampler generates a sample
from an arbitrary multidimensional distribution by sampling from each of the
univariate full conditional distributions in turn.
For example, suppose we want to sample from a 2-dimensional distribution
pi. It is assumed that the two univariate conditional densities θ1 → pi(θ1|θ2) and
θ2 → pi(θ2|θ1) can be sampled from. (We somewhat abuse notation by denoting
these two (typically different) distributions both by pi(.|.)). The algorithm of
Gibbs sampler is as follows :
1. Initialize (θ
(0)
1 , θ
(0)
2 ) and set j = 1.
2. Generate θ
(j)
1 from θ1 7→ pi(θ1|θ(j−1)2 ) and get the point (θ(j)1 , θ(j−1)2 ).
3. Generate θ
(j)
2 from θ2 7→ pi(θ2|θ(j)1 ) and get the point (θ(j)1 , θ(j)2 ).
4. Repeat step 2 and step 3 for j = 2, 3, 4, . . .
The sequence {(θ(j)1 , θ(j)2 )} is a 2-dimensional Markov Chain with stationary
distribution pi. The algorithm is performed until the Markov Chain is close to
stationarity. The algorithm can be generalized to n dimensional distributions.
If the univariate conditional density ν 7→ pi(ν|η) is a non-standard distribu-
tion, it is possible to generate a sample using the Metropolis-Hastings algorithm
as follows :
1. Initialize ν(0) and set k = 1.
2. Generate y from y 7→ q(y|ν(k−1)) where q is a proposed distribution.
3. Generate u from the uniform distribution U(0, 1).
4. If u < α(ν(k−1), y), where
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α(a, b) = min
{ pi(b|η)q(a|b)
pi(a|η)q(b|a) , 1
}
(2.6.2)
then ν(k) = y else ν(k) = ν(k−1).
5. Repeat step 2, step 3 and step 4 for k = 2, 3, 4, . . ..
The sequence {ν(k)} is a one-dimensional Markov Chain. For a given value
of η the Metropolis-Hastings algorithm is performed until the chain is close
to its stationary distribution pi(ν|η). Thus, the Metropolis-Hastings algorithm
is nested within the Gibbs sampler algorithm and then is called Metropolis-
Hastings within Gibbs sampler. Note that we only use the last value of the
Metropolis-Hastings Chain, which is used as the output of step 2 or step 3 in
the Gibbs Sampler algorithm.
A general approach to monitor convergence is based on detecting when the
Markov chains have ’forgotten’ their starting points. To monitoring convergence,
we used an algorithm due to Gelman and Rubin (1992). The algorithm focuses
on a single coordinate of the (typically) multivariate chain. We denote this
coordinate by x in the following :
1. Simulate m ≥ 2 sequences, each of length 2n with starting points drawn
from an over-dispersed distribution and the first n iterations as ’burn in’.
For each sequence calculate the mean x¯i. of the last n numbers.
2. Calculate B/n = the variance between the m sequence means, x¯i., i.e.
B
n
=
1
m− 1
m∑
i=1
(x¯i. − x¯..)2, (2.6.3)
and W = the average of the m within-sequence variances, s2i ,
W =
1
m
m∑
i=1
s2i . (2.6.4)
Based on the central limit theorem the m means x¯i. can be viewed as a
sample from a N(µ, σ2) distribution, or alternatively from a t-distribution
with center µ, scale τ and a high number of degrees of freedom. The t-
distribution is favoured in the present context, because it has somewhat
fatter tails.
3. Estimate the target mean µ by µˆ, the sample mean of the mn simulated
values of xij , i.e. µˆ = x¯...
4. Estimate the target variance σ2 by a weighted average of W and B, namely
σˆ2 =
(n− 1)W
n
+
B
n
. (2.6.5)
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5. Estimate the scale τ of the t-distribution by
√
Vˆ , where
Vˆ = σˆ2 +
B
mn
, (2.6.6)
and estimate the degrees of freedom df = 2Vˆ 2/vˆar(Vˆ ), where
vˆar(Vˆ ) =
(n− 1
n
)2 1
m
vˆar(s2i ) +
(m+ 1
mn
)2 2
m− 1B
2
+ 2
(m+ 1)(n− 1)
mn2
n
m
(
ˆcov(s2i , x¯
2
i.)− 2x¯.. ˆcov(s2i , x¯i.)
)
,
(2.6.7)
and the estimated variances and covariances are obtained from the m
sample values of x¯i. and s
2
i .
6. Monitor convergence of the iterative simulation by estimating the factor
by which the scale of the current distribution of x might be reduced if
the simulations were continued in the limit n → ∞. This potential scale
reduction is estimated by
√
Rˆ =
√
Vˆ
W
df
df − 2 (2.6.8)
which decreases to 1 as n→∞.
7. Once Rˆ is near 1 for all scalar estimands of interest, it is typically desirable
to summarize the target distribution by a set of simulations in order to
detect non-normal features of the target distribution.
Instead of Rˆ, Brooks and Gelman (1998) proposed the corrected potential scale
reduction
√
Rˆc as follows : √
Rˆc =
√
Vˆ
W
df + 3
df + 1
(2.6.9)
instead of
√
Rˆ. In other words, Rˆc can be determined as follows :
Rˆc =
[n− 1
n
+
m+ 1
m
B/n
W
][df + 3
df + 1
]
. (2.6.10)
Usually, if the upper limit of the corrected potential scale reduction
√
Rˆc is less
than 1.1 then the chains are considered convergent. A function (gelman.diag) in
R-CODA (Convergence Diagnostics and Output Analysis) package by Plummer
et al. (2006) can be used to calculate the coefficient
√
Rˆc.
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Chapter 3
SNP Data Analysis in
Association Studies
In this chapter, we describe several methods to analyze whether a biallelic
marker, e.g. a SNP or a set of such markers is associated to a disease of inter-
est. After presenting the chi-square test in the first section, we next describe
the likelihood ratio test and the generalized T 2 test. We end with a comparison
of the genotypic mapping, haplotypic mapping and causal mapping in logistic
regression.
All methods are based on a case-control design and try to find marker loci
that are associated to the disease by comparing allele frequencies between ran-
dom samples of cases (diseased individuals) and controls. The methods can
be classified as single marker, double marker or multiple marker according to
whether they take into account frequencies of markers at one locus or com-
binations of markers at two or more loci. In current practice, phase is not
observed, i.e. the raw data consists of unordered genotypes at the marker loci
and not of multi-locus haplotypes. For single marker methods phase is not con-
sidered important, because it is commonly assumed that parental and maternal
origins of alleles are not important for determining phenotype. Single marker
methods are, however, classified as allele-based or genotype-based according to
whether they assume Hardy-Weinberg equilibrium or not. If pAA, pAa and paa
are the relative frequencies of genotypes AA,Aa, aa in the population, then
Hardy-Weinberg equilibrium is said to hold if
pAA = p
2
A, pAa = 2pApa, paa = p
2
a,
for pA and pa = 1−pA the frequencies of allelesA and a in the population. Allele-
based single marker methods parameterize the genotype frequencies through
the single parameter pA, using the preceding identities, whereas genotype-based
methods let the vector (pAA, pAa, paa) vary freely over the two-dimensional unit
simplex.
Under assumptions of infinite population size, discrete generations, random
mating, no selection, no migration, no mutation and equal initial genotype fre-
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quencies in the two sexes, Hardy-Weinberg equilibrium arises after one gener-
ation and thereafter the genotype frequencies in the population are constant
from generation to generation.
Hardy-Weinberg equilibrium implies independence of the two alleles at a lo-
cus and as such can be extended to two loci. Consider two loci with alleles A and
a at the first locus and B and b at the second locus, occurring at frequencies
pA, pa and pB , pb in the population, respectively. The genotype of each indi-
vidual consists of two haplotypes, one from the paternal gamete and the other
from the maternal gamete. There are 4 possible two loci haplotypes, which
can be denoted as AB,Ab, aB and ab and whose frequencies in the population
can be denoted as pAB , pAb, paB and pab, respectively. There are 10 possible
(unordered) combinations of two haplotypes of this type, corresponding to 10
different types of individuals. As noted, in current practice the two haplotypes
of an individual are not observed, but instead only the two unordered genotypes
at the two loci are known. There are 9 possible sets of two unordered genotypes,
8 of which corresponding to a unique unordered pair of haplotypes, and one cor-
responding to the 2=10-8 remaining possible pairs. For example, an individual
with genotype AABB (unordered genotype AA at the first locus and BB at
the second) has received AB from both father and mother. The genotypes
AABb,AAbb,AaBB,Aabb, aaBB, aaBb and aabb can also be resolved in pairs
of haplotypes. However, an individual with genotype AaBb, results from haplo-
types AB and ab, but also from haplotypes Ab and aB. This type of individual,
for whom the haplotypes cannot be determined is called an individual with
phase unknown. The two-locus Hardy-Weinberg assumption is that haplotypes
are independently combined into two-locus phenotypes. The population fre-
quencies of the 10 possible unordered pairs of haplotypes can then be expressed
in the four haplotype frequencies pAB , pAb, paB and pab. These 10 frequencies
next determine the frequencies of the 9 possible genotypes. For example, the
frequency of genotypes AABB, AaBB and AaBb satisfy equations
pAABB = p
2
AB , pAaBB = 2pABpaB , pAaBb = 2pABpab + 2pAbpaB ,
respectively. Other genotype frequencies in the population can be expressed
similarly.
In the following we illustrate the techniques on data collected by the Depart-
ment of Medical Genetics at the Vrije Universiteit Medical Center Amsterdam.
The genotype data came from a genetically isolated population in Turkey with
current population size around 6000 people. Ninety percent of these people
are supposed to be descendants of 23 families that originally inhabited the re-
gion approximately 400 years ago. Genotyping was done using the Affimetrix
10K SNP chip to 27 controls and 31 cases. We summarized characteristics of
the 11229 SNPs, such as the identity of the SNP in the chromosome and the
genotype of every individual in the control and case samples. The genotype
of individuals are defined as AA,AB or BB; a missing genotype is coded as
”NoCall”, meaning that the marker did not pass the discrimination filter.
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3.1 The Chi-square Test
In this section, we describe the chi-square test for a single marker method. The
method can be extended to multiple marker methods as long as not too many
cells in the contingency table are empty.
3.1.1 Single Marker Allele-Based Method
Let pi and qi for i = 1, 2 denote the allele frequencies of alleles A and a among
controls and cases, respectively. We take random samples of n controls and m
cases yielding 2n and 2m alleles, respectively. The layout of the data is given in
Table 3.1. Testing association between the marker and the disease is equivalent
to testing the null hypothesis H0 : p = q versus the alternative hypothesis
H1 : p 6= q where p = (p1, p2), q = (q1, q2).
A a Total
Controls X 2n−X 2n
Cases Y 2m − Y 2m
Pooled X + Y 2(n +m) − (X + Y ) 2(n+m)
Table 3.1: Table of the number of alleles in control and case samples.
Suppose that the random variables X and Y are the numbers of common
alleles A in the control and case samples, respectively. The random variable X
possesses a Binom(2n, p1) distribution and Y possesses a Binom(2m, q1) distri-
bution. The test statistic Q2 is defined as
Q2 =
2∑
i=1
2∑
j=1
(Oij −Eij)2
Eij
, (3.1.1)
where Oij is the observed number of outcomes in cell (i, j) and Eij is the max-
imum likelihood estimate of the expected number of outcomes in cell (i, j) for
i, j = 1, 2 under the null hypothesis. The statistic Q2 has a chi-squared distri-
bution with 1 degree of freedom asymptotically as n,m→∞ under H0.
Under the null hypothesis H0, the MLE of p1 (the allele frequency A) is the
number of alleles A divided by the number of alleles in the pooled sample, i.e.
pˆ10 =
x+y
2(n+m) . Thus, the expected number of alleles A in the controls sample
is E11 = 2npˆ10 =
n(x+y)
n+m . Similarly, E12 =
n(2(n+m)−(x+y))
n+m , E21 =
m(x+y)
n+m and
E22 =
m(2(n+m)−(x+y))
n+m . By straightforward calculations,
Q2 =
8(n+m)nm
(x+ y)(n2 +m2)
(pˆ1 − qˆ1)2, (3.1.2)
where pˆ1 =
x
2n and qˆ1 =
y
2m .
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Example 3.1 Table 3.2 gives the numbers of common alleles A and rare alleles
a of the SNP with identity 1513978 in the chromosome number 2 in random
samples of 27 controls and 31 cases. Based on Table 3.2, we have
Q2 =
8(58)(27)(31)
(96)(20)
[(36/54)− (60/62)]2 = 18.3355
and the p-value is 1.8523× 10−5. Thus, the null hypothesis is rejected at the
usual level of significance α = 0.05 and we conclude that there is an association
between the allele of marker and the disease.
A a Total
Controls 36 18 54
Cases 60 2 62
Pooled 96 20 116
Table 3.2: Table of the number of alleles in control and case samples for Example 3.1.
3.1.2 Single Marker Genotype-Based Method
Let (p1, p2, p3) and (q1, q2, q3) be the genotype frequencies in the populations
of controls and cases, respectively. We take random samples of n controls and
m cases, respectively. The layout of the data is given in Table 3.3. Testing
association between the genotype of the marker locus and the disease is equiva-
lent to testing the null hypothesis H0 : p = q versus the alternative hypothesis
H1 : p 6= q where p = (p1, p2, p3) and q = (q1, q2, q3).
AA Aa aa Total
Controls X1 X2 X3 n
Cases Y1 Y2 Y3 m
Pooled X1 + Y1 X2 + Y2 X3 + Y3 n+m
Table 3.3: Table of the number of genotypes in control and case samples.
Suppose that random vectors X = (X1, X2, X3) and Y = (Y1, Y2, Y3) are
the numbers of genotype AA, Aa and aa in the samples of controls and cases,
respectively. These vectors possess Multi(n,p) and Multi(m,q) distributions,
respectively. The test statistic Q2 is defined as
Q2 =
2∑
i=1
3∑
j=1
(Oij −Eij)2
Eij
, (3.1.3)
where Oij is the observed number of outcomes in cell (i, j) and Eij is the max-
imum likelihood estimate of the expected number of outcomes in cell (i, j) for
i = 1, 2 and j = 1, 2, 3 under the null hypothesis. The statistic Q2 has a chi-
squared distribution with 2 degrees of freedom asymptotically as n,m → ∞,
under H0.
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Under the null hypothesis H0, the MLE of pj0 is pˆj0 =
xj+yj
n+m for j = 1, 2, 3.
By straightforward calculations,
Q2 =
3∑
j=1
(pˆj − qˆj)2
pˆj
m +
qˆj
n
, (3.1.4)
where pˆj =
xj
n and qˆj =
yj
m for j = 1, 2, 3.
Example 3.2 A case-control study with a biallelic marker was conducted from
SNPs analysis with identity 1513978 in chromosome 2; the results are given in
Table 3.4. We have
pˆ = (pˆ1, pˆ2, pˆ3) = (0.4074, 0.5185, 0.0741),
qˆ = (qˆ1, qˆ2, qˆ3) = (0.9355, 0.0645, 0),
and
Q2 =
(0.4074− 0.9355)2
0.4074
31 +
0.9355
27
+
(0.5185− 0.0645)2
0.5185
31 +
0.0645
27
+
(0.0741− 0)2
0.0741
31 +
0
27
= 5.8357 + 10.7831 + 2.2971
= 18.9159.
Finally, the p-value of Q2 is 7.8066×10−5. Thus, the null hypothesis is rejected
and we conclude that there is an association between the marker genotype and
the disease.
AA Aa aa Total
Controls 11 14 2 27
Cases 29 2 0 31
Pooled 40 16 2 58
Table 3.4: Table of the number of genotypes in control and case samples for Example 3.2.
3.2 The Likelihood Ratio Test
A likelihood ratio test is a statistical test based on the ratio between the max-
imum of the likelihood function under the null hypothesis and the maximum
under the alternative. In this section, we describe this test for single marker
methods (allele-based methods and genotype-based methods). We also describe
it for double marker methods without or with missing genotype data.
3.2.1 Single Marker Allele-Based Method
In this subsection, we consider the situation of subsection 3.1.1, but instead of
the chi-square test we consider testing the null hypothesis
H0 : p = q
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using the likelihood ratio test. Because X possesses the Binom(2n, p1) distri-
bution and Y possesses the Binom(2m, q1), the log-likelihood function is
l(p,q) = log
((
2n
x
)
px1(1− p1)2n−x
(
2m
y
)
qy1 (1− q1)2m−y
)
= log
(
2n
x
)
+ log
(
2m
y
)
+ log
(
px1p
2n−x
2 q
y
1q
2m−y
2
)
= log
(
2n
x
)
+ log
(
2m
y
)
+ x log p1 + (2n− x) log p2
+y log q1 + (2m− y) log q2,
where p2 = 1 − p1 and q2 = 1 − q1. Under the null hypothesis H0, the log-
likelihood function is
l0(p0) = log
(
2n
x
)
+ log
(
2m
y
)
+ (x+ y) log(p1)
+(2(n+m)− (x+ y)) log(p2).
The MLE of p1 under H0 is pˆ10 =
x+y
2(n+m) , and the MLE of p1 and q1 under
H0
⋃
H1 are pˆ1 =
x
2n and qˆ1 =
y
2m , respectively. Thus, the likelihood ratio
statistic G2 is defined as
G2 = −2[l0(pˆ0)− l(pˆ, qˆ)], (3.2.1)
where pˆ0 = (pˆ10, pˆ20), pˆ = (pˆ1, pˆ2) and qˆ = (qˆ1, qˆ2). Under the null hypothe-
sis this approximately has a chi-square distribution with 1 degree of freedom if
n,m→∞.
Example 3.3 Based on Table 3.2 and using the likelihood ratio test, we have
G2 = −2
[
96 log(96/116) + 20 log(20/116)− 36 log(36/54)− 18 log(18/54)
−60 log(60/62)− 2 log(2/62)
]
= 20.2345,
and the p-value is 6.8506× 10−6. Thus, the null hypothesis is rejected and we
conclude that there is an association between the marker allele and the disease.
3.2.2 Single Marker Genotype-Based Method
In this subsection, we consider the situation of subsection 3.1.2. We wish to test
the null hypothesis H0 : p = q versus the alternative hypothesis H1 : p 6= q
using the likelihood ratio test. Because X possesses a Multi(n,p) distribution
and Y possesses a Multi(m,q) distribution, the log-likelihood function is given
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by
l(p,q) = log
((
n
x1, x2, x3
)
qx11 q
x2
2 (1− q1 − q2)x3
)
+ log
((
m
y1, y2, y3
)
qm11 q
m2
2 (1− q1 − q2)y3
)
= log
(( n
x1, x2, x3
))
+ log
(( m
y1, y2, y3
))
+ log
(
px11 p
x2
2 p
x3
3 q
x1
1 q
x2
2 q
x3
3
)
= log
((
n
x1, x2, x3
))
+ log
((
m
y1, y2, y3
))
+
3∑
i=1
xi log pi +
3∑
i=1
yi log qi,
where x3 = n−x1−x2, p3 = 1−p1−p2, y3 = m−y1−y2, and q3 = 1− q1− q2.
Under the null hypothesis H0, the log-likelihood function is
l0(p) =
3∑
i=1
(xi + yi) log(pi0).
The MLE of pi under the null hypothesis H0 is pˆi0 =
xi+yi
n+m for i = 1, 2, 3 and
the MLE of pi and qi under H0
⋃
H1 are pˆi =
xi
n and qˆi =
yi
m for i = 1, 2, 3,
respectively. Thus, the likelihood ratio statistic is
G2 = −2[l0(pˆ0)− l(pˆ, qˆ)], (3.2.2)
where pˆ0 = (pˆ10, pˆ20, pˆ30) , pˆ = (pˆ1, pˆ2, pˆ3) and qˆ = (qˆ1, qˆ2, qˆ3). Under the null
hypothesis, this approximately has a chi-square distribution with 2 degrees of
freedom if n,m→∞.
Example 3.4 The likelihood ratio test can be applied to Table 3.4 and we
have
pˆ0 = (0.6879, 0.2759, 0.0344),
pˆ = (0.4074, 0.5185, 0.0741),
qˆ = (0.9355, 0.0645, 0),
and straightforward computation yields
l0(pˆ0) = 40 log(0.6897) + 16 log(0.2759) + 2 log(0.0344)
= −14.8599− 20.6035− 6.7394
= −42.2028,
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l(pˆ, qˆ) = 11 log(0.4074) + 14 log(0.5185) + 2 log(0.0741)
+29 log(0.9355) + 2 log(0.0645)
= −9.8776− 9.1954− 5.2047− 1.9336− 5.4822
= −31.6935.
The likelihood ratio test is
G2 = −2[l0(pˆ0)− l(pˆ, qˆ)] = −2[−42.2028 + 31.6935] = 21.0186
and the p-value of G2 is 2.7282× 10−5. Thus, by using the likelihood ratio test
we conclude that there is an association between the genotype of the marker
and the disease.
3.2.3 Double Marker Haplotype-Based Method
Before we describe the method, we present a general principle of the multino-
mial distribution. If the random vector (N1, . . . , NK) possesses a Multi(n,p)-
distribution where p = (p1, . . . , pK) and the random vector (M1, . . . ,ML) are
sums of components of N ’s, say Mj =
∑
i∈Ij Ni for a partition
{1, 2, . . . ,K} =
L⋃
j=1
Ij ,
then given M1, . . . ,ML the following properties hold :
1. (Ni)i∈Ij possesses a Multi(Mj , (p∗i )i∈Ij ), where p
∗
i =
piP
i∈Ij pi
for j =
1, 2, . . . , L.
2. (Ni)i∈I1 , . . . , (Ni)i∈IL are independent.
Suppose that we observe the unordered genotypes at two biallelic loci for the
control and case samples. Consider two loci in Hardy-Weinberg equilibrium. In
a random sample of n individuals, let XAABB denote the observed number of
individuals of genotype AA at the first locus and of genotype BB at the second
locus. The eight additional observed double-genotype frequencies are denoted
similarly. We assume two-loci Hardy-Weinberg equilibrium, so that the relative
frequencies of the ordered genotypes can be described in terms of the relative
frequencies of the haplotypes AB,Ab, aB, and ab. To carry out the likelihood
ratio test we need to compute the maximum likelihood estimators these fre-
quencies, for controls and cases separately and in the pooled sample. Direct
estimation of the likelihood is nontrivial, but the MLEs can be conveniently es-
timated using the EM-algorithm, using the (unordered) haplotypes as full data.
We first describe this algorithm.
The data of two biallelic loci can be represented as Table 3.5. Denote the
population frequencies of the haplotypes AB, Ab, aB and ab by pAB , pAb, paB
and pab, respectively. To estimate these frequencies, we use the EM-algorithm
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BB Bb bb
AA XAABB XAABb XAAbb
Aa XAaBB XAaBb XAabb
aa XaaBB XaaBb Xaabb
Table 3.5: Table of data of two biallelic loci in the sample (control, case and pooled sample),
where for example, XAABB denotes the observed number of individuals of genotype AA at
the first locus and of genotype BB at the second locus.
as follows. The observed numbers of people in each of the nine phenotypic
categories (see Table 3.5) constitute the observed data
Y = (XAABB , XAABb, XAAbb, XAaBB , XAaBb, XAabb, XaaBB , XaaBb, Xaabb),
while the unknown numbers of people in each of the ten genotypic categories
constitute the complete data
X = (XAABB , XAABb, XAAbb, XAaBB , XAB/ab, XAb/aB, XAabb, XaaBB, XaaBb, Xaabb).
For examples, XAB/ab is the number of individuals with haplotypes AB and ab
and XAb/aB is the number of individual with haplotypes Ab and aB. As noted
in the introduction of the chapter 8 out of the 9 coordinates of Y are identical
to 8 out of the 10 coordinates of X, whereas the remaining coordinate of Y
(corresponding to the central cell in the 3× 3 table in Table 3.5) is the sum of
the 2 remaining coordinates of X : XAaBb = XAB/ab +XAb/aB . The complete
data X has a multinomial distribution with parameters n and q, where
n = xAABB +xAABb+xAAbb+xAaBB +xAaBb+xAabb+xaaBB +xaaBb+xaabb,
and
q = (qAABB , qAABb, qAAbb, qAaBB , qAB/ab, qAb/aB , qAabb, qaaBB , qaaBb, qaabb),
while the observed data Y has a multinomial distribution with parameters n
and p where
p = (qAABB , qAABb, qAAbb, qAaBB , qAB/ab + qAb/aB , qAabb, qaaBB , qaaBb, qaabb).
Under Hardy-Weinberg equilibrium, these probabilities can be expressed in the
haplotype frequencies as in Table 3.6 where qAB/ab = 2pABpab and qAb/aB =
2pAbpaB .
BB Bb bb
AA p2AB 2pABpAb p
2
Ab
Aa 2pABpaB Two Possibilities : qAB/ab and qAb/aB 2pAbpab
aa p2aB 2paBpab p
2
ab
Table 3.6: Table of the probability of q according to Hardy-Weinberg equilibrium.
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The complete data log-likelihood is
log[f(x|q)] = xAABB log(p2AB) + xAABb log(2pABpAb) + xAAbb log(p2Ab)
+xAaBB log(2pABpaB) + xAB/ab log(2pABpab)
+xAa/Bb log(2pAbpaB) + xAabb log(2pAbpab)
+xaaBB log(p
2
aB) + xaaBb log(2paBpab) + xaabb log(p
2
ab)
+ log(u),
where
u =
„
n
xAABB , xAaBB , xaaBB , xAaBB , xAB/ab, xAb/aB , xAabb, xaaBB , xaaBb, xaabb
«
.
In the E-step of the EM algorithm, we take the expectation of log f(X|q) con-
ditional on the observed counts Y using the current parameter vector ps =
(ps,AB , ps,Ab, ps,aB , ps,ab)
t where ps is the s-th iteration (Lange, 2002). It is
trivial that
E(XAABB |Y,ps) = xAABB , E(XAABb|Y,ps) = xAABb,
E(XAAbb|Y,ps) = xAAbb, E(XAaBB |Y,ps) = xAaBB ,
E(XAabb|Y,ps) = xAabb, E(XaaBB |Y,ps) = xaaBB ,
E(XaaBb|Y,ps) = xaaBb, E(Xaabb|Y,ps) = xaabb.
Furthermore, in view of the general principle on conditioning in multinomial
vectors,
xs,AB/ab = E(XAaBb|Y,ps)
= xAaBb
2ps,ABps,ab
2ps,ABps,ab + 2ps,Abps,aB
= xAaBb
ps,ABps,ab
ps,ABps,ab + ps,Abps,aB
,
xs,Ab/aB = E(XAaBb|Y,ps)
= xAaBb
2ps,Abps,aB
2ps,ABps,ab + 2ps,Abps,aB
= xAaBb
ps,Abps,aB
ps,ABps,ab + ps,Abps,aB
.
In the M-step of the EM algorithm, we maximize the function p 7→ Q(p|ps),
where
Q(p|ps) = E[log f(X|p)|Y,ps]
= 2xAABB log(pAB) + xAABb log(2pABpAb)
+2xAAbb log(pAb) + xAaBB log(2pABpaB)
+xs,AB/ab log(2pABpab) + xs,Ab/aB log(2pAbpaB)
+xAabb log(2pAbpab) + 2xaaBB log(paB)
+xaaBb log(2paBpab) + 2xaabb log(pab).
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We introduce a Lagrange multiplier to maximize Q(p|ps),
H(p, λ) = Q(p|ps) + λ(pAB + pAb + paB + pab − 1).
Setting the partial derivatives
∂
∂pAB
H(p, λ) =
2xAABB
pAB
+
xAABb
pAB
+
xAaBB
pAB
+
xs,AB/ab
pAB
+ λ,
∂
∂pAb
H(p, λ) =
xAABb
pAb
+
2xAAbb
pAb
+
xs,Ab/aB
pAb
+
xAabb
pAb
+ λ,
∂
∂paB
H(p, λ) =
xAaBB
paB
+
xs,Ab/aB
paB
+
2xaaBB
paB
+
xaaBb
paB
+ λ,
∂
∂pab
H(p, λ) =
xs,AB/ab
pab
+
xAabb
pab
+
xaaBb
pab
+
2xaabb
pab
+ λ,
∂
∂λ
H(p, λ) = pAB + pAb + paB + pab − 1,
equal to 0 provides the unique stationary point of H(p, λ). Finally, we define
the solution of the resulting equations as the next estimate ps+1. This gives the
following iteration formulas :
ps+1,AB =
2xAABB + xAABb + xAaBB + xs,AB/ab
2n
,
ps+1,Ab =
xAABb + 2xAAbb + xs,Ab/aB + xAabb
2n
,
ps+1,aB =
xAaBB + xs,Ab/aB + 2xaaBB + xaaBb
2n
,
ps+1,ab =
xs,AB/ab + xAabb + xaaBb + 2naabb
2n
. (3.2.3)
We can carry out the EM-iterations separately for the control sample and case
sample, and for the pooled sample. The likelihood ratio statistic is the
G2 = −2[lpooled(pˆ0)− lcontrols(pˆ)− lcases(qˆ)] (3.2.4)
for pˆ, qˆ and pˆ0 the estimates for the control, case and pooled samples and l the
corresponding likelihood. For instance, the log-likelihood of the control sample
can be found by using formula :
lcontrols(pˆ) = xAABB log(pˆ
2
AB) + xAABb log(2pˆABpˆAb) + xAAbb log(pˆ
2
Ab)
+xAaBB log(2pˆABpˆaB) + xAB/ab log(2pˆABpˆab)
+xAa/Bb log(2pˆAbpˆaB) + xAabb log(2pˆAbpˆab)
+xaaBB log(pˆ
2
aB) + xaaBb log(2pˆaBpˆab)
+xaabb log(pˆ
2
ab). (3.2.5)
Similarly, lcases(qˆ) and lpooled(pˆ0) can be defined from the case sample and the
pooled sample, respectively. Under the null hypothesis G2 approximately has a
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chi-square distribution with k − 1 degrees of freedom if n,m → ∞, where k is
the number of haplotypes in the case-control sample.
Example 3.5 A case-control study with two biallelic markers was conducted
in a SNP-Disease association study in the chromosome 2 with identity 1513978
and 1507485 in 26 controls and 25 cases. The results are given in Table 3.7 and
Table 3.8, respectively.
BB Bb bb
AA 1 0 9
Aa 4 9 0
aa 2 0 0
Table 3.7: Table of individual double markers in control sample.
BB Bb bb
AA 1 6 17
Aa 2 0 0
aa 0 0 0
Table 3.8: Table of individual double markers in case sample.
Iteration m pAB pAb paB pab
1 0.3000 0.3000 0.3000 0.1000
2 0.2100 0.4500 0.2500 0.0900
3 0.1459 0.5141 0.3141 0.0259
4 0.1241 0.5359 0.3359 0.0041
5 0.1201 0.5395 0.3395 0.0005
6 0.1200 0.5399 0.3399 0.0001
7 0.1200 0.5400 0.3400 0.0000
8 0.1200 0.5400 0.3400 0.0000
Table 3.9: Iterations of the EM-algorithm estimation of haplotype frequencies in the control
sample.
The EM-algorithm iterations for estimation of p in control sample are given
in Table 3.9 and the haplotype frequencies of pˆ = (pAB , pAb, paB, pab) in controls
sample is (0.1200, 0.5400, 0.3400, 0.0000). Similarly, haplotype frequencies in
case and pooled samples are (0.1923, 0.7692, 0.0385, 0.0000) and (0.1569, 0.6569,
0.1863, 0.0000), respectively. In the control sample, the log-likelihood is
lcontrols(pˆ) = log(0.12
2) + 9 log(0.542) + 4 log[2(0.12)(0.34)]
= 9 log[2(0.54)(0.34)] + 2 log(0.342) = −38.6875.
In a similar way, the log-likelihood of case and pooled samples are lcases =
−27.9522 and lpooled = −75.1720. Finally, the value of the log-likelihood ratio
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statistic is
G2 = −2[lpooled − lcontrols − lcases]
= −2[−75.1720 + 38.6875 + 27.9522] = 17.0646.
The p-value of G2 is 1.9700 × 10−4 and thus, we conclude that there is an
association between the markers and the disease.
3.2.4 Double Marker Haplotype-Based Method
with Missing Genotype Data
BB Bb bb NoCall
AA XAABB XAABb XAAbb XAA/NoCall
Aa XAaBB XAaBb XAAbb XAa/NoCall
aa XaaBB XaaBb Xaabb Xaa/NoCall
NoCall XNoCall/BB XNoCall/Bb XNoCall/bb Ignore
Table 3.10: Table of the number of double markers genotypes with both markers observed,
only first marker observed and only second marker observed.
It may be that for some persons in the samples, the information on the first
or second marker is missing (”No Call”), as illustrated in Table 3.10. Then we
can separate the sample into three parts denote by C, D and E, respectively,
where C includes units for whom both first and second marker are observed, D
includes those for whom only the first marker is observed and E includes those
for whom only the second marker is observed (Schafer, 1997). An individual for
whom the value of neither the first nor the second marker is observed can be
excluded from the analysis.
“1” “2” “3”
“1” WC11 WC12 WC13 WC1+
“2” WC21 WC22 WC23 WC2+
“3” WC31 WC32 WC33 WC3+
WC+1 WC+2 WC+3
(a)
“1” “2” “3”
“1” WD11 WD12 WD13 WD1+
“2” WD21 WD22 WD23 WD2+
“3” WD31 WD32 WD33 WD3+
(b)
Consider WCij is the number of genotypes in cell (i, j) with both markers
observed (see Table 3.11 (a)). Given the number of genotypes with only first
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“1” “2” “3”
“1” WE11 WE12 WE13
“2” WE21 WE22 WE23
“3” WE31 WE32 WE33
WE+1 WE+2 WE+3
(c)
Table 3.11: Classification of the observed markers data : (a) both markers observed, (b)
Only first marker observed, (c) Only second marker observed.
marker observed WDi+, we define variable WDij as the number of genotypes in
cell (i, j) (see Table 3.11 (b)). Similarly, given the number of genotypes with
only second marker observed WE+j , we define the variable WEij as the number
of genotype in cell (i, j) (see Table 3.11 (c)). Furthermore, we define Wij as the
number of genotype in cell (i, j) if there is no missing marker information in the
sample. The variable Wij can be expressed as
Wij = WCij +WDij +WEij ,
for i, j = 1, 2, 3. Although WCij is observed, WDij and WEij are not; for sample
parts D and E, we observe only the marginal totals
WDi+ = WDi1 +WDi2 +WDi3,
and
WE+j = WE1j +WE2j +WE3j ,
respectively. The observed data Z = {WCij ,WDi+,WE+j : i, j = 1, 2, 3} and
the complete data {WCij ,WDij ,WEij : i, j = 1, 2, 3} can be displayed as in
Table 3.11.
If we regard the sum of any set of components of W as fixed, the conditional
distribution of those components becomes another multinomial and is indepen-
dent of the remaining components. For example, the conditional distribution of
(W11,W12,W13) given W1+ = W11 +W12 +W13 is multinomial with parameter
(
θ11
θ1+
,
θ12
θ1+
,
θ13
θ1+
),
where θ1+ = θ11 + θ12 + θ13, and furthermore, is conditionally independent of
(W21,W22,W23) and (W31,W32,W33). Application of this property within parts
D and E of the sample, the distribution of the missing data given the observed
data becomes a set of independent multinomial distributions
(WDi1,WDi2,WDi3)|Z
and (WE1j ,WE2j ,WE3j)|Z, where
(WDi1,WDi2,WDi3)|Z
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possesses a Multi
(
WDi+,
θi1
θi+
, θi2θi+ ,
θi3
θi+
)
distribution and
(WE1j ,WE2j ,WE3j)|Z,
possesses a Multi
(
WE+j ,
θ1j
θ+j
,
θ2j
θ+j
,
θ3j
θ+j
)
distribution for i, j = 1, 2, 3. Again,
the EM algorithm can be used to find θij for i, j = 1, 2, 3. The E-step of the
algorithm replaces the unknown dataWDij and WEij in Wij by their conditional
expectations under an assumed value for θ,
E(Wij |Z) = E(WCij +WDij +WEij |Z)
= E(WCij |Z) +E(WDij |Z) +E(WEij |Z)
= WCij +WDi+
( θij
θi+
)
+WE+j
( θij
θ+j
)
.
The M-step estimates θij by E(Wij |Z)/n. Combining the two-steps yields a
single iteration of the EM algorithm,
θ(s+1),ij =
1
n
[
WCij +WDi+
( θs,ij
θs,i+
)
+WE+j
( θs,ij
θs,+j
)]
,
where θ(s+1),ij is the (s + 1)-th iteration for i, j = 1, 2, 3. Finally, to estimate
the frequency of haplotype AB the following formulas can be used :
ps,AB =
1
2n
[
2xAABB + 2xAA/NoCall
p2s,AB
p2s,AB + 2ps,ABps,Ab + p
2
s,Ab
+2xNoCall/BB
p2s,AB
p2s,AB + 2ps,ABps,aB + p
2
s,aB
+ xAABb
+xAA/NoCall
2ps,ABps,Ab
p2s,AB + 2ps,ABps,Ab + p
2
s,Ab
+xNoCall/BB
2ps,ABps,aB
p2s,AB + 2ps,ABps,aB + p
2
s,aB
+ xAaBB
+xAb/NoCall
ps,ABps,aB
ps,ABps,aB + ps,ABps,ab + ps,Abps,aB + ps,Abps,ab
+xNoCall/BB
ps,ABps,aB
p2s,AB + 2ps,ABps,aB + p
2
s,aB
+ xs,1
+xs,2
ps,ABps,ab + ps,Abps,aB
ps,ABps,aB + ps,ABps,ab + ps,Abps,aB + ps,Abps,ab
+xs,3
ps,ABps,ab + ps,Abps,aB
ps,ABps,Ab + ps,ABps,ab + pAbps,aB + ps,aBps,ab
]
, (3.2.6)
where
xs,1 = xAaBb
ps,ABps,ab
ps,ABps,ab + ps,Abps,aB
,
xs,2 = xAa/NoCall
ps,ABps,ab
ps,ABps,ab + ps,Abps,aB
,
xs,3 = xNoCall/Bb
ps,ABps,ab
ps,ABps,ab + ps,Abps,aB
. (3.2.7)
61
Similarly, the frequencies of haplotypes Ab, aB and ab can be found.
To find the log-likelihood without the multinomial coefficient, we can find
the log-likelihood contribution from the part C multinomial log-likelihood :
lC(p|Z) = xAABB log(p2AB) + xAABb log(2pABpAb) + xAAbb log(p2Ab)
+xAaBB log(2pABpaB) + xAaBb
pABpab
pABpab + pAbpaB
log(2pABpab)
+xAaBb
pAbpaB
pABpab + pAbpaB
log(2pAbpaB) + xAabb log(2pAbpab)
+xaaBB log(p
2
aB) + xaaBb log(2paBpab) + xaabb log(p
2
ab).
The second contribution is
lD(p|Z) = xAA/NoCall log(p2AB + 2pABpAb + p2Ab)
+xAb/NoCall log(2pABpaB + 2pABpab + 2pAbpaB + 2pAbpab)
+xaa/NoCall log(p
2
aB + 2paBpab + p
2
ab),
and the third contribution is
lE(p|Z) = xNoCall/BB log(p2AB + 2pABpaB + p2aB)
+xNoCall/Bb log(2pABpAb + 2pABpab + 2pAbpaB + 2paBpab)
+xNoCall/bb log(p
2
Ab + 2pAbpab + p
2
ab).
The observed-data log-likelihood is the sum of the log-likelihood contributions
from each missingness pattern,
l(p|Z) = lC(p|Z) + lD(p|Z) + lE(p|Z). (3.2.8)
The procedure can be used in the control, the case and the pooled samples to
find the log-likelihood in control, case and pooled samples, respectively. Finally,
under the null hypothesis the likelihood ratio statistical test G2 asymptotically
has a chi-squared distribution with k − 1 degrees of freedom, where k is the
number of haplotypes as n,m→∞.
Example 3.6 A case-control study of two biallelic markers with missing data
was conducted from SNP-Disease association study with identity 1513978 and
1507485 in 27 controls and 31 cases and the results are given in Table 3.12 and
Table 3.13, respectively. Based on Table 3.12 and Table 3.13, the haplotype fre-
quencies of p in control, case and pooled sample are (0.1212, 0.5455, 0.3333, 0),
(0.1936, 0.7742, 0.0323, 0), and
(0.1595, 0.6681, 0.1724, 0),
respectively. In control sample, the log-likelihood contribution of part C is
lC(pˆ) = log(0.1212
2) + 9 log(0.54552) + 4 log(2(0.1212)(0.3333))
+9 log(2(0.5455)(0.3333)) + 2 log(0.33332)
= −38.6825.
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BB Bb bb NoCall
AA 1 0 9 1
Aa 4 9 0 1
aa 2 0 0 0
NoCall 0 0 0 0
Table 3.12: Table of the number of genotypes with both markers observed (C), only first
marker observed (E) and only second marker observed (D) in control sample.
BB Bb bb NoCall
AA 1 6 17 5
Aa 2 0 0 0
aa 0 0 0 0
NoCall 0 0 0 0
Table 3.13: Table of the number of genotypes with both markers observed (C), only first
marker observed (E) and only second marker observed (D) in case sample.
The log-likelihood contribution of part D is
lD(pˆ) = log[0.1212
2 + 2(0.1212)(0.5455) + 0.54552]
+ log[2(0.1212)(0.3333) + 2(0.5455)(0.3333)]
= −1.6218,
and the log-likelihood contribution of part E is lE(pˆ) = 0. Thus, the log-
likelihood of the control sample is
lcontrols(pˆ) = lC(pˆ) + lD(pˆ) + lE(pˆ) = −38.6925− 1.6218 + 0 = −40.3143.
Similarly, the log-likelihood of case sample is lcases = −28.3103 and for pooled
sample is lpooled = −78.7631. Finally, the log-likelihood ratio statistical value is
G2 = −2[lpooled − lcontrols − lcases]
= −2[−78.7631 + 40.3143 + 28.3103]
= 20.2770.
The p-value of G2 is 3.9528× 10−5. Thus, the null hypothesis is rejected and
we conclude that there is an association between the markers and the disease.
3.3 Generalized T 2 Test
The generalized T 2 statistic for case-control association studies of complex dis-
ease is proposed by Xiong et al. (2002). We describe this method in the case of
data without missing genotype for a single marker in subsection 3.3.1 and for a
double marker in subsection 3.3.2.
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3.3.1 Single Marker Genotype-Based Method
Suppose we take random samples of n controls and m cases, where their geno-
types have one of three forms AA,Aa and aa. We define a variable Xi for the
i-th individual in the control sample and a variable Yj for the j-th individual in
case sample by
Xi, Yj =

−1 if control i or case j has genotype AA,
0 if control i or case j has genotype Aa,
1 if control i or case j has genotype aa,
for i = 1, 2, . . . , n and j = 1, 2, ...,m. Then X1, X2, ..., Xn and Y1, Y2, ..., Ym
are two independent samples, and we can test the null hypothesis that the two
samples have the same population mean, i.e. H0 : µcontrols = µcases by using the
T 2 statistic, which is defined as
T 2 =
(X¯ − Y¯ )2
S2
(
1
n +
1
m
) = nm
n+m
(
X¯ − Y¯
)2
S2
, (3.3.1)
where
S2 =
∑n
i=1(Xi − X¯)2 +
∑m
i=1(Yi − Y¯ )2
n+m− 2 , (3.3.2)
and
X¯ =
∑n
i=1 Xi
n
, Y¯ =
∑m
i=1 Yi
m
. (3.3.3)
It can be shown that under the null hypothesis T 2 is asymptotically distributed
as a χ21 if n,m→∞.
Example 3.10 Based on Table 3.4, we have n = 27, m = 31 and X¯ = 0.3333,
Y¯ = 0.9355, and S2 = 0.2120. The value of T 2 is
T 2 =
(27)(31)
(27 + 31)
(0.3333− 0.9355)2
0.2120
= 24.6856,
and the p-value of T 2 is 6.7553 × 10−7. Thus, the null hypothesis is rejected
and we conclude that there is an association between the marker genotype and
the disease.
3.3.2 Double Marker Genotype-Based Method
Consider a case-control study with n controls andm cases, where each individual
has been typed for two biallelic markers. We define variables Xi1 and Xi2 for
the i-th individual in the sample of controls where
Xi1 =
 −1 if the genotype in locus 1 is AA,0 if the genotype in locus 1 is Aa,
1 if the genotype in locus 1 is aa,
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and
Xi2 =

−1 if the genotype in locus 2 is BB,
0 if the genotype in locus 2 is Bb,
1 if the genotype in locus 2 is bb,
for i = 1, 2, ..., n. Similarly, we define variable Yj1 and Yj2 for the cases j =
1, 2, . . . ,m. Let
Xi = (Xi1, Xi2), Yi = (Yi1, Yi2),
X¯k =
∑n
i=1 Xik
n
, Y¯k =
∑m
i=1 Yik
m
,
for k = 1, 2, and let X¯ = (X¯1, X¯2)
t and Y¯ = (Y¯1, Y¯2)
t be the mean vectors for
controls and cases, respectively. The T 2 statistic is defined as
T 2 =
nm
n+m
(X¯ − Y¯ )tS−1(X¯ − Y¯ ), (3.3.4)
where
S =
1
n+m− 2
[ n∑
i=1
(Xi − X¯)(Xi − X¯)t +
m∑
i=1
(Yi − Y¯ )(Yi − Y¯ )t
]
.
It can be shown that under the null hypothesis T 2 possesses a χ2 with two
degrees of freedom if n,m→∞.
Example 3.11 Based on Table 3.7 and 3.8, we have n = 25, m = 26, X¯ =
(0.3200,−0.0800)t, Y¯ = (0.9231,−0.5385)t, and
S =
(
0.2303 −0.3192
−0.3192 0.5576
)
.
Then the statistical value is
T 2 =
(25)(26)
51
(−0.6031, 0.4585)
(
21.0204 12.0332
12.0332 8.6818
)(−0.6031
0.4585
)
= 35.8902.
The p-value of T 2 is almost 1.6089 × 10−8. Thus, the null hypothesis is re-
jected and we conclude that there is an association between the markers and
the disease.
3.4 Logistic Regression
The idea is to code, for each individual i, the genotypic information in regression
variables Xi1, Xi2, . . . , XiL and apply logistic regression of the affection status
Yi on Xi1, Xi2, . . . , XiL. To set up the coding there are several possibilities :
1. Genotypic mapping
The observed marker data (unordered genotypes at one or more marker
loci) are mapped in the regression variables in a simple and dirrect manner.
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2. Haplotypic mapping
The regression variables give a coding of haplotypes at a set of marker loci.
Because haplotypes are typically not fully observable, it is then required to
apply logistic regression with incomplete data on the regression variables.
This is easiest implemented using the score statistic.
3. Causal mapping
The regression variables are defined in term of a set of causal genotypes
or haplotypes, i.e. the genomic loci that are biologically responsible for
the affection. Because the causal loci are not known, we then need a
model connecting the causal genotypes to the marker genotypes, next to
the logistic regression model for affection status on causal genotypes. It
is then assumed that given the causal genotypes the affection status is
independent of the marker genotypes.
From a modeling perspective the third possibility appears to be the most attrac-
tive. However, this possibility also creates the greatest technical difficulties and
requires additional modeling, which may introduce errors. This possibility was
proposed by Clayton et al. (2004). The special choices made for the regression
models make that the final test statistic is very close to the statistic obtained
through direct regression on the marker data.
Formulation of the testing problem within the context of logistic regres-
sion gives great flexibility, both allowing the use of smaller and bigger models
to describe the genotypic effect. Smaller models are for instance obtained by
modeling the effects of different loci additively. On the other hand, by using
enough dummy variables the regression can also be carried out on a complete
classification of the set of genotypes.
To fix notation we first describe the logistic regression model and next apply
it to each possibility. The methods can be extended to genetic data with missing
genotype information.
3.4.1 Logistic Regression
Suppose we summarize the genotype or haplotype information of individual i
for i = 1, 2, . . . , N , where N is the total number of cases and controls, in L
numerical scores Xi1, Xi2, . . . , XiL. Let Yi = 1 denote that the i-th individual
is affected, and let Yi = 0 otherwise. Let P (Yi = 1|Xi1, Xi2, . . . , XiL) be the
probability that an individual is affected given the genetic information. We
adopt the logistic regression model
pi =
exp(β0 + β1Xi1 + . . .+ βLXiL)
1 + exp(β0 + β1Xi1 + . . .+ βLXiL)
=
exp(Xtiβ)
1 + exp(Xtiβ)
, (3.4.1)
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where Xi = (1, Xi1, . . . , XiL)
t and β = (β0, β1, . . . , βL)
t. The log-likelihood
function of the data can be expressed as
l(β) =
N∑
i=1
[Yi log(pi) + (1− Yi) log(1− pi)]
=
N∑
i=1
[
Yi log
( exp(β0 + β1Xi1 + . . .+ βLXiL)
1 + exp(β0 + β1Xi1 + . . .+ βLXiL)
)
−(1− Yi) log
(
1 + exp(β0 + β1Xi1 + . . .+ βLXiL)
)]
=
N∑
i=1
Yi(β0 + β1Xi1 + . . .+ βLXiL)
−
N∑
i=1
log
(
1 + exp(β0 + β1Xi1 + . . .+ βLXiL)
)
=
N∑
i=1
YiX
t
iβ −
N∑
i=1
log(1 + exp(Xtiβ)).
We want to test the association between the markers and the disease, i.e. to
test the null hypothesis H0 : β1 = . . . = βL = 0.
Deviance
The deviance D is defined as twice the log-likelihood ratio statistic, given by
D = 2 log
( L(βˆ)
L(βˆ0)
)
= 2[logL(βˆ)− logL(βˆ0)] = 2[l(βˆ)− l(βˆ0)],
where βˆ0 is the MLE of β under H0 and βˆ is the MLE of β under the model in
which (β0, β1, . . . , βL) vary freely over RL+1. Under H0, the statistic D has a
chi-squared distribution with L degrees of freedom, asymptotically as N →∞,
(provided that the matrixX tX defined below converges to a matrix of full rank).
Score Test
The score vector is S(β) = ∂l(β)∂β =
(
∂l(β)
∂β0
, ∂l(β)∂β1 , . . . ,
∂l(β)
∂βL
)t
, where
∂l(β)
∂βj
=
N∑
i=1
(Yi − pi)Xij
=
N∑
i=1
YiXij −
N∑
i=1
exp(Xtiβ)
1 + exp(Xtiβ)
Xij (3.4.2)
for j = 0, 1, 2, . . . , L, and Xi0 = 1 for i = 1, 2, . . . , N. Let
H(β) = (hjk(β))(L+1)×(L+1)
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for j, k = 0, 1, 2, . . . , L denote the Hessian matrix, where
hjk(β) =
∂2l(β)
∂βj∂βk
= −
N∑
i=1
XijXik(1− pi)pi
= −
N∑
i=1
exp(Xtiβ))
[1 + exp(Xtiβ)]
2
XijXik.
The Hessian matrix can be expressed as H(β) = −X tWX, where
W =

p1(1− p1) 0 . . . 0
0 p2(1− p2) . . . 0
. . . . . . . . . . . .
0 0 . . . pN (1− pN)

is an N ×N diagonal matrix and
X =

1 X11 X12 . . . X1L
1 X21 X22 . . . X2L
. . . . . . . . . . . . . . .
1 XN1 XN2 . . . XNL
 .
The (j, k)-th element of the Fisher information matrix I(β) is
Ijk(β) = − ∂
2l(β)
∂βj∂βk
= −hjk(β)
for j, k = 0, 1, 2, . . . , L.
Under the null hypothesis, the log-likelihood function is a function of β0 only
and becomes
l0(β0) =
N∑
i=1
Yiβ0 −
N∑
i=1
log
(
1 + exp(β0)
)
and
∂l0(β0)
∂β0
=
N∑
i=1
Yi −
N∑
i=1
p0,
where p0 = e
β0/(1 + eβ0) is the common value of pi under the null hypoth-
esis. Thus, the MLE of p0 is pˆ0 = Y¯ . The MLE of β under H0 is βˆ0 =(
log
(
pˆ0
1−pˆ0
)
, 0, . . . , 0
)
. The score vector evaluated at the value βˆ0 is obtained
by replacing every pi in equation (3.4.1) by pˆ0 and can be written
S(β)|β=βˆ0 =
(∂l(β)
∂β0
,
∂l(β)
∂β1
, . . . ,
∂l(β)
∂βL
)t
|β=βˆ0 = Xt(Y − Y¯ 1),
where Y = (Y1, Y2, . . . , Yn) and 1 = (1, 1, . . . , 1)
t. Under the null hypothesis
H0, the Hessian matrix becomes H(βˆ0) = Y¯ (1 − Y¯ )XtX . Finally, the score
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statistic TS is
TS = (S(β)|β=βˆ0)tH(βˆ0)−1S(β)|β=βˆ0
=
1
Y¯ (1− Y¯ ) (Y − Y¯ 1)
tX(XtX)−1Xt(Y − Y¯ 1) (3.4.3)
and TS has a chi-squared distribution with L degrees of freedom, asymptotically
as N → ∞ under the null hypothesis, provide that X tX is asymptotically of
full rank.
Example 3.12 As illustration we specify the preceding to the case of a sin-
gle regression variable (L = 1), which we denote by Xi rather than Xi1.
S(β)|β=βˆ0 =
(
1 1 1 . . . 1
X1 X2 X3 . . . XN
)
Y1 − Y¯
Y2 − Y¯
. . .
YN − Y¯

=
(
0∑N
i=1(Yi − Y¯ )Xi
)
. (3.4.4)
Under the null hypothesis H0, the Hessian matrix becomes
H(βˆ0) = Y¯ (1− Y¯ )XtX = Y¯ (1− Y¯ )
(
N
∑N
i=1Xi∑N
i=1 Xi
∑N
i=1X
2
i
)
and
H(βˆ0)
−1 =
1
Y¯ (1− Y¯ )
(
N
∑N
i=1 X
2
i − (
∑N
i=1Xi)
2
) ( ∑Ni=1 X2i −∑Ni=1 Xi−∑Ni=1 Xi N
)
.
Finally, the score test becomes
TS = S(β)|tβ=βˆ0H(βˆ0)
−1S(β)|β=βˆ0
=
1
Y¯ (1− Y¯ )
(
N
∑N
i=1X
2
i − (
∑N
i=1 Xi)
2
)
×
(
0,
N∑
i=1
(Yi − Y¯ )Xi
)( ∑N
i=1 X
2
i −
∑N
i=1Xi
−∑Ni=1Xi N
)(
0∑N
i=1(Yi − Y¯ )Xi
)
=
[
∑N
i=1(Yi − Y¯ )Xi]2
Y¯ (1− Y¯ )
(
N
∑N
i=1X
2
i − (
∑N
i=1 Xi)
2
) . (3.4.5)
3.4.2 Genotypic Mapping
Given marker information on L loci we may define for each locus a numerical
score Xij by mapping the genotype to a set of numbers. For instance, we would
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use the numbers {2, 1, 0} in the case of a biallelic marker with alleles A and a,
setting Xij equal to 2, 1 or 0 if the genotype at locus j is AA,Aa or aa.
Given this scoring we can apply the likelihood ratio or score test, as described
in section 3.4.1.
Of course, the scoring method influences the power of the test. For instance,
using scores {1, 1, 0} or {4, 1, 0} would lead to a different test, and possibly a
different conclusion. Scoring in terms of numbers of alleles appears the most
frequent strategy (see e.g. Ott and Hoh, 2001, Byng et al., 2003 and North et
al., 2006).
3.4.3 Haplotypic Mapping
If we expect interactions between loci due to parental origins, then it is natural
to define scores Xij in terms of haplotype instead of unordered genotypes. This
is particularly natural for loci that are closely linked. In this section we illustrate
haplotypic coding for two biallelic marker (loci).
Consider two biallelic marker loci with alleles A and a at the first locus and
alleles B and b at the second locus. The two-loci genotype is given by a pair of
two haplotypes, where each haplotype is AB, Ab, aB and ab. We define variables
X1, X2, and X3 to be the numbers of haplotypes AB,Ab and aB of individual
i, respectively. (Then 2− (Xi1 +Xi2 +Xi3) is the number of haplotypes ab.)
The score vector at βˆ0 for the logistic regression model with observations
(Yi, Xi1, Xi2, Xi3) is
S(β)|β=βˆ0 =

1 1 1 . . . 1
X11 X21 X31 . . . XN1
X12 X22 X32 . . . XN2
X13 X23 X33 . . . XN3


Y1 − Y¯
Y2 − Y¯
. . .
YN − Y¯

=

0∑N
i=1(Yi − Y¯ )Xi1∑N
i=1(Yi − Y¯ )Xi2∑N
i=1(Yi − Y¯ )Xi3
 .
Because we do not observe haplotypes, but instead the unordered genotypes for
the loci, we replace the score vector by its conditional expectation
S(β)|β=βˆ0 =

0∑N
i=1(Yi − Y¯ )E[Xi1|Oi]∑N
i=1(Yi − Y¯ )E[Xi2|Oi]∑N
i=1(Yi − Y¯ )E[Xi3|Oi]
 = N∑
i=1
E[Xti |Oi](Yi − Y¯ ),
where Oi are the observed unordered genotypes. A test statistic TS is now
obtained by replacing the matrix X in (3.4.3) by its conditional expectation
given Oi. Here,
E[X
t
i |Oi]E[X
t
i |Oi] =0BBBB@
N
PN
i=1 E[Xi1|Oi]
PN
i=1 E[Xi2|Oi]
PN
i=1 E[Xi3|Oi]PN
i=1 E[Xi1|Oi]
PN
i=1 E[Xi1|Oi]2
PN
i=1 E[Xi1|Oi]E[Xi2|Oi]
PN
i=1 E[Xi1|Oi]E[Xi3|Oi]PN
i=1 E[Xi2|Oi]
PN
i=1 E[Xi2|Oi]E[Xi3|Oi]
PN
i=1 E[Xi3|Oi]2
PN
i=1 E[Xi2|Oi]E[Xi3|Oi]PN
i=1 E[Xi3|Oi]
PN
i=1 E[Xi1|Oi]E[Xi3|Oi]
PN
i=1 E[Xi2|Oi]E[Xi3|Oi]
PN
i=1 E[Xi3|Oi]2
1CCCCA .
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can be considered an estimate of the covariance matrix of S(βˆ0).
Table 3.14 gives the expected score vector given the observed genotype. For
most observed pairs of unordered genotypes the haplotypes, and hence the vari-
ables Xi1, Xi2, Xi3 can be inferred with certainty. For instance, the expected
numbers of haplotypes AB, Ab and aB in the observed unordered genotype
AABB are 2, 0, 0, respectively. The unordered genotype AaBb is the ex-
ceptional in that it results from two possible ordered genotypes : AB/ab and
Ab/aB. The expected number of haplotypes AB given this observed unordered
genotype is given by
E[Xi1|AaBb] = 1× P (AB/ab|AaBb) + 0× P (Ab/aB|AaBb)
=
2pABpab
2pABpab + 2pAbpaB
=
pABpab
pABpab + pAbpaB
.
Here pAB , pab, pAb, paB are the relative frequencies of the haplotypes AB, ab,
Ab, aB in the population. In the test statistic these are replaced by their
maximum likelihood estimates under the null hypothesis, where we assume HW
equilibrium at the haplotype level. Similarly, E[X2|AaBb] and E[X3|AaBb] can
be found.
In case the genotype at one of loci is unobserved, we can follow a similar pro-
cedure, by conditioning on the observed, we can follow a similar procedure, by
conditioning on the observed data only. For instance, the genotype AA/NoCall
leads to three possible unordered genotypes, i.e AABB, AABb and AAbb, where
each has probability
P (AABB|AA/NoCall),
P (AABb|AA/NoCall), and P (AAbb|AA/NoCall), respectively. Because, the ex-
pected numbers of haplotypes AB, in the unordered genotypes AABB, AABb
and AAbb are 2, 1, and 0, then we have
E[Xi1|AA/NoCall] = 2× P (AABB|AA/NoCall) + 1× P (AABb|AA/NoCall)
+ 0× P (AAbb|AA/NoCall)
=
2p2AB + 2pABpAb
p2AB + 2pABpAb + p
2
Ab
.
Similarly, E[Xi2|AA/NoCall] and E[Xi3|AA/NoCall] can be found.
3.4.4 Causal Mapping
In this subsection, we describe the method developed by Clayton et al. (2004).
It is assumed that the genetic basis of the affection can be coded in two
vectors X
(1)
i , X
(2)
i , for each individual i, which are summaries of the paternal
and maternal haplotypes. For intance, the affection might be caused by k loci
and are vectors of length k coding the status of the haplotypes at locus j in their
j-th coordinate. More complicated coding schemes are possible too. Clayton et
al. (2004) actually assume that X
(1)
i and X
(2)
i are one dimensional and refer
to a single causal locus. It is assumed that the probability of affection can be
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modelled as a logistic regression on the sum Xi = X
(1)
i +X
(2)
i of the two causal
haplotype encodings. Of course, we observe the genome at marker loci only. It
is assumed that the haplotype encodings X
(1)
i +X
(2)
i satisfy a linear regression
model
E(Xi|O˜i) = ω + γtO˜i,
for O˜i vectors that encode the haplotypes at the marker loci.
Would we have observed the causal haplotypes (X
(1)
i , X
(2)
i ), then, under the
assumption of the logistic regression model for affection on causal haplotypes,
we would have used the score statistic(∑N
i=1(Yi − Y¯ )X(1)i∑N
i=1(Yi − Y¯ )X(2)i
)
as the basis for a test. Under the assumption that the two haplotypes contribute
additively, we would reduce this vector to
N∑
i=1
(Yi − Y¯ )(X(1)i +X(2)i ) =
N∑
i=1
(Yi − Y¯ )Xi.
Given only marker data O˜i, it is reasonable to replace this statistic by its
conditional expectation
N∑
i=1
(Yi − Y¯ )E(X(1)i +X(2)i |O˜i) = γt
N∑
i=1
(Yi − Y¯ )O˜i.
The haplotype encodings O˜i might simply be indicator variables corresponding
to the different haplotypes, but this typically leads to vectors of high dimension.
A decomposition in main and interaction effects appears more attractive.
Lacking phase information we typically do not observe the marker haplo-
type either. The variables O˜i are then replaced by the conditional expectations
given the observed data. We describe single marker and double marker cases in
subsection 3.4.4.1 and subsection 3.4.4.2, respectively.
3.4.4.1 Single Marker
We consider the situation of subsection 3.4.2 in the single marker case. In the
single marker case, O˜i is 2, 1, 0 for genotype AA,Aa and aa, respectively. We
base the statistical test T on U =
∑N
i=1(Yi − Y¯ )O˜i and T becomes
T = U tV −1U, (3.4.6)
where V = Var(U), under H0, and V can be estimated by
Vˆ =
1
N − 1
N∑
i=1
(Yi − Y¯ )2
N∑
i=1
(O˜i − ¯˜O)2.
The statistical test T has a chi-squared distribution with 1 degree of freedom
as N →∞.
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Oi E[Xi1|Oi] E[Xi2|Oi] E[Xi3|Oi]
AABB 2 0 0
AABb 1 1 0
AAbb 0 2 0
AaBB 1 0 1
AaBb
pABpab
pABpab+pAbpaB
pAbpaB
pABpab+pAbpaB
pAbpaB
pABpab+pAbpaB
Aabb 0 1 0
aaBB 0 0 2
aaBb 0 0 1
aabb 0 0 0
AA/NoCall
2p2AB+2pABpAb
p2
AB
+2pABpAb+p
2
Ab
2pABpAb+2p
2
Ab
p2
AB
+2pABpAb+p
2
Ab
0
Aa/NoCall
pABpaB+pABpab
pABpaB+pABpab+pAbpaB+pAbpab
pAbpaB+pAbpab
pABpaB+pABpab+pAbpaB+pAbpab
pABpaB+pAbpaB
pABpaB+pABpab+pAbpaB+pAbpab
aa/NoCall 0 0
2p2aB+2paBpab
p2
aB
+2paBpab+p
2
ab
NoCall/BB
2p2AB+2pABpaB
p2
AB
+2pABpaB+p
2
aB
0
2pABpaB+2p
2
aB
p2
AB
+2pABpaB+p
2
aB
NoCall/Bb
pABpAb+pABpab
pABpAb+pABpab+pAbpaB+paBpab
pABpAb+pAbpaB
pABpAb+pABpab+pAbpaB+paBpab
pAbpaB+paBpab
pABpAb+pABpab+pAbpaB+paBpab
NoCall/bb 0
2p2Ab+2pAbpab
p2
Ab
+2pAbpab+p
2
ab
0
Table 3.14: The expected score vector (E[Xi1|Oi], E[Xi2|Oi], E[Xi3|Oi]) given the observed genotype Oi.
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3.4.4.2 Double Marker
We consider the situation of subsection 3.4.2 in double marker case. We base
the test on the vector U =
∑N
i=1(Yi − Y¯ )O˜i and the statistical test T becomes
T = U tV U, (3.4.7)
where V = Var(U), under H0 and  denotes a generalized inverse. The matrix
V can be estimated by
Vˆ =
1
N − 1
N∑
i=1
(Yi − Y¯ )2
N∑
i=1
(
O˜i − ¯˜O
)(
O˜i − ¯˜O
)t
. (3.4.8)
Under the null hypothesis the statistical test T has a chi-squared distribution
with degrees of freedom equal to the rank of V asymptotically as N →∞.
Table 3.15 gives the expected score vector given the observed genotype using
causal mapping (Clayton’s method). For instance, the observed genotype AABb
gives a pair of haplotypes AB/Ab so that E[Xi|AABb] = (2, 1)t. The observed
genotype AaBb has two possible pairs of haplotypes, i.e. AB/ab and Ab/aB.
Both of them give E[Xi|AaBb] = (1, 1)t. The genotype AA/NoCall can be one
of three possible unordered genotypes, i.e AABB, AABb and AAbb, with proba-
bility P (AABB|AA/NoCall), P (AABb|AA/NoCall) and P (AAbb|AA/NoCall),
respectively. Then
E[Xi|AA/NoCall]
= (2, 2)t × P (AABB|AA/NoCall) + (2, 1)t × P (AABb|AA/NoCall)
+ (2, 0)t × P (AAbb|AA/NoCall)
=
(
2,
2p2AB + 2pABpAb
p2AB + 2pABpAb + p
2
Ab
)t
.
3.4.5 Examples
Based on the data in Table 3.4, the value of the deviance D, the score statistic
TS and Clayton’s statistic T are given in Table 3.16, together with the p-values
for testing the null hypothesis of no association. The null hypothesis is rejected
for all statistics and we conclude that there is an association between the marker
and the disease. Using Table 3.7 and Table 3.8, the value of score statistic T
and Clayton’s statistic are given in Table 3.17. The null hypothesis is rejected
for all statistics. Finally, we apply the score test T and Clayton’s method to
the data in Tables 3.12 and 3.13 and find the values given in Table 3.18. The
null hypothesis is rejected for all statistics and we conclude that there is an
association between the markers and the disease.
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Oi O˜i
AABB (2, 2)t
AABb (2, 1)t
AAbb (2, 0)t
AaBB (1, 2)t
AaBb (1, 1)t
Aabb (1, 0)t
aaBB (0, 2)t
aaBb (0, 1)t
aabb (0, 1)t
AA/NoCall
“
2,
2p2AB+2pABpAb
p2
AB
+2pABpAb+p
2
Ab
”t
Aa/NoCall
“
1, 2pABpABpaB+pABpab+pAbpaB
pABpaB+pABpab+pAbpaB+pAbpab
”t
aa/NoCall
“
0,
2p2aB+2paBpab
p2
aB
+2paBpab+p
2
ab
”t
NoCall/BB
“
2p2AB+2pABpaB
p2
AB
+2pABpaB+p
2
ab
, 2
”t
NoCall/Bb
“
2pABpAb+pABpab+pAbpaB
pABpAb+pABpab+pAbpaB+paBpab
, 1
”t
NoCall/bb
“
2p2Ab+2pAbpab
p2
Ab
+2pAbpab+p
2
ab
, 0
”t
Table 3.15: The expected score vector given the observed genotype using Clayton’s method.
Statistic Value p-value
D 20.9890 4.6193 × 10−6
TS 17.7440 2.5271 × 10−5
T 17.4381 2.9681 × 10−5
Table 3.16: Table of values and p-values for deviance D, score statistic TS and Clayton’s
statistic T using Table 3.4.
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Statistic Value p-value
TS 15.7744 1.2614 × 10−3
T 15.4651 4.3833 × 10−4
Table 3.17: Table of values and p-values for score statistic and Clayton’s statistic using
Table 3.7 and Table 3.8.
Statistic Value p-value
TS 18.6057 3.2983 × 10−4
T 18.1921 1.1211 × 10−4
Table 3.18: Table of values and p-values for score statistic and Clayton’s statistic using
Table 3.12 and Table 3.13.
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Chapter 4
Bayesian SNP Data
Analysis
In this chapter we describe and apply two Bayesian approaches to analyze asso-
ciation of biallelic markers to a disease. The first approach is based on Bayesian
model choice, where the two models are a null model, in which population fre-
quencies of alleles, genotypes or haplotypes are equal for controls and cases, and
an alternative model in which they are different. The second approach comes
from the objective Bayesian school and attempts to obtain a measure of evi-
dence in favour or against a null hypothesis by using an information criterion
and objective priors.
4.1 Bayesian Model Choice Approach
Suppose that we obtain data X and Y on a sample of controls and an inde-
pendent sample of cases and we wish to investigate whether controls and cases
are different. If X and Y possess densities x 7→ p(x|θ) and y 7→ q(y|θ) indexed
by a common parameter set Θ, then we may view this a choice between two
statistical models for the joint observation (X,Y ) :
1. Model (0) : (X,Y ) possesses density (x, y) 7→ p(x, θ)q(y|θ), where θ ∈ Θ
is unknown,
2. Model (1) : (X,Y ) possesses density (x, y) 7→ p(x, θ)q(y|θ′), where (θ, θ′) ∈
Θ×Θ is unknown,
Model (0) corresponds to a “null hypothesis” H0 : θ = θ
′ within model (1).
A choice based on a Bayesian approach is to put prior probabilities, on the
models (1) and (0) and priors on the parameters in each of the models, and
next calculate the posterior probability of the model. To set this up, it is
convenient to introduce an indicator value S, which is 0 or 1 indicating validity
of model (0) or (1). Next in the Bayesian formulation :
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1. Given S and (θ, θ′) the observation (X,Y ) has density
(x, y) 7→ p(x|θ)q(y|θ′).
2. Given S = 0, θ is distributed according to some prior pi0 on Θ, and θ
′ = θ.
3. Given S = 1, the variables θ and θ′ are independent and distributed
according to priors pi and pi′ on Θ.
Within this Bayesian set-up we may now compute the posterior probability
P (S = 1|X,Y ). A large value of this probability indicates that the null hypoth-
esis is false. Of course, the value of P (S = 1|X,Y ) will depend on the prior
probability t = P (S = 1). Table 4.1 gives a scale of the posterior probability
P (S = 1|X,Y ) related to the strength of evidence that the null hypothesis is
false using modified Jeffreys’ criteria by assumption t = P (S = 1) = 0.5 (Kass
and Raftery, 1995). For instance, if the posterior probability is equal to 0.96
then we have strong evidence that the null hypothesis is false. Statistical anal-
ysis of microarray data using this idea is proposed by Gottardo et al. (2003).
In this section, we adapt this method to SNP data.
P (S = 1|X, Y ) Strength of evidence
P (S = 1|X, Y ) < 0.500 Negative
0.500 ≤ P (S = 1|X,Y ) < 0.7500 Barely worth mentioning
0.7500 ≤ P (S = 1|X, Y ) < 0.9231 Positive
0.9231 ≤ P (S = 1|X, Y ) < 0.9934 Strong
P (S = 1|X, Y ) ≥ 0.9934 Very Strong
Table 4.1: Relation of P (S = 1|X, Y ) and the strength of evidence using modified Jeffreys’
criteria.
4.1.1 Single Marker Allele-Based Method
In this section, we use the notations and assumptions of subsection 3.1.1, but
we replace p1 by p and q1 by q. We introduce a random variable S indicating
whether the marker is associated to the disease. A priori it is assumed that S
is 0 or 1 with probabilities 1− t and t, respectively.
Given the parameters, the observations X and Y are independent and pos-
sess Binom(2n, p) and Binom(2m, q)-distributions, respectively. When S = 1
we choose p and q a priori independent with Beta(α1, δ1) and Beta(α2, δ2)-
distributions, where α1, δ1, α2, and δ2 are given parameters, i.e. the densities of
p and q are
pi1(p) =
Γ(α1 + δ1)
Γ(α1)Γ(δ1)
pα1−1(1− p)δ1−1,
pi2(q) =
Γ(α2 + δ2)
Γ(α2)Γ(δ2)
qα2−1(1− q)δ2−1.
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When S = 0, we choose p and q a priori equal and having a Beta(α3, β3)-
distribution with density
pi3(r) =
Γ(α3 + δ3)
Γ(α3)Γ(δ3)
rα3−1(1− r)δ3−1,
where α3 and δ3 are given parameters. Then, the joint distribution of X and Y
given that the marker is associated with the disease (S = 1) is given by
P (X = n1, Y = m1|S = 1)
=
∫
p
∫
q
P (X = n1|S = 1, p)P (Y = m1|S = 1, q)pi1(p)pi2(q)dqdp
=
∫
p
∫
q
Binom(2n, p)Binom(2m, q)pi1(p)pi2(q)dpdq
=
(∫
p
Binom(2n, p)pi1(p)dp
)(∫
q
Binom(2m, q)pi2(q)dq
)
= c2
(∫
p
pn1+α1−1(1− p)2n−n1+δ1−1dp
)
× c3
(∫
q
qm1+α2−1(1− q)2m−m1+δ2−1dq
)
,
where c2 =
(
2n
n1
)
Γ(α1+δ1)
Γ(α1)Γ(δ1)
and c3 =
(
2m
m1
)
Γ(α2+δ2)
Γ(α2)Γ(δ2)
. Thus
P (X = n1, Y = m1|S = 1)
= c2c3
Γ(n1 + α1)Γ(2n− n1 + δ1)
Γ(2n+ α1 + δ1)
Γ(m1 + α2)Γ(2m−m1 + δ2)
Γ(2m+ α2 + δ2)
.
The joint distribution of X and Y given that the marker is not associated with
the disease (S = 0) is given by
P (X = n1, Y = m1|S = 0)
=
∫
r
P (X = n1|S = 0, r)P (Y = m1|S = 0, r)pi3(r)dr
=
∫
r
Binom(2n, r)Binom(2m, r)pi3(r)dr
=
∫
r
f1(r)pi3(r)dr,
where
f1(r) =
(
2n
n1
)(
2m
m1
)
rn1+m1(1− r)2n+2m−n1−m1 .
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Thus,
P (X = n1, Y = m1|S = 0)
= c1
∫
r
rn1+m1+α3−1(1− r)2(n+m)−n1−m1+δ3−1dr,
= c1
Γ(n1 +m1 + α3)Γ(2n− n1 + 2m−m1 + δ3)
Γ(2(n+m) + α3 + δ3)
,
where
c1 =
(
2n
n1
)(
2m
m1
)
Γ(α3 + δ3)
Γ(α3)Γ(δ3)
.
By Bayes’ rule, the posterior probability that the marker is associated to the
disease given the marker data X = n1 and Y = m1, is
P (S = 1|X = n1, Y = m1)
=
P (X = n1, Y = m1|S = 1)P (S = 1)
P (X = n1, Y = m1|S = 0)P (S = 0) + P (X = n1, Y = m1)|S = 1)P (S = 1)
=
h
1 +
P (X = n1, Y = m1|S = 0)
P (X = n1, Y = m1|S = 1)
P (S = 0)
P (S = 1)
i−1
=
h
1 +
P (X = n1, Y = m1|S = 0)
P (X = n1, Y = m1|S = 1)
1− t
t
i−1
, (4.1.1)
where
P (X = n1, Y = m1|S = 0)
P (X = n1, Y = m1|S = 1)
=
Γ(α3 + δ3)Γ(α1)Γ(δ1)Γ(α2)Γ(δ2)
Γ(α3)Γ(δ3)Γ(α1 + δ1)Γ(α2 + δ2)
× Γ(n1 +m1 + α3)Γ(2n− n1 + 2m−m1 + δ3)Γ(2n+ α1 + δ1)Γ(2m + α2 + δ2)
Γ(2(n +m) + α3 + δ3)Γ(n1 + α1)Γ(2n − n1 + δ1)Γ(m1 + α2)Γ(2m −m1 + δ2)
.
(4.1.2)
Example 4.1 Based on Table 3.2 and using a Bayesian model choice for single
marker allele-based methods, all parameters for the Beta priors equal to one
and an uninformative prior of t = P (S = 1), we find the posterior probability
that the marker is associated with the disease is equal to 0.9996. Thus, we have
very strong evidence that there is an association between the marker and the
disease.
4.1.2 Single Marker Genotype-Based Method
As in subsection 4.1.1, let S indicate whether the marker is associated to the
disease, and possess a priori a Bernoulli(t)-distribution.
Given the parameters, the observations X and Y are independent and pos-
sess multinomial distributions with parameters n and p = (p1, p2, p3), and m
and q = (q1, q2, q3). When S = 1, the parameters p and q are a priori inde-
pendent and possess Dirichlet(α4, δ4, η4) and Dirichlet(α5, δ5, η5)-distributions,
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respectively. Thus, the densities of p and q are
pi4(p) =
Γ(α4 + δ4 + η4)
Γ(α4)Γ(δ4)Γ(η4)
pα4−11 p
δ4−1
2 p
η4−1
3 ,
pi5(q) =
Γ(α5 + δ5 + η5)
Γ(α5)Γ(δ5)Γ(η5)
qα5−11 q
δ5−1
2 q
η5−1
3 ,
where p = (p1, p2, p3), q = (q1, q2, q3), and α4, δ4, η4, and α5, δ5, η5 are given
parameters. When S = 0, the parameters p and q are a priori equal and
Dirichlet(α6, δ6, η6)-distributed, i.e. p = q has density
pi6(r) =
Γ(α6 + δ6 + η6)
Γ(α6)Γ(δ6)Γ(η6)
rα6−11 r
δ6−1
2 r
η6−1
3 ,
where r = (r1, r2, r3), and α6, δ6, η6 are given parameters. Then, the joint
distribution of X and Y given that the marker is associated with the disease
(S = 1) is
P (X = x,Y = y|S = 1)
=
Z
p
Z
q
P (X = x|S = 1,p)P (Y = y|S = 1,q)pi4(p)pi5(q)dpdq
=
Z
p
Z
q
Multi(n,p)Multi(m,q)pi4(p)pi5(q)dpdq
=
“Z
p
c5p
n1+α4−1
1 p
n2+δ4−1
2 p
n3+η4−1
3 dp
”“Z
q
c6q
n1+α5−1
1 q
n2+δ5−1
2 q
n3+η5−1
3 dq
”
,
where
c5 =
(
n
x
)
Γ(α4 + δ4 + η4)
Γ(α4)Γ(δ4)Γ(η4)
, c6 =
(
m
y
)
Γ(α5 + δ5 + η5)
Γ(α5)Γ(δ5)Γ(η5)
.
Thus, the joint distribution of X and Y given that the marker is associated with
the disease (S = 1) is
P (X = x,Y = y|S = 1)
= c5c6
Γ(n1 + α4)Γ(n2 + δ4)Γ(n3 + η4)
Γ(n+ α4 + δ4 + η4)
Γ(m1 + α5)Γ(m2 + δ5)Γ(m3 + η5)
Γ(m+ α5 + δ5 + η5)
.
Similarly, the joint distribution of X and Y given that the marker is not asso-
ciated with the disease (S = 0) is
P (X = (n1, n2, n3),Y = (m1,m2,m3)|S = 0)
=
∫
r
P (X = (n1, n2, n3)|S = 0, r)P (Y = (m1,m2,m3)|S = 0, r)pi6(r)dr
=
∫
r
Multi(n, r)Multi(m, r)pi6(r)dr
=
∫
r
f2(r)pi6(r)dr,
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where
f2(r) =
(
n
x
)(
m
y
)
rn1+m11 r
n2+m2
2 r
n3+m3
3 ,
x = (n1, n2, n3), y = (m1,m2,m3).
Thus,
P (X = x,Y = y|S = 0) = c4
∫
r
rn1+m1+α6−11 r
n2+m2+δ6−1
2 r
n3+m3+η6−1
3 dr,
where
c4 =
(
n
x
)(
m
y
)
Γ(α6 + δ6 + η6)
Γ(α6)Γ(δ6)Γ(η6)
.
Furthermore,
P (X = x,Y = y|S = 0)
= c4
Γ(n1 +m1 + α6)Γ(n2 +m2 + δ6)Γ(n3 +m3 + η6)
Γ(n+m+ α6 + δ6 + η6)
. (4.1.3)
Finally, the posterior probability that the marker is associated to the disease
given the observations X = (n1, n2, n3) and Y = (m1,m2,m3), i.e.
P (S = 1|X = x,Y = y)
can be computed from P (X = x,Y = y|S = 0) and P (X = x,Y = y|S = 1) by
Bayes’ theorem as in (4.1.1).
Example 4.2 Using Table 3.4 and a Bayesian model choice for single marker
genotype-based methods, all parameters for the Dirichlet priors is equal to one
and an uninformative prior for t = P (S = 1), we have the posterior probability
that the marker is associated with the disease is equal to 0.9994. Thus, we have
very strong evidence that there is an association between the marker and the
disease.
4.1.3 Double Marker Genotype-Based Method
Consider two loci in Hardy-Weinberg equilibrium. Let the random vector
X = (XAABB , XAABb, XAAbb, XAaBB , XAaBb, XAabb, XaaBB , XaaBb, Xaabb)
gives the numbers of individuals in the control sample with the given two loci
(unordered) genotypes as given in Table 3.5. Define a random vector Y in
the same way for the sample of cases. Given the parameters the vectors X
and Y are assumed independent with Multi(n,w) and Multi(n,u)-distributions,
respectively, where
w = (wAABB , wAABb, wAAbb, wAaBB , wAaBb, wAabb, waaBB , waaBb, waabb)
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and u is indexed similarly. Thus
P (X = x|S = 1,w) =
(
n
x
)
(wAABB)
xAABB (wAABb)
xAABb(wAAbb)
xAAbb
×(wAaBB)xAaBB (wAaBb)xAaBb(wAabb)xAabb
×(waaBB)xaaBB (waaBb)xaaBb(waabb)xaabb . (4.1.4)
In this method, the basic parameters are the frequencies of the haplotypes
AB,Ab, aB and ab, i.e. pAB, pAb, paB and pab, respectively. Of the nine two
loci unordered genotypes in Table 3.5, eight can be resolved uniquely in their
haplotypes, and their frequencies can be expressed in the haplotype frequen-
cies under the assumption of Hardy-Weinberg equilibrium. For example, the
genotype of individual AABB can be resolved uniquely as AB/AB so that
(wAABB)
xAABB = (pAB)
2xAABB .
The exceptional genotype is AaBb, which can be resolved as AB/ab and Ab/aB.
The corresponding frequency can be decomposed as
wAaBb = 2pABpab + 2pAbpaB
and hence
(wAaBb)
xAaBb = (2pABpab + 2pAbpaB)
xAaBb
= 2xAaBb
xAaBb∑
k=0
(
xAaBb
k
)
pkABp
k
ab(pAbpaB)
xAaBb−k.
Therefore, always assuming Hardy-Weinberg equilibrium, we can rewrite equa-
tion (4.1.4) as
P (X = x|S = 1,w)
=
(
n
x
)
2n−xAABB−xAAbb−xaaBB−xaabb
×
[ xAaBb∑
k=0
(
xAaBb
k
)
(pAB)
xAB(k)(pAb)
xAb(k)(paB)
xaB(k)(pab)
xab(k)
]
,
where
xAB(k) = 2xAABB + xAABb + xAaBB + k,
xAb(k) = xAABb + 2xAAbb + xAabb + xAaBb − k,
xaB(k) = xAaBB + 2xaaBB + xaaBb + xAaBb − k,
xab(k) = xAabb + xaaBb + 2xaabb + k,
and pAB , pAb, paB and pab are the frequencies of haplotypes AB, Ab, aB and
ab in the control sample. Note that, although the quantities in the last display
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depend on the summation index, they are observable. Similarly,
P (Y = y|S = 1,u)
=
(
m
y
)
2m−yAABB−yAAbb−yaaBB−yaabb
×
[ yAaBb∑
l=0
(
yAaBb
l
)
(qAB)
yAB(l)(qAb)
yAb(l)(qaB)
yaB(l)(qab)
yab(l)
]
,
where
yAB(l) = 2yAABB + yAABb + yAaBB + l,
yAb(l) = yAABb + 2yAAbb + yAabb + yAaBb − l,
yaB(l) = yAaBB + 2yaaBB + yaaBb + yAaBb − l,
yab(l) = yAabb + yaaBb + 2yaabb + l,
and qAB , qAb, qaB , qab are the frequencies of haplotypes AB, Ab, aB, ab in
sample of cases, respectively.
Suppose the prior density of the haplotype frequencies
p = (pAB , pAb, paB , pab)
and q = (qAB , qAb, qaB , qab) are
pi7(p) =
Γ(α7 + δ7 + η7 + τ7)
Γ(α7)Γ(δ7)Γ(η7)Γ(τ7)
(pAB)
α7−1(pAb)δ7−1(paB)η7−1(pab)τ7−1,
pi8(q) =
Γ(α8 + δ8 + η8 + τ8)
Γ(α8)Γ(δ8)Γ(η8)Γ(τ8)
(qAB)
α8−1(qAb)δ8−1(qaB)η8−1(qab)τ8−1.
Then, the joint distribution of X and Y given that the genotype of markers are
associated with the disease is
P (X = x,Y = y|S = 1)
=
Z
p
Z
q
P (X = x|S = 1, p)P (Y = y|S = 1, q)pi7(p)pi8(q)dpdq
=
“ Z
p
c8
xAaBbX
k=0
„
xAaBb
k
«
(pAB)
xAB (k)+α7−1(pAb)xAb(k)+δ7−1(paB )xaB(k)+η7−1(pab)xab(k)+τ7−1dp
”
×
“ Z
q
c9
yAaBbX
l=0
„
yAaBb
l
«
(qAB )
yAB (l)+α8−1(qAb)yAb(l)+δ8−1(qaB )yaB (l)+η8−1(qab)yab(l)+τ8−1dq
”
=
“
c8
xAaBbX
k=0
„
xAaBb
k
« Γ(xAB (k) + α7)Γ(xAb(k) + δ7)Γ(xaB (k) + η7)Γ(xab(k) + τ7)
Γ(xAB (k) + xAb(k) + xaB(k) + xab(k) + α7 + δ7 + η7 + τ7)
”
×
“
c9
yAaBbX
l=0
„
yAaBb
l
« Γ(yAB (l) + α8)Γ(yAb(l) + δ8)Γ(yaB (l) + η8)Γ(yab(l) + τ8)
Γ(yAB (l) + yAb(l) + yaB(l) + yab(l) + α8 + δ8 + η8 + τ8)
”
, (4.1.5)
where
c8 =
„
n
x
«
2n−xAABB−xAAbb−xaaBB−xaabb
Γ(α7 + δ7 + η7 + τ7)
Γ(α7)Γ(δ7)Γ(η7)Γ(τ7)
,
c9 =
„
m
y
«
2m−yAABB−yAAbb−yaaBB−yaabb
Γ(α8 + δ8 + η8 + τ8)
Γ(α8)Γ(δ8)Γ(η8)Γ(τ8)
. (4.1.6)
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Similarly, P (X = x,Y = y|S = 0) can be found. Finally, the posterior proba-
bility that the markers are associated to the disease given the data X = x and
Y = y, i.e. P (S = 1|X = x,Y = x) can be computed from
P (X = x,Y = y|S = 0)
and P (X = x,Y = y|S = 1) by Bayes’ theorem as in (4.1.1).
Example 4.3 Based on Table 3.7, Table 3.8 and using a Bayesian model choice
for double marker genotype-based methods, all parameters for the Dirichlet pri-
ors equal to one and an uninformative prior for t = P (S = 1), we have that the
posterior probability that the marker is associated with the disease is equal to
0.9560. Thus, we have strong evidence that there is an association between the
markers and the disease.
4.1.4 Double Marker Genotype-Based Method
with Missing Data
Consider two loci in Hardy-Weinberg equilibrium. Let the random vector X =
(XC ,XD ,XE), where
XC = (XAABB , XAABb, XAAbb, XAaBB , XAaBb, XAabb, XaaBB , XaaBb, Xaabb),
XD = (XAA/NoCall, XAa/NoCall, Xaa/NoCall),
XE = (XNoCall/BB , XNoCall/Bb, XNoCall/bb).
are the vectors of genotype of double markers in control sample as given in
Table 3.10. The vectors XC ,XD ,XE are independent. The random vector XC
possesses Multi(nC ,vC)-distribution, where
nC = xAABB +xAABb+xAAbb+xAaBB+xAaBb+xAabb+xaaBB+xaaBb+xaabb
and
vC = (vAABB , vAABb, vAAbb, vAaBB , vAaBb, vAabb, vaaBB , vaaBb, vaabb),
where, for example, vAABB is the probability of genotype AABB in control
sample. Furthermore, the random vector XD possesses Multi(nD,vD) and the
random vector XE possesses Multi(nE ,vE)-distribution where
nD = xAA/NoCall + xAa/NoCall + xaa/NoCall,
nE = xNoCall/BB + xNoCall/Bb + xNoCall/bb,
and
vD = (vAA/NoCall, vAa/NoCall, vaa/NoCall),
vE = (vNoCall/BB , vNoCall/Bb, vNoCall/bb).
The probability of vAA/NoCall can be expressed as
vAA/NoCall = vAABB + vAABb + vAAbb
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and by using Hardy-Weinberg equilibrium,
vAA/NoCall = p
2
AB + 2pABpAb + p
2
Ab = (pAB + pAb)
2 = p2A,
where pA is the allele frequency of A, and pAB and pAb are the frequencies of
haplotypes AB and Ab, respectively. Similarly,
vAa/NoCall = 2pApa, vaa/NoCall = p
2
a,
vNoCall/BB = p
2
B , vNoCall/Bb = 2pBpb, vNoCall/bb = p
2
b ,
where pa, pB and pb are the allele frequencies of a, B and b, respectively; and
paB and pab are the frequencies of haplotype aB and ab, respectively. Then
P (XD = xD|S = 1, v)
=
(
nD
xD
)
(vAA/NoCall)
xAA/NoCall(vAa/NoCall)
xAa/NoCall(vaa/NoCall)
xaa/NoCall
=
(
nD
xD
)
(p2A)
xAA/NoCall(2pApa)
xAa/NoCall(p2a)
xaa/NoCall
=
(
nD
xD
)
2xAa/NoCall(pA)
2xAA/NoCall+xAa/NoCall(pa)
xAa/NoCall+2xaa/NoCall
=
(
nD
xD
)
2xAa/NoCall
(pAB + pAb)
2xAA/NoCall+xAa/NoCall(paB + pab)
xAa/NoCall+2xaa/NoCall
=
(
nD
xD
)
2xAa/NoCall
×
[ d1∑
h=0
(
d1
h
)
(pAB)
h(pAb)
d1−h
][ d2∑
l=0
(
d2
l
)
(paB)
l(pab)
d2−l
]
=
(
nD
xD
)
2xAa/NoCall
×
[ d1∑
h=0
d2∑
l=0
(
d1
h
)(
d2
l
)
(pAB)
h(pAb)
d1−h(paB)l(pab)d2−l
]
, (4.1.7)
where d1 = 2xAA/NoCall + xAa/NoCall and d2 = xAa/NoCall + 2xaa/NoCall. Simi-
larly,
P (XE = xE |S = 1, v)
=
(
nE
xE
)
(vNoCall/BB)
xNoCall/BB (vNoCall/Bb)
xNoCall/Bb(vNoCall/bb)
xNoCall/bb
=
(
nE
xE
)
2xNoCall/Bb
×
[ d3∑
i=0
d4∑
j=0
(
d3
i
)(
d4
j
)
(pAB)
i(paB)
d3−i(pAb)j(pab)d4−j
]
, (4.1.8)
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where d3 = 2xNoCall/BB + xNoCall/Bb and d4 = xNoCall/Bb + 2xNoCall/bb. Fur-
thermore, by using the results in the previous subsection, we have
P (X = (xC ,xD ,xE)|S = 1,p)
= P (XC = xC |S = 1,p)P (XD = xD |S = 1,p)P (XE = xE |S = 1,p)
=
(
nC
xC
)
(vAABB)
xAABB (vAABb)
xAABb(vAAbb)
xAAbb
×(vAaBB)xAaBB (vAaBb)xAABb(vAAbb)xAAbb
×(vaaBB)xaaBB (vaaBb)xaaBb(vaabb)xaaAbb
×
(
nD
xD
)
(vAA/NoCall)
xAA/NoCall(vAa/NoCall)
xAa/NoCall(vaa/NoCall)
xaa/NoCall
×
(
nE
xE
)
(vNoCall/BB)
xNoCall/BB (vNoCall/Bb)
xNoCall/Bb(vNoCall/bb)
xNoCall/bb
=
(
nC
xC
)
2xAABb+xAaBB+xAaBb+xAabb+xaaBb
×
(
nD
xD
)(
nE
xE
)
2xAa/NoCall+xNoCall/Bb
×
[ xAaBb∑
k=0
(
xAaBb
k
)
(pAB)
xAB(k)(pAb)
xAb(k)(paB)
xaB(k)(pab)
xab(k)
]
×
[ d1∑
h=0
d2∑
l=0
(
d1
h
)(
d2
l
)
(pAB)
h(pAb)
d1−h(paB)l(pab)d2−l
]
×
[ d3∑
i=0
d4∑
j=0
(
d3
i
)(
d4
j
)
(pAB)
i(paB)
d3−i(pAb)j(pab)d4−j
]
,
where
xAB(k) = 2xAABB + xAABb + xAaBB + k,
xAb(k) = xAABb + 2xAAbb + xAabb + xAaBb − k,
xaB(k) = xAaBB + 2xaaBB + xaaBb + xAaBb − k,
xab(k) = xAabb + xaaBb + 2xaabb + k.
Thus,
P (X = (xC ,xD,xE)|S = 1,p)
= c10
xAaBb∑
k=0
d1∑
g=0
d2∑
l=0
d3∑
i=0
d4∑
j=0
[
f4(pAB)
x′AB(k,h,l,i,j)(pAb)
x′Ab(k,h,l,i,j)
×(paB)x′aB(k,h,l,i,j)(pab)x′ab(k,h,l,i,j)
]
, (4.1.9)
87
where
c10 =
(
nC
xC
)
2xAABb+xAaBB+xAaBb+xAabb+xaaBb
×
(
nD
xD
)(
nE
xE
)
2xAa/NoCall+xNoCall/Bb ,
f4 =
(
xAaBb
k
)(
d1
h
)(
d2
l
)(
d3
i
)(
d4
j
)
,
x′AB(k, h, l, i, j) = 2xAABB + xAABb + xAaBB + k + i+ h,
x′Ab(k, h, l, i, j) = xAABb + 2xAAbb + xAabb + xAaBb − k + d1 − h+ j,
x′aB(k, h, l, i, j) = xAaBB + 2xaaBB + xaaBb + xAaBb − k + l + d3 − i,
x′ab(k, h, l, i, j) = xAabb + xaaBb + 2xaabb + k + d2 − l + d4 − j. (4.1.10)
Suppose the prior density of haplotype frequencies vector
p = (pAB , pAb, paB , pab)
is
pi10(p) =
Γ(α10 + δ10 + η10 + τ10)
Γ(α10)Γ(δ10)Γ(η10)Γ(τ10)
(pAB)
α10−1(pAb)δ10−1(paB)η10−1(pab)τ10−1.
Then,
P (X = (xC ,xD,xE)|S = 1)
=
Z
p
P (X = (xC ,xD,xE)|S = 1,p)pi10(p)dp
=
Z
p
c10
xAaBbX
k=0
d1X
g=0
d2X
l=0
d3X
i=0
d4X
j=0
h
f4(pAB)
x′AB(k,h,l,i,j)(pAb)
x′Ab(k,h,l,i,j)(paB)
x′aB(k,h,l,i,j)
×(pab)x
′
ab(k,h,l,i,j)
i
pi10(p)dp
= c10
xAaBbX
k=0
d1X
h=0
d2X
l=0
d3X
i=0
d4X
j=0
f4
Z
p
(pAB)
x′AB(k,h,l,i,j)(pAb)
x′Ab(k,h,l,i,j)
×(paB)x
′
aB(k,h,l,i,j)(pab)
x′ab(k,h,l,i,j)pi10(p)dp
= c11c10
xAaBbX
k=0
d1X
g=0
d2X
l=0
d3X
i=0
d4X
j=0
f4f5,
where
f5 =
Γ(x′AB (k, h, l, i, j) + α10)Γ(x
′
Ab(k, h, l, i, j) + δ10)Γ(x
′
aB (k, h, l, i, j) + η10)Γ(x
′
ab(k, h, l, i, j) + τ10)
Γ(x′
AB
(k, h, l, i, j) + x′
Ab
(k, h, l, i, j) + x′
aB
(k, h, l, i, j) + x′
ab
(k, h, l, i, j) + α10 + δ10 + η10 + τ10)
,
c11 =
Γ(α10 + δ10 + η10 + τ10)
Γ(α10)Γ(δ10)Γ(η10)Γ(τ10)
.
By using similar reasoning and with the prior density of haplotype frequencies
vector q = (qAB , qAb, qaB , qab) equal to
pi11(q) =
Γ(α11 + δ11 + η11 + τ11)
Γ(α11)Γ(δ11)Γ(η11)Γ(τ11)
(qAB)
α11−1(qAb)δ11−1(qaB)η11−1(qab)τ11−1,
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we have
P (Y = (yC ,yD,yE)|S = 1)
=
Z
q
P (Y = (yC ,yD ,yE)|S = 1,q)pi11(q)dq
=
Z
q
c12
yAaBbX
k′=0
d5X
h′=0
d6X
l′=0
d7X
i′=0
d8X
j′=0
h
f6(qAB)
y′AB(k
′,l′,h′,i′,j′)(qAb)
y′Ab(k
′,l′,h′,i′,j′)
×(qaB)y
′
aB(k
′,l′,h′,i′,j′)(qab)
y′ab(k
′,l′,h′,i′,j′)
i
pi11(q)dq
= c12
yAaBbX
k′=0
d5X
h′=0
d6X
l=0
d7X
i′=0
d8X
j′=0
f6
Z
q
(qAB)
y′AB(k
′,l′,h′,i′,j′)(qAb)
y′Ab(k
′,l′,h′,i′,j′)
×(qaB)y
′
aB(k
′,l′,h′,i′,j′)(pab)
y′ab(k
′,l′,h′,i′,j′)pi11(q)dq
= c13c12
yAaBbX
k′=0
d5X
h′=0
d6X
l′=0
d7X
i′=0
d8X
j′=0
f6f7, (4.1.11)
where
c13 =
Γ(α11 + δ11 + η11 + τ11)
Γ(α11)Γ(δ11)Γ(η11)Γ(τ11)
,
c12 =
„
mC
yC
«
2yAABb+yAaBB+yAaBb+yAabb+yaaBb„
mD
yD
«„
mE
yE
«
2yAa/NoCall+yNoCall/Bb ,
f6 =
„
yAaBb
k′
«„
d5
h′
«„
d6
l′
«„
d7
i′
«„
d8
j′
«
,
f7 =
Γ1Γ2
Γ3
,
Γ1 = Γ(y
′
AB(k
′, l′, h′, i′, j′) + α11)Γ(y′Ab(k
′, l′, h′, i′, j′) + δ11),
Γ2 = Γ(y
′
aB(k
′, l′, h′, i′, j′) + η11)Γ(y′ab(k
′, l′, h′, i′, j′) + τ11),
Γ3 = Γ(z + α11 + δ11 + η11 + τ11),
z = y′AB(k
′, l′, h′, i′, j′) + y′Ab(k
′, l′, h′, i′, j′)
+y′aB(k
′, l′, h′, i′, j′) + y′ab(k
′, l′, h′, i′, j′),
y′AB(k
′, l′, h′, i′, j′) = 2yAABB + yAABb + yAaBB + k′ + i′ + h′,
y′Ab(k
′, l′, h′, i′, j′) = yAABb + 2yAAbb + yAabb + yAaBb − k′ + d5 − h′ + j′,
y′aB(k
′, l′, h′, i′, j′) = yAaBB + 2yaaBB + yaaBb + yAaBb − k′ + l′ + d′7 − i′,
y′ab(k
′, l′, h′, i′, j′) = yAabb + yaaBb + 2yaabb + k′ + d6 − l′ + d8 − j′,
d5 = 2yAA/NoCall + yAa/NoCall, d6 = yAa/NoCall + 2yaa/NoCall,
d7 = 2yNoCall/BB + yNoCall/Bb, d8 = yNoCall/Bb + 2yNoCall/bb.
When S = 1, the conditional probabilities are
(X|S = 1,w) = (XC ,XD,XE |S = 1,w) = (XC ,XD ,XE |S = 1,p),
(Y|S = 1,u) = (YC ,YD,YE |S = 1,u) = (YC ,YD,YE |S = 1,q),
and the prior density of haplotype frequencies p and q are pi12(p) and pi13(q),
respectively. Then the joint probability of X and Y given that the genotype of
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markers are associated with the disease is
P (X = (xC, xD, xE),Y = (yC, yD, yE)|S = 1)
=
Z
p
Z
q
P (X = (xC, xD, xE)|S = 1,w)P (Y = (yC, yD, yE)|S = 1,u)pi12(p)pi13(q)dqdp
=
Z
p
Z
q
P (X = (xC, xD, xE)|S = 1, p)P (Y = (yC, yD, yE)|S = 1, q)pi12(p)pi13(q)dqdp
=
“ Z
p
P (X = (xC, xD, xE)|S = 1,p)pi12(p)dp
”
“ Z
q
P (Y = (yC, yD, yE)|S = 1, q)pi13(p)dq
”
= P (X = (xC, xD, xE)|S = 1)P (Y = (yC, yD, yE)|S = 1). (4.1.12)
Similarly, P (X = (xC ,xD,xE),Y = (yC ,yD,yE)|S = 0) can be found. Finally,
the posterior probability that the markers are associated to the disease given
the markers data X = (xC ,xD ,xE) and Y = (yC ,yD,yE), i.e.
P (S = 1|X = (xC ,xD,xE),Y = (yC ,yD,yE)),
can be computed from P (X = (xC ,xD,xE),Y = (yC ,yD,yE)|S = 0) and
P (X = (xC ,xD,xE),Y = (yC ,yD,yE)|S = 1)
by Bayes’ theorem as in (4.1.1).
Example 4.4 Using Table 3.12, Table 3.13, a Bayesian model choice for double
markers genotype-based methods, all parameters for the Dirichlet priors equal
to one and an uninformative prior for t = P (S = 1), we have that the posterior
probability that the marker is associated with the disease is equal to 0.9899.
Thus, we have strong evidence that there is an association between the markers
and the disease.
4.2 Bayesian Reference Approach
Bayesian inference is often criticized for its reliance on prior distributions, whose
choice influences the conclusions. In particular, in testing theory the necessity
of assigning prior probabilities to the two hypotheses appears awkward. The
Bayesian reference approach overcomes this criticism by an objective choice
of priors. It aims at producing inference statements that only depend on the
assumed model and the available data (Bernardo, 2005). In the next subsection,
we describe a reference approach for general testing problems. In subsection
4.2.2 and 4.2.3, we propose a reference approach for single marker using allele-
based methods and genotype-based methods, respectively.
4.2.1 Introduction
Suppose that we observe data X whose distribution is governed by a parameter
θ belonging to a parameter set Θ and we wish to investigate whether θ belongs
to a subset Θ0 ⊂ Θ. Given a prior on Θ and a function δ(θ,Θ0) measuring
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discrepancy between a parameter θ and the null parameter set Θ0, it is natural
to base inference on the posterior discrepancy
d(Θ0, X) =
∫
δ(θ,Θ0)pi(θ|X)dθ (4.2.1)
where pi(θ|X) is the posterior distribution of θ. Bernardo and Rueda (2002) pro-
pose to use a reference prior and the (symmetrized) Kullback-Leibler divergence
as the discrepancy measure. The latter is defined as
δ(θ,Θ0) = inf
θ0∈Θ0
min{K(p(x|θ), p(x|θ0)),K(p(x|θ0), p(x|θ))},
for x 7→ p(x|θ) the density of X and K the Kullback-Leibler divergence of p1
from p2
K(p1, p2) =
∫
p1(x) log
(p1(x)
p2(x)
)
dx.
Bernardo and Rueda (2002) call equation (4.2.1) based on these choices the
intrinsic statistic. Reference priors are proposed as consensus priors designed
to have a minimal effect, relative to the data, on the posterior inference. If the
observed data X follows a smooth one-parameter model, the reference prior will
be the Jeffreys’ prior, i.e. pi(θ) ∝ i(θ)1/2, and for a k-parameter model where
k > 1, we can also use Jeffreys’ prior, but then pi(θ) ∝
[
det
(
i(θ)
)]1/2
, where
i(θ) is the Fisher information function.
We shall apply this approach to testing whether the distributions of two
independent observations X and Y are governed by the same parameters, as
in section 4.1. The full parameter is a pair (θ, θ′) ranging over a product set
Θ = Θ¯× Θ¯, and the observation (X,Y ) possesses density
(x, y) 7→ p(x|θ)q(y|θ′).
The null model corresponds to the parameter set Θ0 = {(θ, θ) : θ ∈ Θ¯}. Because
X and Y are independent, the reference prior is the product of the reference
priors for the two parameters θ and θ′. In our examples these are the Jeffreys’
priors.
The intrinsic statistic can be considered a measure of evidence against the
null model Θ0. Bernardo and Rueda (2002) claim that the numerical value may
be interpreted on an absolute scale independent of sample size and dimension-
ality. The null model is false if the intrinsic statistic d(Θ0, (X,Y )) is sufficiently
large. Formally, if d(Θ0, (X,Y )) ≤ 2.5 then we have no evidence that the null
model is false, if 2.5 < d(Θ0, (X,Y )) ≤ 5 then we have mild evidence that the
null model is false, if 5 < d(Θ0, (X,Y )) ≤ 8.5 then we have strong evidence that
the null model is false, and finally if d(Θ0, (X,Y )) > 8.5 then we have conclusive
evidence that the null model is false (Bernardo, 2003).
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4.2.2 Single Marker Allele-Based Method
In this section, we consider the situation of subsection 3.1.1. The probability
density function of X is
f(x|p) =
(
2n
x
)
px(1− p)2n−x
for x = 0, 1, 2, . . . , 2n and its logarithm is
log f(x|p) = log
(
2n
x
)
+ x log(p) + (2n− x) log(1− p).
Furthermore, the first and second partial derivative with respect to p are given
by
∂ log f(x|p)
∂p
=
x
p
− (2n− x)
(1− p)
and
∂2 log f(x|p)
∂p2
= − x
p2
− (2n− x)
(1− p)2 .
The Fisher information is
I(p) = −Ep
[∂2 log f(X |p)
∂p2
]
=
Ep[X ]
p2
+
Ep[2n−X ]
(1− p)2 = 2n
( 1
p(1− p)
)
.
The reference prior (Bernardo and Rueda, 2002) is in this case the Jeffreys’
prior, given by the density
pi1(p) ∝ |I(p)|1/2 ∝
( 1
p(1− p)
)1/2
= p
1
2−1(1− p) 12−1. (4.2.2)
Thus the reference prior is the Beta( 12 ,
1
2 )-distribution. The reference prior for
q is of course also this Beta-distribution and the reference prior for (p, q) has
density pi(p, q) = pi1(p)pi2(q).
The joint probability density function of X and Y is
h(x, y|p, q) = f(x|p)g(y|q)
=
(
2n
x
)
px(1− p)2n−x
(
2m
y
)
qy(1− q)2m−y.
Then the posterior density function of p and q given X = x and Y = y is
pi(p, q|x, y) ∝ pi(p, q)h(x, y|p, q)
∝ p 12−1(1− p) 12−1q 12−1(1− q) 12−1px(1− p)2n−xqy(1− q)2m−y
∝ px+ 12−1(1− p)2n−x+ 12−1qy+ 12−1(1− q)2m−y+ 12−1
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and thus p and q are independent under the posterior distribution, with a
Beta(x+ 12 , 2n−x+ 12 )-distribution and a Beta(y+ 12 , 2m− y+ 12 )-distribution,
respectively.
We wish to test the null hypothesis H0 : p = q. Let
Θ = {(p, q)t : 0 < p < 1, 0 < q < 1}
and Θ0 = {(p, q)t ∈ Θ : p = q}. The quotient of the densities of (X,Y ) for two
parameter values (p, q) and (r, s) is given by
h(x, y|p, q)
h(x, y|r, s) =
(
2n
x
)(
2m
y
)
px(1− p)2n−xqy(1− q)2m−y(
2n
x
)(
2m
y
)
rx(1− r)2n−xsy(1− s)2m−y
=
(p
r
)x(1− p
1− r
)2n−x(q
s
)y(1− q
1− s
)2m−y
and
log
(h(x, y|p, q)
h(x, y|r, s)
)
= x log
(p
r
)
+ (2n− x) log
(1− p
1− r
)
+y log
(q
s
)
+ (2m− y) log
(1− q
1− s
)
.
The Kulback-Leibler divergence between the probability density functions h(x, y|p, q)
and h(x, y|r, s) is the expected value of this expression under parameter value
(p, q)t, given by
K[(p, q)|(r, s)] = E(p,q)[X log
(p
r
)
+ (2n−X) log
(1− p
1− r
)
]
+E(p,q)[Y log
(q
s
)
+ (2m− Y ) log
(1− q
1− s
)
]
= 2np log
(p
r
)
+ (2n− 2np) log
(1− p
1− r
)
+2mq log
(q
s
)
+ (2m− 2mq) log
(1− q
1− s
)
= 2nL(p|r) + 2mL(q|s), (4.2.3)
where L(p|r) = p log
(
p
r
)
+(1−p) log
(
1−p
1−r
)
. The intrinsic discrepancy between
h(x, y|p, q) and h(x, y|p0, q0), where (p0, q0)t ranges over Θ0, is
δ[Θ0, (p, q)
t] = inf
0<p0<1
min
n
K[(p, q)|(p0, p0)], K[(p0, p0)|(p, q)]
o
= inf
0<p0<1
min
n
2nL(p|p0) + 2mL(q|p0), 2nL(p0|p) + 2mL(p0|q)
o
.
(4.2.4)
The intrinsic statistic is by definition the expected value of this discrepancy
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under the posterior distribution. It is given by
d[Θ0, (x, y)] =
Z
p
Z
q
δ[Θ0, (p, q)
t]pi(p, q|x, y)dpdq
=
Z
p
Z
q
inf
0<p0<1
min
n
2nL(p|p0) + 2mL(q|p0), 2nL(p0|p) + 2mL(p0|q)
o
pi(p, q|x, y)dpdq.
(4.2.5)
The exact value of the intrinsic statistic is not available in closed form, but may
easily be found by two-dimensional numerical integration.
Alternatively, we can obtain an asymptotic approximation for m,n → ∞.
Based on the Central Limit Theorem we know that, if n,m → ∞ such that
m
n → c then
√
m
(( x
2n
y
2m
)
−
(
p
q
))
; N2
((
0
0
)
, Q
)
, (4.2.6)
where ; denotes convergence in distribution and
Q =
(
p(1−p)c
2 0
0 q(1−q)2
)
.
The transformation φ : R2 → R2 given by
φ((a, b)t) = (2arcsin
√
a, 2arcsin
√
b)t
is variance-stabilizing and improves the approximation. By using the Delta
method, we have
√
m
(
φ
(( x
2n
y
2m
))
− φ
((
p
q
)))
; N2
((
0
0
)
,Σ
)
,
where
Σ = (φ′((p, q)t))tQφ′((p, q)t)
= (
1√
p
√
1− p,
1√
q
√
1− q )
(
p(1−p)
2 c 0
0 q(1−q)2
)(
1√
p
√
1−p
1√
q
√
1−q
)
=
(
c 0
0 1
)
.
These limit results suggest to make the approximation(
2 arcsin
√
x
2n
2 arcsin
√
y
2m
)
∼ N2
((
2 arcsin
√
p
2 arcsin
√
q
)
,
(
1
2n 0
0 12m
))
. (4.2.7)
Here ∼ denotes an approximation in distribution, valid for m,n→∞. We shall
from now on act as if this approximation is exact, event for finite m, n.
We thus consider the vector on the left of (4.2.7) to be normally distributed
with unknown mean and known covariance matrix. The mean is restricted to
the square [0, pi]2 through its parametrization in p and q, but we shall ignore
this fact and act as if it is completely unknown. Because the Fisher information
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in the normal location model is constant in the location parameter, the Jeffrey’s
prior is the uniform prior, which is improper if considered on the full real line.
We approximate it by N(0, λI) priors for λ → ∞. If the random variable W
possesses a N(α, 12n )-distribution and the prior distribution of α possesses a
N(0, λ)-distribution then the posterior distribution of α given W possesses a
N
(
2n
2n+ 1λ
w, 1
2n+ 1λ
)
-distribution. If λ→∞ the posterior distribution of α given
W possesses a N(w, 12n )-distribution. The coordinates in equation (4.2.7) are
independent, and so are the parameter p and q under the prior. Hence the
parameters are also independent under the posterior, where the posterior of p
depends only on X and the posterior of q depends only on Y also in prior so
are also independent in posterior. Thus, the posterior distribution is
((
2 arcsin
√
p
2 arcsin
√
q
)
|X,Y
)
∼ N2
(2 arcsin√ X2n
2 arcsin
√
Y
2m
 ,( 12n 0
0 12m
))
.
Then, it is easy to prove that
E
h
(2 arcsin
√
p− 2 arcsin√q)2|X,Y
i
=
1
2n
+
1
2m
+
h
2 arcsin
“rX
2n
”
− 2 arcsin
“r Y
2m
”i2
.
The Kullback-Leibler divergence between N2(µ,V) and N2(ν,V) is
K[µ|ν] =
∫
x
∫
y
h(x, y|µ) log
(h(x, y|µ)
h(x, y|ν)
)
dxdy
= Eµ
[
log
(h(X,Y |µ)
h(X,Y |ν)
)]
= Eµ
[
log exp
(
− 1
2
(U − µ)tV−1(U − µ) + 1
2
(U − ν)tV−1(U − ν)
)]
= Eµ
[
− 1
2
(U − µ)tV−1(U − µ) + 1
2
(X − ν)tV−1(U − ν)
]
= Eµ
[1
2
U tV−1(µ− ν) + 1
2
(µ− ν)tV−1U − 1
2
µtV−1µ+
1
2
νtV−1ν
]
= Eµ
[
U tV−1(µ− ν)− 1
2
µtV−1µ+
1
2
νtV−1ν
]
= µtV−1(µ− ν)− 1
2
µtV−1µ+
1
2
νtV−1ν
=
1
2
µtV−1µ− µtV−1ν + 1
2
νtV−1ν
=
1
2
(µ− ν)tV−1(µ− ν), (4.2.8)
where U = (X,Y ). Then, the intrinsic discrepancy between
N2
(
φ((p, q)t),
(
1
2n 0
0 12m
))
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and N2
(
φ((p0, p0)
t),
(
1
2n 0
0 12m
))
, where (p0, p0) varies over Θ0, is given by
δ[Θ0, (p, q)
t]
= inf
0<p0<1
K[φ((p, q)t)|φ((p0, p0)t)]
= inf
0<p0<1
2n
2
h
φ
“„p
q
«”
− φ
“„p0
p0
«”ith „ 1
2n
0
0 1
2m
«i−1h
φ
“„p
q
«”
− φ
“„p0
p0
«”i
= inf
0<p0<1
h
n(2 arcsin(
√
p)− 2 arcsin(√p0))2 +m(2 arcsin(√q)− 2 arcsin(√p0))2
i
.
(4.2.9)
For a, b ∈ [0, pi] the minimum of the function f1 : [0, pi] 7→ R given by
f1(c) = n(a− c)2 +m(b− c)2, c ∈ [0, pi],
is f1(
na+mb
m+n ) =
mn(a−b)2
m+n . Hence
δ[Θ0, (p, q)
t] =
mn
m+ n
(
2 arcsin(
√
p)− 2 arcsin(√q)
)2
. (4.2.10)
Finally, the intrinsic statistic is
d[Θ0, (X, Y )] ≈ E
h mn
m+ n
“
2 arcsin(
√
p)− 2 arcsin(√q)
”2|X, Y i
=
mn
m+ n
E
h
(2 arcsin(
√
p)− 2 arcsin(√q)
”2|X,Y i
=
mn
m+ n
h 1
2n
+
1
2m
+
“
2 arcsin
“p
X/(2n)
”
− 2 arcsin
“p
Y/(2m)
””2i
=
1
2
+
mn
m+ n
“
2 arcsin(
p
X/(2n))− 2 arcsin(
p
Y/(2m)
”2
. (4.2.11)
This formula will provide a reasonable approximation to the exact intrinsic
statistic if the observed values x, 2n− x, y, 2m − y, 2n and 2m are moderate
large (Bernardo, 2003). If the data do not satisfy this condition, Monte Carlo
or numerical integration is necessary to obtain a better approximation.
Example 4.4 Based on Table 3.2 and using the Bayesian reference approach for
single marker allele-based methods, we find the intrinsic statistic 10.4391. Thus,
we have conclusive evidence that there is an association between the marker and
the disease.
4.2.3 Single Marker Genotype-Based Method
In this section, we consider the situation of subsection 3.1.2. The probability
density function of X is
f(x|p) =
(
n
x
)
px11 p
x2
2 p
x3
3
for x1, x2, x3 = 0, 1, 2, . . . , n, x1 + x2 + x3 = n, 0 < p1, p2, p3 < 1, and p3 =
1− p1 − p2. The Fisher information matrix can be computed to be
I(p1, p2) =
(
n(1−p2)
p1(1−p1−p2)
n
1−p1−p2
n
1−p1−p2
n(1−p1)
p2(1−p1−p2)
)
.
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The reference prior is given by
pi1(p) ∝
( 1
p1p2p3
)1/2
= p
1
2−1
1 p
1
2−1
2 p
1
2−1
3 .
Thus, the reference prior is the Dirichlet( 12 ,
1
2 ,
1
2 )-distribution. The reference
prior for q is the same distribution, and the reference prior for (p,q) is the
independent combination of the two marginal priors.
The joint probability density function of X and Y is
h(x,y|p,q) = f(x|p)g(y|q) =
(
n
x
)
px11 p
x2
2 p
x3
3
(
m
y
)
qy11 q
y2
2 q
y3
3 .
Then the posterior density function of (p,q) given X = x and Y = y is
pi3(p,q|x,y) ∝ pi1(p)pi2(q)h(x,y|p,q)
∝ p 12−11 p
1
2−1
2 p
1
2−1
3 q
1
2−1
1 q
1
2−1
2 q
1
2−1
3 p
x1
1 p
x2
2 p
x3
3 q
y1
1 q
y2
2 q
y3
3
= p
x1+
1
2−1
1 p
x2+
1
2−1
2 p
x3+
1
2−1
3 q
y1+
1
2−1
1 q
y2+
1
2−1
2 q
y3+
1
2−1
3 .
Thus the posterior pi3(p,q|x,y) is the independent combination of the
Dirichlet(x1 +
1
2
, x2 +
1
2
, x3 +
1
2
)
distribution for p and the Dirichlet(y1 +
1
2 , y2 +
1
2 , y3 +
1
2 )-distribution for q.
We wish to test the null hypothesis H0 : p = q. Let
Θ = {(p,q) : 0 < p1, p2, p3 < 1, p1 + p2 + p3 = 1,
0 < q1, q2, q3 < 1, q1 + q2 + q3 = 1}
and Θ0 = {(p,q) ∈ Θ : p = q}. The quotient of the densities of (X,Y) for two
parameter values (p,q) and (r, s) is given by
h(x,y|p,q)
h(x,y|r, s) =
(
n
x
)(
m
y
)
px11 p
x2
2 p
x3
3 q
y1
1 q
y2
2 q
y3
3(
n
x
)(
m
y
)
rx11 r
x2
2 r
x3
3 s
y1
1 s
y2
2 s
y3
3
=
(p1
r1
)x1(p2
r2
)x2(p3
r3
)x3(q1
s1
)y1(q2
s2
)y2(q3
s3
)y3
and
log
(h(x,y|p,q)
h(x,y|r, s)
)
= x1 log
(p1
r1
)
+ x2 log
(p2
r2
)
+ x3 log
(p3
r3
)
+y1 log
(q1
s1
)
+ y2 log
(q2
s2
)
+ y3 log
(q3
s3
)
.
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The Kulback-Leibler divergence between the probability density functions h(x,y|p,q)
and h(x,y|r, s) is the expected value of this expression under parameter value
(p,q)t, given by
K[(p,q)|(r, s)] = E(p,q)
[
X1 log
(p1
r1
)
+X2 log
(p2
r2
)
+X3 log
(p3
r3
)]
+E(p,q)
[
Y1 log
(q1
s1
)
+ Y2 log
(q2
s2
)
+ Y3 log
(q3
s3
)]
= np1 log
(p1
r1
)
+ np2 log
(p2
r2
)
+ np3 log
(p3
r3
)
+mq1 log
(q1
s1
)
+mq2 log
(q2
s2
)
+mq3 log
(q3
s3
)
= nL(p|r) +mL(q|s),
where L(p|r) =
[
p1 log
(
p1
r1
)
+ p2 log
(
p2
r2
)
+ p3 log
(
p3
r3
)]
.
The intrinsic discrepancy between h(x,y|p,q) and h(x,y|p0,q0) where (p0,q0)
ranges over Θ0, is
δ[Θ0, (p,q)] = inf
p0
min
n
K[(p,q)|(p0,p0)], K[(p0,p0)|(p,q)]
o
= inf
p0
min
n
nL(p|p0) +mL(q|p0), nL(p0|p) +mL(p0 |q)
o
, (4.2.12)
where the infimum is taken over all probability vectors p0 = (p01, p02, p03). Then
the intrinsic statistic is given by
d[Θ0, (x,y)] =
Z
p
Z
q
δ[Θ0, (p,q)]pi(p,q|x,y)dpdq
=
Z
p
Z
q
inf
p0
min
n
nL(p|p0) +mL(q|q0), nL(p0|p) +mL(q0|q)
o
pi(p,q|x,y)dpdq.
(4.2.13)
The intrinsic statistic cannot be found in closed form, but may easily be com-
puted by Monte Carlo integration.
Example 4.4 Using Table 3.4 and the Bayesian reference approach for single
marker genotype-based methods, we find the intrinsic statistic 9.8827. Thus, we
have conclusive evidence that there is an association between the marker and
the disease.
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Chapter 5
Whole-genome SNP Data
Analysis
The case-control methods of Chapter 3 and Chapter 4 can be applied to each
SNP separately or to sets of SNPs, adjacent or not, but then require adjustment
for multiple testing. In this chapter we review and apply methods for adjusting
p-values, describe modeling of p-values distribution, describe some approaches
with a Bayesian flavour, and propose a two-stage procedure to search for interac-
tions between SNPs, where we take into account both computational feasibility
and statistical correctness.
5.1 Multiple Testing Correction Methods
A whole-genome analysis often consists of carrying out a large number of tests,
for instance a test for every separate SNP or every combination of SNPs. Car-
rying out such tests at the usual level of significance (e.g. 5 %) would result in
many false positives, i.e. markers that are found to be statistically significant
but in reality do not differ between the conditions. In this section, we review
several methods to adjust p-values.
We assume that M tests are performed, yielding p-values p1, p2, . . . , pM .
We let pr1 ≤ pr2 ≤ . . . ≤ prM , denote the ordered p-values. The adjustment
for multiple testing is expressed through replacing each of the p-values by a
different (larger) p-value.
Bonferroni Correction
The Bonferroni correction is the simplest possible correction. It simply multi-
plies every p-value by the number of tests
p˜ri = min{Mpri , 1}. (5.1.1)
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Holm Correction
The Holm correction is slightly less conservative than the Bonferroni correction.
It is given by the formula
p˜ri = max
k=1,2,...,i
{min{(M − k + 1)prk , 1}}. (5.1.2)
The p-values are sorted from the smallest to the largest. The smallest is mul-
tiplied by M, the second smallest by (M − 1), etc. These numbers are next
replaced by the monotone sequence consisting of the first number, the maxi-
mum of the first two numbers, etc. Of course, we can truncate these numbers
by 1.
Single-step Westfall and Young Permutation
This method applies to two sample (case-control) tests. Given the observations
(X,Y ) on the N = n+m individuals we randomly assign the labels “controls”
and “cases” to n and m individuals and next recompute the value of the test
statistic and corresponding p-values P1, P2, . . . , PM . Next the adjusted p-values
are defined as
p˜ri = P ( min
l=1,2,...,M
Pl ≤ pri |X,Y ). (5.1.3)
In practice, these p-values are computed by simulation of permutations, using
the algorithm :
1. Permute the sample labels.
2. Compute the p-values P1,b, P2,b, . . . , PM,b for the M markers.
3. Repeat step 1 and step 2 for B times and estimate the adjusted p-value
by
p˜ri =
#{1 ≤ b ≤ B : mini=1,2,...,M Pi,b ≤ pri}
B
. (5.1.4)
Step-down Westfall and Young Permutation
This method uses the same permutation as the single-step method, but the
formula for the adjusted p-values is
p˜ri = max
k=1,2,...,i
P ( min
l∈{rk,rk+1,...,rM}
Pl ≤ prk |X,Y ). (5.1.5)
Note that the probability on the right (without the maximum) is the single-step
Westfall and Young adjusted p-value computed after dropping the k − 1 tests
with the smallest original p-values. The maximum is added to ensure that the
adjusted p-values form a monotone sequence. To estimate these p-values we can
use the algorithm :
1. Permute the sample labels.
2. Compute the p-values P1,b, P2,b, . . . , PM,b for the M markers.
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3. Repeat step 1 and step 2 for B times and estimate the adjusted p-value
p˜ri by the proportion of minl∈{ri,ri+1,...,rM} Pl smaller than pri for i =
1, 2, . . . ,M .
4. Make the estimates monotone in i by replacing the ith by the maximum
of the first i estimates.
Benjamini and Hochberg Correction
The adjusted p-value can be formulated by
p˜ri = min
k=i,i+1,...,M
{min(Mprk/k, 1)}. (5.1.6)
This formula can be implemented by the algorithm :
1. The p-values are multiplied by M and divided by the numbers 1, 2, . . . ,M
(the smallest by 1, the second smallest by 2, etc).
2. The i-th adjusted p-value is the minimum of the i-th, (i+1)-th, . . . , M -th
values thus obtained.
Denote by R the number of rejected hypotheses from M null hypotheses
Hi, i = 1, 2, . . . ,M, and let M0 and M1 be the numbers of true and false null
hypotheses, respectively. The situation can be summarized as in Table 5.1.
Rejection of Hi corresponds to declaring that marker i is associated to the
disease. We want to minimize the number V of type I errors (false positives)
and the number T of type II errors (false negatives). Usually, we prespecify an
acceptable type I error rate α and seek tests that minimize type II error rate,
within the class of tests with type error rate α.
In this context, we can define the family-wise error rate (FWER) as the
probability of at least one type I error FWER = P (V ≥ 1). The false discovery
rate (FDR) is defined as the expected proportion of type I errors among rejected
hypotheses, FDR = E(V/R,R > 0) = E(V/R|R > 0)P (R > 0). The preceding
expectation and probability are conditional on which hypotheses are true or false
(i.e., on which markers are associated to the disease). We distinguish between
strong and weak control of the type I error rate. The terminology of strong
control refers to control of the type I error rate under any combination of true
and false hypotheses. In contrast, weak control refers to control of the type
I error rate only when none of the markers are associated to the disease (i.e.,
under the complete null hypothesis HC0 that all null hypotheses are true). In
our case, it seems particularly important to have strong control of type I error
rate (Yang and Speed, 2003).
For Bonferroni correction, control of the FWER in the strong sense follows
from Boole’s inequality. Assume without loss of generality that the true null
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No. not rejected No. rejected Total
No. true null hypotheses U V M0
No. false null hypotheses T S M1
M − R R M
Table 5.1: Counting errors in multiple testing.
hypotheses are Hi, for i = 1, 2, . . . ,M0. Then
FWER = P (V ≥ 1)
= P
( M0⋃
i=1
{p˜i ≤ α}
)
≤
M0∑
i=1
P (pi ≤ α
M
)
≤ M0
M
α,
where the last inequality follows from P (pi ≤ y|Hi) ≤ y, for any y ∈ [0, 1].
The Holm correction is less conservative than the Bonferroni correction,
which would multiply the p-values by M at each step. Note that taking suc-
cessive maxima of the quantities min{(M − k+ 1)prk , 1} enforces monotonicity
of the adjusted p-values. That is, p˜r1 ≤ p˜r2 ≤ . . . ≤ p˜rM , and one can only re-
ject a particular hypothesis provided all hypotheses with smaller p-values were
rejected beforehand (Ge et al., 2003).
To prove the correctness of the Westfall and Young adjusted p-values, we
introduce some formal notation. Let (X,Y ) be observations on n controls and m
cases, respectively, and let pi = pi(X,Y ) be the p-value corresponding to the ith
test (i = 1, 2, . . . ,M). Let Z = Z(X,Y ) be the collection of N = n+m values
X,Y stripped of the information whether they derive from a case or control.
Let W refer to a random split of N objects in two groups of sizes n and m and
let ZW = (ZW1 , ZW2) denote the corresponding split of the N values Z in two
groups.
The rationale of the Westfall and Young correction is that under the null
hypothesis the split ZW is equaly likely to lead back to the original data (X,Y ).
More formally : the conditional distributions of ZW given Z and of (X,Y ) given
Z are the same, for any set of values Z.
Each of the M tests can be carried out on the ”permuted” data ZW and
then leads to a p-value pi(ZW ), written Pi in the preceding. Let cα(ZW ) be the
α-quantile of the conditional distribution of mini pi(ZW ) given Z, i.e.
P (min
i
pi(ZW ) ≤ cα(Z)|Z) ' α.
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More precisely, to take into account the discreteness of the permutation distri-
bution, we define
cα(Z) = max{u : P (min
i
pi(ZW ) ≤ u|Z) ≤ α}.
The probabilities in these expressions refer to the randomness in the splitting,
expressed in W only. The probabilities would be the same if we conditioned
them on (X,Y ) rather than on Z, since ZW depends on (X,Y ) through Z only.
In this notation the single-step Westfall and Young adjusted p-values are
given by
p˜rk(X,Y ) = P (min
i
pri(ZW ) ≤ prk(X,Y )|X,Y ).
It is immediate from the definitions of cα(Z) that, for every k,
{p˜rk(X,Y ) ≤ α} = {prk(X,Y ) ≤ cα(Z)}. (5.1.7)
The event on the left is exactly the event that the kth null hypothesis H0k is
rejected. The event that H0k is rejected for some k in a set K ⊂ {1, 2, . . . ,M}
is the union over k ∈ K of the events of the left and hence
P ( H0k is rejected for some k ∈ K|HC0 , Z)
= P (
⋃
k∈K
{prk(X,Y ) ≤ cα(Z)}|HC0 , Z) (5.1.8)
= P (
⋃
k∈K
{prk(X,Y ) ≤ cα(Z)}|Z)
≤ P (min
i
prk(ZW ) ≤ cα(Z)|Z) ≤ α,
by the definition of cα(Z). In the second equality we use that under H
C
0 and
given Z the vectors (X,Y ) and ZW are equal in distribution. By taking expec-
tation on Z we infer
P ( H0k is rejected for some k ∈ K|HC0 ) ≤ α.
This proves weak control of the FWER of the single-step Westfall and Young
adjusted p-value.
In many situations, including the one considered in the present chapter, the
Westfall and Young correction procedure provides strong control as well. If we
replace the full null hypothesis HC0 in (5.1.8) by the hypothesis H0K that the
null hypotheses (H0k , k ∈ K) are true, then the crucial question is whether
the second equality, in which (X,Y ) is replaced by ZW , is still valid. The other
steps in (5.1.8) go through unchanged. In other words, strong control pertains if
under H0K and given Z the vectors (prk(X,Y ) : k ∈ K) and (prk(ZW ) : k ∈ K)
are equal in distribution.
In our situation the data (X,Y ) can be represented as an (M ×N)-matrix
with the columns representing individuals and the rows SNPs. The p-values prk
for k belonging to some set K refer to a subset of all SNPs and the corresponding
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null hypotheses assert that cases and controls are indistinguishable on SNPs in
this subset. This implies the required equality in distribution of the vectors
(prk(X,Y ) : k ∈ K) and (prk (ZW ) : k ∈ K) given Z. Thus the Westfall and
Young correction provides strong control in our setting.
The single-step Westfall and Young adjusted p-values are by their definition,
larger than the step-down Westfall and Young adjusted p-values. Thus the step-
down Westfall and Young correction is less conservative than the single-step
Westfall and Young correction.
Under the assumption of subset pivotality, the step-down Westfall and Young
gives strong control to the FWER and this property can be proved in more
complex way.
The Benjamini and Hochberg correction gives strong controls FDR at level
α under independence of the p-values (Benjamini and Hochber, 1995).
In the next subsection, we apply multiple testing corrections to single marker
allele-based methods. In this case, missing data are deleted from the analysis.
Then we present the application of double adjacent marker methods.
5.1.1 Single Marker Methods
We applied the single marker allele-based method discussed in subsection 3.2.1
to find markers associated to the disease. The 10 smallest unadjusted p-values
together with the corresponding SNP identies are given in Table 5.2. Table 5.3
presents the unadjusted p-value and adjusted p-value for each multiple testing
correction method. We find only one significant marker at the usual level of
significance for all correction methods, i.e. marker with identity 1510558 in
chromosome 9, except for the Benjamini and Hochberg correction, which yields
two significant markers, i.e. markers with identity 1510558 in chromosome 9
and 1513978 in chromosome 2.
No. Chromosome SNP Identity LR Statistical Value p-value
1 9 1510558 25.9850 3.4407 × 10−7
2 2 1513978 20.2345 6.8505 × 10−6
3 10 1513821 16.7986 4.1565 × 10−5
4 5 1509565 16.2964 5.4168 × 10−5
5 9 1517485 15.1604 9.8755 × 10−5
6 20 1517344 14.8695 1.1521 × 10−4
7 5 1512513 14.4445 1.4435 × 10−4
8 8 1509881 14.3932 1.4834 × 10−4
9 5 1519150 14.3650 1.5058 × 10−4
10 6 1513556 13.9843 1.8434 × 10−4
Table 5.2: Table of the 10 smallest p-values in allele-based methods.
5.1.2 Double Adjacent Marker Methods
We applied the double adjacent marker haplotype-based method of subsection
3.2.4 to find which markers are associated to the disease. Table 5.4 presents
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No. p-value Bonferroni Holm SSWY SDWY BH
1 3.4407× 10−7 0.0039 0.0039 0.0265 0.0265 0.0039
2 6.8505× 10−6 0.0769 0.0769 0.2480 0.2480 0.0385
3 4.1565× 10−5 0.4667 0.4667 0.7185 0.7185 0.1556
4 5.4168× 10−5 0.6083 0.6081 0.7955 0.7955 0.1521
5 9.8755× 10−5 1.0000 1.0000 0.9205 0.9205 0.2218
6 1.1521× 10−4 1.0000 1.0000 0.9405 0.9405 0.2218
7 1.4435× 10−4 1.0000 1.0000 0.9695 0.9695 0.2316
8 1.4834× 10−4 1.0000 1.0000 0.9715 0.9715 0.2316
9 1.5058× 10−4 1.0000 1.0000 0.9720 0.9720 0.2316
10 1.8434× 10−4 1.0000 1.0000 0.9850 0.9850 0.2316
Table 5.3: Table of the 10 smallest unadjusted and adjusted p-values using 5 correction
methods, where SSWY= Single-Step Westfall and Young, SDWY=Step-Down Westfall and
Young, BH=Benjamini-Hochberg.
the 10 smallest p-values together with the corresponding identities. Table 5.5
gives the unadjusted p-values and adjusted p-values for each multiple correction
method. We conclude that with all correction methods, pairs of marker with
identity (1510558, 1510822) and (1508323, 1510558) in chromosome 9 become
significant markers. By using Benjamini and Hochberg correction, the pairs of
markers with identity (1512903, 1510274) in chromosome 7 and (1518782, 1517205)
in chromosome 3 also become significant markers. Thus the double marker
method leads to more significant markers. An increase in signal, due to linkage
disequilibrium in adjacent markers relative to single marker, plays a role in this.
No. Chr. SNP Identity Chr. SNP Identity Stat. Value df p-value
1 9 1510558 9 1510822 31.8903 3 5.5198× 10−7
2 9 1508323 9 1510558 29.8781 3 1.4640× 10−6
3 7 1512903 7 1510274 25.7482 3 1.0768× 10−5
4 3 1518782 3 1517205 25.1542 3 1.4336× 10−5
5 2 1507960 2 1509876 23.7987 3 2.7518× 10−5
6 2 1509876 2 1507485 20.2770 2 3.9528× 10−5
7 1 1516198 1 1508602 23.0111 3 4.0170× 10−5
8 3 1510901 3 1513593 19.8926 2 4.7904× 10−5
9 20 1515199 20 1509681 21.3970 3 8.7068× 10−5
10 4 1512205 4 1519314 21.0958 3 1.4044× 10−4
Table 5.4: Table of the 10 smallest p-values in double adjacent marker method.
5.1.3 Multiple Adjacent Marker Methods
The method described in subsection 3.2.4 can be extended to more than two
markers. The function haplo.em, available in the haplo.stat package in the R
statistical language, can be conveniently used to find the likelihood ratio statis-
tical test and the corresponding degrees of freedom (the number of haplotypes
in case-control sample minus 1). Figure 5.1 shows the quantity -log10(p-value)
for every group of three until six adjacent markers and the Bonferroni correction
threshold (the dotted horizontal line). Using the Bonferroni correction and 3,
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No. p-value Bonferroni Holm SSWY SDWY BH
1 5.5198 × 10−7 0.006 0.006 0.020 0.020 0.006
2 1.4640 × 10−6 0.016 0.016 0.040 0.040 0.008
3 1.0768 × 10−5 0.121 0.121 0.300 0.300 0.040
4 1.4336 × 10−5 0.169 0.161 0.370 0.370 0.040
5 2.7518 × 10−5 0.309 0.309 0.530 0.530 0.062
6 3.9528 × 10−5 0.444 0.444 0.650 0.650 0.074
7 4.0170 × 10−5 0.451 0.451 0.660 0.660 0.064
8 4.7904 × 10−5 0.538 0.538 0.690 0.690 0.067
9 8.7068 × 10−5 0.978 0.978 0.910 0.910 0.109
10 1.4044 × 10−4 1.000 1.000 0.940 0.940 0.113
Table 5.5: Table of the 10 smallest unadjusted and adjusted p-values in double adjacent
marker methods.
4, 5 and 6 adjacent markers, we find 1, 3, 1, 2 significant groups, respectively.
But by using the Benjamini and Hochberg correction and 3, 4, 5 and 6 adjacent
markers, we find 2, 3, 2 and 4 significant groups, respectively. Furthermore,
Figure 5.1 shows that only in the 4 adjacent marker cases, we find 2 significant
groups in different regions.
5.2 Two-Stage Methods
If two or more loci together influence a trait, and their causal effect is determined
through interaction rather than as a sum of effects, then a single marker analysis
may not reveal the loci. In principle we could form all possible pairs of two loci
and apply a case-control test to each pair. In practice in a full genome SNP
study this is impossible, for computational reasons and also because of the very
stringent control for multiple testing that it would necessitate. In this section
we propose a two-stage procedure that tries to select interesting markers in the
first stage and tests pairs of these “interesting” markers in the second. We find
a critical value by a permutation method. This method can be compared to
two-stage methods by Marchinni et al. (2005).
The first stage consists of testing single markers, yielding a p-value for every
marker. We perform allele-based tests in this stage, as explained in subsection
3.2.1. For the second stage we select all markers with first-stage p-value smaller
than a prescribed value α1, and apply the double marker, as explained in section
3.2.4, to every pair of two selected markers. Table 5.6 presents the 10 pairs with
the smallest p-value in the second stage. We used α1 = 0.001 in the first stage,
which lead to the selection of na = 35 SNPs for the second stage.
We now want to adjust the p-values in Table 5.6 for multiple testing and the
two-stage procedure. Denote the double marker p-values by
pr1 ≤ pr2 ≤ . . . ≤ prma ,
where ri is the ith rank and ma = na(na − 1)/2. To estimate the adjusted
p-value, we use this following algorithm :
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Figure 5.1: Plot of the quantity -log10(p-value) by using (a) three adjacent markers, (b)
four adjacent markers, (c) five adjacent markers, and (d) six adjacent markers. The x-axis
gives the SNP number. The dotted horizontal line gives the Bonferroni correction threshold.
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No. Chr. SNP Identity Chr. SNP Identity LR Stat.Value p-value
1 9 1510558 3 1510901 44.8816 9.8049 × 10−10
2 9 1510558 20 1516813 43.1727 2.2617× 10−9
3 9 1510558 11 1508808 42.7811 2.7389× 10−9
4 9 1510558 11 1513457 42.3399 3.3981× 10−9
5 9 1510558 11 1512930 42.3399 3.3981× 10−9
6 9 1510558 2 1513978 41.7104 4.6219× 10−9
7 9 1510558 9 1517485 41.3509 5.5094× 10−9
8 9 1510558 18 1508064 40.4039 8.7486× 10−9
9 2 1513978 5 1512513 39.2932 1.5043× 10−8
10 9 1510558 10 1513821 39.2324 1.5496× 10−8
Table 5.6: Table of the 10 smallest p-values using two-stage methods.
1. Permute the sample labels.
2. Carry out the first stage testing procedure, using the single marker method
and select the markers that have p-value smaller than α1. Suppose there
are nb markers which have that property.
3. Apply the double marker methods to every pair of the nb selected markers
to find a p-value pib for i = 1, 2, . . . ,mb, where
mb = nb(nb − 1)/2
and mb > ma. If mb < ma then we define pi := 1 for
i = nb(nb − 1) + 1, . . . , na(na − 1).
4. Repeat step 1 to step 3 until B times, where B is a big number, and
estimate the single-step Westfall and Young permutation adjusted p-value
by
#{1 ≤ b ≤ B : mini=1,2,...,mb pi ≤ pri}
B
. (5.2.1)
The estimation of the Step-down Westfall and Young permutation adjusted
p-value can be implemented in a similar way. Table 5.7 presents the unad-
justed p-value and adjusted p-value for Single-step and Step-down Westfall
and Young Permutation. We find one pair of significant markers with iden-
tity (1510558, 1510901) for both methods of correction.
5.3 Modeling of p-values distribution
Let pi be the proportion of null hypotheses that are true. Choose at random
one of the null hypotheses from the M hypotheses and consider its p-value. If
the null hypothesis is true, then the corresponding p-value is equivalent to a
uniform [0, 1]-variable. If the null hypothesis is false, then the p-value ought to
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No. p-value Single-step Westfall Young Step-down Westfall Young
1 9.8049 × 10−10 0.0386 0.0386
2 2.2617× 10−9 0.0736 0.0736
3 2.7389× 10−9 0.0840 0.0836
4 3.3981× 10−9 0.0958 0.0952
5 3.3981× 10−9 0.0958 0.0952
6 4.6219× 10−9 0.1202 0.1188
7 5.5094× 10−9 0.1346 0.1322
8 8.7486× 10−9 0.1816 0.1792
9 1.5043× 10−8 0.2534 0.2490
10 1.5496× 10−8 0.2566 0.2512
Table 5.7: Table of the 10 smallest unadjusted p-values and adjusted p-values by using
B = 5000.
have a distribution with density f1 that puts its mass “closer to 0” than the
uniform distribution. Marginally the density of the p-value is
p 7→ pi1[0,1](p) + (1− pi)f1(p).
It is reasonable to assume that f1 is decreasing. Assume that the density in the
preceding display takes the form, for some (λ, c) ∈ (0, 1)2,
g(p|λ, c) = λ+ (1− λ)cpc−1. (5.3.1)
We compare this to the mixture density in the preceding display. If f1(1) > 0
then pi is not identifiable, because f1 can then itself be decomposed as
α1[0,1] + (1− α)f1 − α
1− α ,
where (f1 − α)/(1 − α) is a probability density for every α ∈ [0, f1(1)]. On the
other hand, if we assume f1(1) = 0, then
pi = g(1|λ, c) = λ+ (1− λ)c.
We may estimate (λ, c) from the set p1, p2, . . . , pM of all p-values by maximizing
the (pseudo) likelihood
l = log
M∏
i=1
g(pi) =
M∑
i=1
log
(
λ+ (1− λ)cpc−1i
)
. (5.3.2)
Given the p-value pi the null hypothesis Hi is rejected if pi ≤ τ for some
threshold τ. Again choose an arbitrary hypothesis from the set of hypotheses.
Consider the four events :
A. this null hypothesis is false and rejected (true positive).
B. this null hypothesis is false and not rejected (false negative/type II error).
C. this null hypothesis is true and rejected (false positive/type I error).
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D. this null hypothesis is true and not rejected (true negative).
The probabilities of these events are equal to the areas of regions A, B, C, and
D in Figure 5.2. For instance,
P (A) = P ( Hi is false, pi ≤ τ )
= P ( Hi is false)P ( pi ≤ τ |Hi is false)
= (1− pi)
∫ τ
0
f1(p)dp.
This is the area of region A, the area of A ∪ C being ∫ τ
0
(pi + (1 − pi)f1(p))dp
and the area of C being piτ.
As a measure of overall control of false positives, we define
FDR =
P ( Hi is true, Hi is rejected at threshold τ )
P ( Hi is rejected at threshold τ)
=
P (A)
P (A ∪ C) .
This is related to the “usual” false discovery rate, defined as the expectation of
the fraction of false positives among the positives. If the usual FDR is written
E(V/R), then the present definition is EV/ER. Under the null model (5.3.1)
we have
FDR(τ) =
piτ∫ τ
0 g(p|λ, c)dp
=
piτ
λτ + (1− λ)τ c . (5.3.3)
For some prespecified level of significance α, the equation FDR(τ) = α is solved
for
τ(α) =
( pi − αλ
α(1− λ)
)1/(c−1)
. (5.3.4)
We can replace the parameters pi = λ+ (1− λ)c, λ and c by their estimates to
find an threshold τˆ (α).
We applied the nlm function in the R-language to estimate the parameters
λ and c on the set of p-values resulting from single marker and double adjacent
marker (the likelihood ratio statistic) methods. Figure 5.3 gives the histogram
of the p-values and the estimated density for single marker and double adja-
cent marker methods. Table 5.8 next presents the estimates of the described
quantities. Using the level of singnificance 0.05 and by comparing the p-values
given in Table 5.2 with the estimated threshold τˆ = 2.3283 × 10−7, we find
no significant marker in single marker method. Similarly, by comparing the
p-values given in Table 5.4 with the estimated threshold τˆ = 3.1159 × 10−7,
we find no pair of significant markers in the double adjacent marker method.
However, using the level of singnificance 0.10, we find one significant marker
in the single marker method and one pair of significant markers in the double
adjacent marker method.
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Figure 5.2: Graphical illustration of error-control quantities.
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Figure 5.3: The histogram of p-values and estimated density for the single marker method
((a)) and the double adjacent marker method ((b)).
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Quantity Estimate : Single Marker Estimate : Double Adjacent Marker
λ 0.4818 0.4213
c 0.7709 0.7745
τˆ(α = 0.05) 2.3283 × 10−7 3.1159 × 10−7
PˆA(τˆ ) 3.9659 × 10−6 5.1476 × 10−6
PˆB(τˆ) 0.1187 0.1305
PˆC(τˆ) 2.0519 × 10−7 2.7093 × 10−7
τˆ(α = 0.10) 5.4331 × 10−6 7.5327 × 10−6
PˆA(τˆ ) 4.4663 × 10−5 5.8947 × 10−5
PˆB(τˆ) 0.1187 0.1304
PˆC(τˆ) 4.7882 × 10−6 6.5497 × 10−6
Table 5.8: Table of the estimated quantity using single marker and double adjacent marker
methods.
5.4 Bayesian Model Choice Approach
The Bayesian approach described in subsection 4.1 to formulate the testing
problem as a choice between two models, solved by choosing the model with
the largest posterior probability, requires that prior probabilities are attached
to the two hypotheses. If we want to test many hypotheses, then an uninforma-
tive prior for the models appears not suitable. In this section we describe the
suggestion by Gottardo et al. (2003) to estimate the prior probability from the
data.
As in section 4.1 let Si = 1 express that the i-th null hypothesis is re-
jected (and hence the marker is associated). Given a prior probability t =
P (Si = 1) and the data (X,Y) we can calculate the posterior probability
P (Si = 1|X,Y, t). Suppose that we decide to reject the null hypothesis if this
probability is larger than a given threshold c ∈ (0, 1). Then a fraction
1
M
#(1 ≤ i ≤M : P (Si = 1|X,Y, t) > c)
hypotheses are rejected. This is a monotone function of t, increasing from 0 at
t = 0 to 1 at t = 1. Gottardo et al. (2003) propose to set t equal to a value such
that
1
M
#(1 ≤ i ≤M : P (Si = 1|X,Y, t) > c) = t.
It is not clear that this equation has a solution, apart from the trivial solutions
t = 0 and t = 1. If there is a nontrivial solution, then it is not clear that t
is unique. Gottardo et al. (2003) propose instead to implement the following
algorithm :
1. start with an initial value t(0) (initial guess).
2. while t(s+1) 6= t(s) and t(s) > 0 do
3. d⇐ #{P (Si = 1|X,Y, t) > c : 1 ≤ i ≤M} (number of associated markers
detected)
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4. up-date t(s) to t(s+1) = dM (proportion of associated markers detected)
5. end while,
where M is the number of SNPs. The rationale of the method is not quite clear
to us.
Applied with the allele-based method and the parameters in Dirichlet prior
taken equal to 1, the algorithm yields the numbers of associated markers indi-
cated in Table 5.9, as a function of c. For a reasonable threshold (say, threshold
c ≥ 0.95), we find no associated markers by using both methods.
No. c Single marker allele-based method Double adjacent marker method
1 0.75 1 1
2 0.80 1 0
3 0.85 1 0
4 0.90 0 0
5 0.95 0 0
6 0.99 0 0
Table 5.9: Table of the number of associated markers for a given threshold c by using
allele-based and double adjacent marker methods.
5.5 Bayesian Reference Approach
The Bayesian reference approach of subsection 4.2 can be applied to each SNP in
the whole-genome SNP data. In this approach, a SNP is called associated to the
disease of interest if the intrinsic statistic is larger than 5. As the method claims
to produce a measure of evidence that can be interpreted on an absolute scale,
no correction for multiple testing appears to be necessary. Table 5.10 shows the
markers with the 10 largest intrinsic statistics using allele-based method. Based
on this approach, we find 58 associated markers. Using genotype-based method,
we find 63 associated markers.
No. Chr. SNP Identity Numerical Int. Monte Carlo Int. Asymptotic
1 9 1510558 12.8553 12.9617 14.6070
2 2 1513978 10.4391 9.9493 11.4176
3 5 1509565 8.3696 8.4250 8.8646
4 20 1517344 7.4063 7.4195 8.3907
5 5 1512513 7.3958 7.3954 8.0190
6 5 1519150 7.2441 7.2638 8.0197
7 8 1509881 7.2297 7.2865 8.2360
8 5 1513556 7.1865 7.2248 7.7582
9 3 1510901 7.0512 6.5560 6.9107
10 18 1508064 7.0119 7.0841 7.4324
Table 5.10: Table of the 10 largest intrinsic statistics using allele-based methods.
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5.6 Discussion
We have described how to apply multiple testing correction methods, two-stage
methods, modeling of p-values distribution, a Bayesian model choice approach
and a Bayesian reference approach in the whole-genome SNP data. Multiple
testing correction methods, two-stage methods and modeling of p-values dis-
tribution give only a small number of significant SNPs. A Bayesian reference
approach gives many more significant SNPs. The disease of interest is a com-
plex disease so that many genes involved to the disease of individuals and a
Bayesian reference approach seems a promising method to find which SNPs are
associated to the disease of interest. However, a Bayesian model of choice does
not succeed in this case.
Using recent technology, it is allowed to have highly dense SNP data in the
whole-genome which use hundreds of thousands of SNPs (see e.g., Cheung et
al. (2005), Klein et al. (2005), Franke et al. (2006), and then the multiple
testing correction methods become very conservative while two-stage methods
are very time-consuming. Modeling of p-values distribution and a Bayesian
reference approach can be used as alternative methods because the methods do
not depend on the number of markers in the analysis. However, the assumption
of independence of p-values becomes more unrealistic because of the existence
of linkage disequilibrium in highly dense SNP data. In the future, the Bayesian
reference approach using multiple markers need to be explored.
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Summary
In studies in human genetics we want to answer questions such as: how im-
portant are genetic effects on a phenotype; what kind of action and interaction
exists between gene products in the pathways between genotypes and pheno-
type; are the genetic effects on a phenotype consistent across sexes; do some
genes have particularly outstanding effects when compared to others; what are
the locations of the genes involved in the phenotype of interest ? Twin studies
and association studies as described in this thesis are designed to answer the
first and the last questions in this list.
A twin study is designed to determine genetic and environmental influences
on phenotypes by comparing the similarity of monozygotic (identical) and the
similarity of dizygotic (fraternal) twins. A study designed to test the association
between a phenotype and a specific candidate gene or region in the human
genome is called an association study. This study can use Single Nucleotide
Polymorphisms (SNPs) in the human genome as markers to find which locations
on the chromosomes are associated to the disease. A review of twin studies and
association studies is described in the first chapter.
In the second chapter, we describe statistical modeling in twin studies to
estimate the genetic component of phenotypes of interest. We develop a statis-
tical model for the menarcheal status in girls as a dichotomic trait and estimate
the tetrachoric correlation and the heritability using the Markov Chain Monte
Carlo method implemented in WinBUGS. The model can be extended to poly-
chotomic trait, such as breast development and pubic hair development. We
also propose a model of two traits and the model can be applied to breast-
pubic hair development traits, breast-menarcheal development traits and pubic
hair-menarcheal development traits.
In the third chapter, we describe several methods to analyze whether a
biallelic marker, e.g. a SNP or a set of such markers is associated to a disease
of interest. After presenting the chi-square test, we describe the likelihood ratio
test and the generalized T 2 test. We end with a comparison of the genotypic
mapping, haplotypic mapping and causal mapping in logistic regression.
We describe and apply two Bayesian approaches to analyze association of
biallelic markers to a disease in the fourth chapter. The first approach is based
on a Bayesian model choice, where the two models are a null model, in which
population frequencies of alleles, genotypes or haplotypes are equal for controls
and cases, and an alternative model in which they are different. The second
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approach comes from the objective Bayesian school and attempts to obtain a
measure of evidence in favour or against a null hypothesis by using an informa-
tion criterion and objective priors.
In the fifth chapter we review and apply methods for adjusting p -values, de-
scribe modeling of p-values distribution, propose a two-stage procedure to search
for interactions between SNPs and describe some approaches with a Bayesian
flavour, where we take into account both computational feasibility and statisti-
cal correctness. The described methods are then applied to the whole-genome
SNP data. Multiple testing correction methods, two-stage methods and mod-
eling of p -values distribution give only a small number of significant SNPs. A
Bayesian reference approach gives many more significant SNPs. The disease
of interest is a complex disease so that many genes are involved in the disease
of individuals and a Bayesian reference approach seems a promising method to
find which SNPs are associated to the disease of interest. However, a Bayesian
model of choice does not succeed in this case. Using recent technology, it is
allowed to have highly dense SNP data in the whole-genome which use hun-
dreds of thousands of SNPs, and then the multiple testing correction methods
become very conservative while two-stage methods are very time-consuming.
Modeling of p -values distribution and a Bayesian reference approach can be
used as alternative methods because the methods do not depend on the number
of markers in the analysis. However, the assumption of independence of p-values
becomes more unrealistic because of the existence of linkage disequilibrium in
highly dense SNP data. In the future, the Bayesian reference approach using
multiple markers needs to be explored.
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Samenvatting
Statistische analyse van genetische data
in tweeling onderzoek en associatie onderzoek
Hoe belangrijk zijn genetische effecten op een fenotype? Waar zijn genen
gelokaliseerd die betrokken zijn bij een bepaald fenotype? Wat voor soort acties
en interacties bestaan er tussen genen? Zijn de genetische effecten op een feno-
type constistent tussen geslachten? Bestaan er genen die opvallende effecten
hebben, vergeleken met andere? Het beantwoorden van dit soort vragen is het
doel van menselijke genetica studies. Voor het beantwoorden van de eerste
twee vragen zijn tweelingonderzoek en associatie onderzoek ontwikkeld, zoals
beschreven in dit proefschrift.
Tweelingonderzoek is ontwikkeld om genetische en omgevings-invloeden op
fenotypes te bepalen, door het vergelijken van overeenkomsten bij monozygo-
tische (een-ei¨ıge) tweelingen en overeenkomsten bij dizygotische (twee-ei¨ıge)
tweelingen. Een onderzoek ontwikkeld om de associatie te testen tussen een
fenotype en een specifiek kandidaat-gen of een kandidaat-regio in het menselijk
genoom, wordt associatie onderzoek genoemd. Dit soort onderzoek kan gebruik
maken van Single Nucleotide Polymorphisms (SNP’s) in het menselijk genoom
als indicatoren voor het vinden van lokaties op de chromosomen die betrokken
zijn bij de ziekte. Een overzicht van tweelingonderzoek en associatie onderzoek
is beschreven in het eerste hoofdstuk.
In het tweede hoofdstuk, beschrijven we de statistische modellering in tweelin-
gonderzoek om de genetische component van bepaalde fenotypes te testen. We
ontwikkelen een statistisch model voor menstruatie bij meisjes als een dichotome
eigenschap en schatten de tetrachorische correlatie en de erfelijkheid door ge-
bruik te maken van de Markov Chain Monte Carlo methode die ge¨ımplementeerd
is in WinBUGS. Het model kan worden uitgebreid naar polychotome eigenschap-
pen, zoals borst ontwikkeling en schaamhaar ontwikkeling. We suggereren ook
een model voor de gezamenlijke studie van twee eigenschappen, dat kan wor-
den toegepast op bijvoorbeeld bort-schaamhaar ontwikkeling, borst-menstruatie
ontwikkeling en schaamhaar-menstruatie ontwikkeling.
In het derde hoofdstuk beschrijven we verschillende methodes om te analyseren
of een biallelische indicator, bijvoorbeeld een SNP, of een verzameling van zulke
indicatoren, betrokken is bij de bepaalde ziekte. Na het presenteren van de chi-
kwadraat toets, beschrijven we de aannemelijkheidsquotie¨nt toets en de gegen-
eraliseerde T 2 toets. We eindigen met een vergelijking van de genotypische
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afbeelding, de haplotypische afbeelding en de causale afbeelding in logistische
regressie.
We beschijven twee Bayesiaanse benaderingen voor het analyseren van de
associatie tussen biallelische indicatoren en een ziekte in het vierde hoofdstuk,
en passen ze toe op een data-voorbeeld. De eerste benadering is gebaseerd op
Bayesiaanse modelkeuze, waarbij de twee modellen een nul-model zijn waarin
populatie frequenties van allelen, genotypes of haplotypes gelijk zijn voor con-
troles en gevallen, en een alternatief model waarin zij verschillen. De tweede
benadering is afkomstig van de objectieve Bayesiaanse school en probeert een
maat te vinden voor bewijsmateriaal voor of tegen de nul-hypothese, door ge-
bruik te maken van een informatie criterium en een objectieve prior.
In het vijfde hoofdstuk passen we methodes toe voor het aanpassen van p -
waarden, beschrijven we het modelleren van een p -waarden verdeling, stellen
we een twee-stappen procedure voor om interacties te vinden tussen SNP’s,
en beschrijven we enkele aanpakken met Bayesiaanse trekken, waarbij we zowel
rekening houden met rekenkundige uitvoerbaarheid als met statistische correctheid.
De beschreven methoden worden vervolgens toegepast op de volledige genoom
SNP gegevens. Meervoudige test correctie methodes, twee-stappen methodes
en het modelleren van een p -waarden verdeling, geven slechts een klein aantal
significante SNP’s. Een Bayesiaanse referentie aanpak levert veel meer signif-
icante SNP’s. De te onderzoeken ziekte is complex in de zin dat veel genen
betrokken zijn bij de ziekte van individuen en een Bayesianse referentie aanpak
lijkt een veelbelovende methode voor het vinden van SNP’s die gerelateerd zijn
aan de te onderzoeken ziekte. Een Bayesiaanse modelkeuze slaagt echter niet in
dit geval. Gebruikmakend van recente technologie, is het mogeijk SNP gegevens
te verzamelen met een zeer hoge dichtheid in het volledige genoom, bestaande
uit honderdduizenden SNP’s, maar meervoudige test correctie methodes worden
dan zeer behoudend, terwijl twee-stappen methodes erg tijd verslindend wor-
den. Het modelleren van een pwaarden verdeling en een Bayesiaanse referentie
aanpak kunnen worden gebruikt als alternatieve methodes, omdat de methodes
niet afhangen van het aantal idicatoren in de analyse. Echter, de aanname van
onafhankelijkheid van de p -waarden wordt onrealistischer door het bestaan van
’linkage disequilibrium’ in SNP gegevens met een hoge dichtheid. In de toekomst
dient de Bayesiaanse referentie aanpak met meervoudige indicatoren te worden
onderzocht.
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